
<html lang="en"     class="pb-page"  data-request-id="05bacedd-0567-40b5-ac1f-f966a646c991"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2014.57.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm5010539;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor" /></meta><meta name="dc.Creator" content="Romain  Gosmini" /></meta><meta name="dc.Creator" content="Van Loc  Nguyen" /></meta><meta name="dc.Creator" content="Jérôme  Toum" /></meta><meta name="dc.Creator" content="Christophe  Simon" /></meta><meta name="dc.Creator" content="Jean-Marie G.  Brusq" /></meta><meta name="dc.Creator" content="Gael  Krysa" /></meta><meta name="dc.Creator" content="Olivier  Mirguet" /></meta><meta name="dc.Creator" content="Alizon M.  Riou-Eymard" /></meta><meta name="dc.Creator" content="Eric V.  Boursier" /></meta><meta name="dc.Creator" content="Lionel  Trottet" /></meta><meta name="dc.Creator" content="Paul  Bamborough" /></meta><meta name="dc.Creator" content="Hugh  Clark" /></meta><meta name="dc.Creator" content="Chun-wa  Chung" /></meta><meta name="dc.Creator" content="Leanne  Cutler" /></meta><meta name="dc.Creator" content="Emmanuel H.  Demont" /></meta><meta name="dc.Creator" content="Rejbinder  Kaur" /></meta><meta name="dc.Creator" content="Antonia J.  Lewis" /></meta><meta name="dc.Creator" content="Mark B.  Schilling" /></meta><meta name="dc.Creator" content="Peter E.  Soden" /></meta><meta name="dc.Creator" content="Simon  Taylor" /></meta><meta name="dc.Creator" content="Ann L.  Walker" /></meta><meta name="dc.Creator" content="Matthew D.  Walker" /></meta><meta name="dc.Creator" content="Rab K.  Prinjha" /></meta><meta name="dc.Creator" content="Edwige  Nicodème" /></meta><meta name="dc.Description" content="Through their function as epigenetic readers of the histone code, the BET family of bromodomain-containing proteins regulate expression of multiple genes of therapeutic relevance, including those i..." /></meta><meta name="Description" content="Through their function as epigenetic readers of the histone code, the BET family of bromodomain-containing proteins regulate expression of multiple genes of therapeutic relevance, including those i..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 24, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5010539" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5010539" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5010539" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5010539" /></link>
        
    
    

<title>The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5010539" /></meta><meta property="og:title" content="The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0021.jpeg" /></meta><meta property="og:description" content="Through their function as epigenetic readers of the histone code, the BET family of bromodomain-containing proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation. BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncology and inflammation models, and the first compounds have now progressed into clinical trials. The exciting biology of the BETs has led to great interest in the discovery of novel inhibitor classes. Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compounds active in murine models of septic shock and neuroblastoma. At the molecular level, these effects are produced by inhibition of BET bromodomains. X-ray crystallography reveals the interactions explaining the structure–activity relationships of binding. The resulting lead molecule, I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5010539"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5010539">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5010539&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5010539&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5010539&amp;href=/doi/10.1021/jm5010539" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8111-8131</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5010495" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5012098" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romain++Gosmini">Romain Gosmini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Van+Loc++Nguyen">Van Loc Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%A9r%C3%B4me++Toum">Jérôme Toum</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Simon">Christophe Simon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Marie+G.++Brusq">Jean-Marie G. Brusq</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gael++Krysa">Gael Krysa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Mirguet">Olivier Mirguet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alizon+M.++Riou-Eymard">Alizon M. Riou-Eymard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+V.++Boursier">Eric V. Boursier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lionel++Trottet">Lionel Trottet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bamborough">Paul Bamborough</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hugh++Clark">Hugh Clark</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chun-wa++Chung">Chun-wa Chung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leanne++Cutler">Leanne Cutler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuel+H.++Demont">Emmanuel H. Demont</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rejbinder++Kaur">Rejbinder Kaur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonia+J.++Lewis">Antonia J. Lewis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+B.++Schilling">Mark B. Schilling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+E.++Soden">Peter E. Soden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Taylor">Simon Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann+L.++Walker">Ann L. Walker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+D.++Walker">Matthew D. Walker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rab+K.++Prinjha">Rab K. Prinjha</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edwige++Nicod%C3%A8me">Edwige Nicodème</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Candidate Discovery, <sup>‡</sup>Discovery Biology, <sup>§</sup>DMPK, GlaxoSmithKline Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline R&D, 25 Avenue du Québec, 91140 Villebon-sur-Yvette, France</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>∥</sup>Epinova Discovery Performance Unit, <sup>⊥</sup>Computational & Structural Chemistry, <sup>#</sup>Experimental Medicine Unit, <sup>∇</sup>Biological Sciences, <sup>○</sup>Exploratory Development Sciences, <sup>◆</sup>Discovery Partnerships Medicinal Chemistry, GlaxoSmithKline Stevenage, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div><div class="corresp-info"><strong>*</strong>For P.B.: phone, +44 (0)20 8047 5000; fax, +44 1438 764486; E-mail, <a href="/cdn-cgi/l/email-protection#99e9f8ecf5b7f8b7fbf8f4fbf6ebf6ecfef1d9feeaf2b7faf6f4"><span class="__cf_email__" data-cfemail="cabaabbfa6e4abe4a8aba7a8a5b8a5bfada28aadb9a1e4a9a5a7">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For R.K.P. (requests for material, research collaboration, etc.): phone, +44 1438 764303; E-mail: <a href="/cdn-cgi/l/email-protection#4a382b2823242e2f38643a38232420222b0a2d392164292527"><span class="__cf_email__" data-cfemail="9eecfffcf7f0fafbecb0eeecf7f0f4f6ffdef9edf5b0fdf1f3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5010539&amp;href=/doi/10.1021%2Fjm5010539" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8111–8131</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 July 2014</li><li><span class="item_label"><b>Published</b> online</span>24 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 October 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5010539" title="DOI URL">https://doi.org/10.1021/jm5010539</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8111%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRomain%2BGosmini%252C%2BVan%2BLoc%2BNguyen%252C%2BJ%25C3%25A9r%25C3%25B4me%2BToum%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D19%26contentID%3Djm5010539%26title%3DThe%2BDiscovery%2Bof%2BI-BET726%2B%2528GSK1324726A%2529%252C%2Ba%2BPotent%2BTetrahydroquinoline%2BApoA1%2BUp-Regulator%2Band%2BSelective%2BBET%2BBromodomain%2BInhibitor%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8131%26publicationDate%3DOctober%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5010539"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4535</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">113</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5010539" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Romain&quot;,&quot;last_name&quot;:&quot;Gosmini&quot;},{&quot;first_name&quot;:&quot;Van&quot;,&quot;last_name&quot;:&quot;Loc Nguyen&quot;},{&quot;first_name&quot;:&quot;Jérôme&quot;,&quot;last_name&quot;:&quot;Toum&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Simon&quot;},{&quot;first_name&quot;:&quot;Jean-Marie&quot;,&quot;last_name&quot;:&quot;G. Brusq&quot;},{&quot;first_name&quot;:&quot;Gael&quot;,&quot;last_name&quot;:&quot;Krysa&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Mirguet&quot;},{&quot;first_name&quot;:&quot;Alizon&quot;,&quot;last_name&quot;:&quot;M. Riou-Eymard&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;V. Boursier&quot;},{&quot;first_name&quot;:&quot;Lionel&quot;,&quot;last_name&quot;:&quot;Trottet&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bamborough&quot;},{&quot;first_name&quot;:&quot;Hugh&quot;,&quot;last_name&quot;:&quot;Clark&quot;},{&quot;first_name&quot;:&quot;Chun-wa&quot;,&quot;last_name&quot;:&quot;Chung&quot;},{&quot;first_name&quot;:&quot;Leanne&quot;,&quot;last_name&quot;:&quot;Cutler&quot;},{&quot;first_name&quot;:&quot;Emmanuel&quot;,&quot;last_name&quot;:&quot;H. Demont&quot;},{&quot;first_name&quot;:&quot;Rejbinder&quot;,&quot;last_name&quot;:&quot;Kaur&quot;},{&quot;first_name&quot;:&quot;Antonia&quot;,&quot;last_name&quot;:&quot;J. Lewis&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;B. Schilling&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;E. Soden&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;L. Walker&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;D. Walker&quot;},{&quot;first_name&quot;:&quot;Rab&quot;,&quot;last_name&quot;:&quot;K. Prinjha&quot;},{&quot;first_name&quot;:&quot;Edwige&quot;,&quot;last_name&quot;:&quot;Nicodème&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;8111-8131&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5010539&quot;},&quot;abstract&quot;:&quot;Through their function as epigenetic readers of the histone code, the BET family of bromodomain-containing proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation. BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncology and inflammation models, and the first compounds have now progressed into clinical trials. The exciting biology of the BETs has led to great interest in the discovery of novel inhibitor classes. Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compounds active in murine models of septic shock and neuroblastoma. At the molecular level, these effects are produced by inhibition of BET bromodomains. X-ray crystallography reveals the interactions explaining the structure–activity relationships of binding. The resulting lead molecule, I-BET726, rep&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5010539&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010539" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5010539&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010539" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5010539&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010539" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5010539&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010539&amp;href=/doi/10.1021/jm5010539" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5010539" /></input><a href="/doi/pdf/10.1021/jm5010539" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5010539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5010539%26sid%3Dliteratum%253Aachs%26pmid%3D25249180%26genre%3Darticle%26aulast%3DGosmini%26date%3D2014%26atitle%3DThe%2BDiscovery%2Bof%2BI-BET726%2B%2528GSK1324726A%2529%252C%2Ba%2BPotent%2BTetrahydroquinoline%2BApoA1%2BUp-Regulator%2Band%2BSelective%2BBET%2BBromodomain%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D19%26spage%3D8111%26epage%3D8131%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jmcmar.2014.57.issue-19/20141009/jmcmar.2014.57.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Through their function as epigenetic readers of the histone code, the BET family of bromodomain-containing proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation. BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncology and inflammation models, and the first compounds have now progressed into clinical trials. The exciting biology of the BETs has led to great interest in the discovery of novel inhibitor classes. Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compounds active in murine models of septic shock and neuroblastoma. At the molecular level, these effects are produced by inhibition of BET bromodomains. X-ray crystallography reveals the interactions explaining the structure–activity relationships of binding. The resulting lead molecule, I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Atherosclerosis is a significant cause of mortality, and although currently treated by lipid-modifying drugs such as statins, a need remains for novel treatments. Decreased risk of atherosclerosis is associated with higher levels of high density lipoprotein (HDL) cholesterol. The apolipoprotein A1 protein (ApoA1) is a major component of HDL, and its overexpression is correlated with increased HDL cholesterol levels.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> ApoA1 up-regulation therefore offers a novel alternative to existing treatments for atherosclerosis, although until quite recently no molecular mechanism to bring that about was known.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">We recently reported the use of a cellular reporter assay to discover novel ApoA1 up-regulators, such as the benzodiazepine (BZD) compounds exemplified by <b>1</b> (GSK525762A/I-BET762, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which is currently in clinical development.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> These were shown via chemoproteomics and other approaches to bind to the tandem bromodomains of the bromodomain and extra terminal domain (BET) family proteins and also have potent anti-inflammatory activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The four members of this family, BRD2, BRD3, and BRD4 (together with BRDT, whose expression is restricted to testis and ovary), activate transcription via recognition of the acetylated lysine state of histone tails and other proteins and recruitment of polymerases and transcription factors.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Each BET protein contains two bromodomains, modules which specifically recognize the acetylated state of their partners, including the histone protein tails whose acetylation forms part of the histone code of epigenetic gene regulation. Small molecule inhibitors of bromodomain binding to histones have emerged over recent years and are now of great current interest for wide-ranging applications including atherosclerosis, inflammation, and oncology.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some examples of BET bromodomain inhibitors, <b>1</b>–<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A thienotriazolodiazepine with structural similarity to <b>1</b>, discovered by a group at Mitsubishi Tanabe as an inhibitor of CD28-dependent T-cell growth and inflammation, was also found to target the BET bromodomains.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> An exemplar of this chemotype, <b>2</b> (JQ1), has been released to the worldwide academic community by the Chemical Probe Consortium.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This molecule shows strong effects in a range of cancer cell types. For example, NUT midline carcinoma (NMC) is an aggressive tumor in which the BRD4–NUT fusion oncoprotein prevents normal cell differentiation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Treatment of NMC cell lines with <b>2</b> halted proliferation and restored normal differentiation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>2</b> and other BET inhibitors also show effects in models of hematologic cancers (including acute myeloid leukemia, Burkitt’s lymphoma, MLL-fusion leukemia, multiple myeloma, and B-cell lymphoblastic leukemia) and neuroblastoma.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23">(19-23)</a></div><div class="NLM_p">Other classes of BET bromodomain inhibitors have been reported. We recently described an unrelated series of quinoline isoxazole ApoA1 up-regulators (e.g., <b>3</b>, I-BET151), which also exert their effects through binding to the BET bromodomains.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a><b>3</b> has been investigated for indications including acute leukemia, including MLL-related acute myeloid leukemia, and JAK2-driven myeloproliferative neoplasms.<a onclick="showRef(event, 'ref20 ref26'); return false;" href="javascript:void(0);" class="ref ref20 ref26">(20, 26)</a> Compound <b>4</b> (RVX-208) was also discovered as an ApoA1 up-regulator and has entered clinical trials for atherosclerosis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It has since been found that its molecular binding partners include the BET tandem bromodomains.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">Beyond cell-based screening, the BET bromodomains are highly tractable to structure-based and fragment-based drug discovery, taking advantage of increasing understanding of the molecular architecture and binding preferences of the acetyl-lysine site.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Examples of molecules developed from fragments binding in the AcK site and growing outward to exploit additional binding interactions include the tetrahydroquinazolinone <b>5</b> (PFI-1), isoxazoles such as <b>6</b> and <b>7</b>, and compounds incorporating elements of these such as <b>8</b>.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35">(30-35)</a> In this manuscript we describe the discovery of a new series of tetrahydroquinoline-based ApoA1 up-regulators that function through BET inhibition and their optimization to a potent and selective compound active in models of acute inflammation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Molecular Targets of the Tetrahydroquinolines</h3><div class="NLM_p last">Throughout the optimization work reported here, the molecular mode of action of the tetrahydroquinolines was unknown. In due course, we discovered that other families of ApoA1 up-regulators operate by specific, histone-competitive binding to the BET family of bromodomain-containing proteins.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> We therefore screened representative compounds from the tetrahydroquinoline series in a fluorescence anisotropy (FA) binding assay by measuring the displacement of a ligand from the acetyl-lysine site of recombinant BET bromodomains. As with previously published series of BET inhibitors, BET binding and ApoA1 reporter activation correlate reasonably well, although this is limited by the tight binding limit of the FA assay and factors such as cell permeability.<a onclick="showRef(event, 'ref4 ref25'); return false;" href="javascript:void(0);" class="ref ref4 ref25">(4, 25)</a> In this article, we show the ApoA1 reporter activation data, which was used to make the decisions that drove lead optimization, alongside the BET bromodomain activity which was gathered later. The <a class="ref internalNav" href="#sec2" aria-label="Results and Discussion">Results and Discussion</a> section concludes with X-ray structures showing the binding modes of representative molecules in BRD2 and BRD4, which will be used to rationalize the structure–activity relationships found.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Identification of Tetrahydroquinolines as ApoA1 Up-Regulators</h3><div class="NLM_p">Tetrahydroquinoline <b>9</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was identified from the output of a high-throughput screening campaign as an up-regulator of ApoA1 in the HepG2 cell luciferase reporter assay. At 10 μM, <b>9</b> increased luciferase luminescence by 2.2–3.3-fold after 16 h. Because of this promising level of activity, this compound and analogues, which were originally purchased from a commercial vendor as mixtures of undefined stereochemistry, were investigated further. The <i>para</i>-methyl analogue was prepared (see Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, <a class="ref internalNav" href="#sec2_5" aria-label="Synthetic Chemistry">Synthetic Chemistry</a>) and separated into its <i>cis</i> and <i>trans</i> stereoisomers <b>10</b> and <b>11</b>. The ApoA1 activation ability of the <i>cis</i> isomer <b>10</b> was similar to <b>9</b>, but its <i>trans</i> isomer <b>11</b> was inactive (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The <i>cis</i> isomer of <b>9</b> was also synthesized, giving <b>12</b>, which retained ApoA1 activity. These results strongly suggested that the activity resided in the <i>cis</i> stereochemistry.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. ApoA1 Luciferase Activation (Fold) of Initial Hits and Analogues after 16 h in HepG2 Cells</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">ApoA1 reporter activation</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">relative stereochemistry<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">1.25 μM</th><th class="colsep0 rowsep0" align="center">10 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">mixture</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">2.3–3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><i>cis</i></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><i>cis</i></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1.7–2.0</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">mixture</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">1.4–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">mixture</td><td class="colsep0 rowsep0" align="left">Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">≤1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">mixture</td><td class="colsep0 rowsep0" align="left">Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">≤1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All compounds are racemates. “Mixture” indicates a mixture of diastereoisomers.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Initial Exploration at the N1 Position</h3><div class="NLM_p last">To understand the effects of modifications at the acetamide position, analogues were first sought within the GSK compound collection. Like <b>9</b>, compounds <b>13</b>–<b>15</b> originated from a commercial supplier. The propionamide analogue <b>13</b> retained levels of ApoA1 activity comparable to those of the acetamide <b>9</b>, but the butyramide and pentanamide analogues <b>14</b> and <b>15</b> were inactive. This suggested that further modification of this position was unlikely to be productive. However, the knowledge that SAR existed in modifications at the N1 position as well as in the stereochemistry of the tetrahydroquinolinone core led us to investigate some of the other positions of this template.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Optimization of the 6-Position</h3><div class="NLM_p">The key 6-bromo tetrahydroquinoline intermediate <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>56</b>) was used to prepare an initial set of aryl substituted racemic <i>cis</i>-stereochemistry analogues through Suzuki chemistry (see Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <a class="ref internalNav" href="#sec2_5" aria-label="Synthetic Chemistry">Synthetic Chemistry</a>). The choice of this substituent position was inspired by a pharmacophore model involving the overlay of THQs such as <b>10</b> with members of another series of ApoA1 up-regulators, which will be reported in due course. Introduction of the unsubstituted phenyl ring at the 6-position (R<sub>6</sub> = H, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) yielded <b>16</b>, which was found to be a highly potent ApoA1 activator. This encouraged us to make additional substituted analogues. Para substitution of the 6-phenyl ring was well tolerated (<b>17</b>–<b>22</b>), with polar groups offering some improvement both in activity and solubility. The ring was particularly tolerant of highly polar functionality, for example the carboxylic acid (<b>19</b>). Interestingly, the acid substituent at this position did not negatively impact the cellular activity of the molecule (compare the acid <b>19</b> to its methyl ester <b>18</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Mean Potency (ApoA1 Luciferase and BET FA) and Solubility of <b>16–29</b> (* Denotes Single Enantiomer, Otherwise Racemic Mixtures with <i>cis</i> Stereochemistry)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0015.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Table S1">Supporting Information, Table S1</a>, for standard deviations and other notes.</p></div></div><div></div></div><div class="NLM_p">Because of the tolerance of charged functionality on this ring, a range of sizable substituents with varying degrees of basicity (morpholine, piperazine, and piperidine) were prepared, for example <b>23</b>–<b>25</b>. These substituents were very well tolerated at both 3- and 4- positions of the 6-phenyl ring, giving enhanced solubility and similar small improvements in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Because of the excellent activity of the piperidine <b>25</b>, it was subjected to chiral separation to yield a pair of enantiomers, compounds <b>28</b> and <b>29</b>. Almost all of the ApoA1 reporter activity resided in one enantiomer, <b>28</b>. Although no sample of the racemate (<b>25</b>) remained for testing by the time the bromodomain assays were developed, the relative activity of the pair of separated enantiomers in the BET assays mirrored that in the ApoA1 reporter assay. The absolute stereochemistry of the active enantiomer was later shown by X-ray crystallography to be the (2<i>S</i>,4<i>R</i>) stereoisomer.</div><div class="NLM_p">Two intermediates (<b>26</b> and <b>27</b>) prepared en route to <b>25</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, <a class="ref internalNav" href="#sec2_5" aria-label="Synthetic Chemistry">Synthetic Chemistry</a>) were tested to determine the effect of removing the THQ 4-position aryl substituent. Both were very much weaker in the ApoA1 and BET assays than <b>25</b> or its active enantiomer <b>28</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), showing the importance of the 4-anilino substituent for maintaining potency.</div><div class="NLM_p">Additional properties of <b>28</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Its solubility was good and in vitro clearance in hepatocytes from three species was low, giving grounds for optimism that the series would have good pharmacokinetic properties. Compound <b>28</b> was potent in an alternative BET bromodomain TR-FRET assay measuring displacement of a labeled histone tail peptide. Furthermore, it showed potent anti-inflammatory activity in vitro, as measured by inhibition of the pro-inflammatory cytokine IL6 in LPS-stimulated peripheral blood mononuclear cells (PBMCs) and human whole blood (HWB). However, moderate inhibition of multiple cytochrome P450 isoforms was also found. Because P450 enzymes are involved in the oxidative metabolism of statins, which are widely used for treatment of atherosclerosis, an additional consideration was to minimize any risk of drug–drug interactions by reducing the P450 inhibition of compounds which might be coadministered.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Some Properties of Compound <b>28</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0017.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>28</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peptide-based FRET (pIC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">BRD4</td><td class="colsep0 rowsep0" align="center">6.7 ± 0.03 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LPS-stimulated IL6 pIC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">PBMC</td><td class="colsep0 rowsep0" align="center">8.5 ± 0.2 (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HWB</td><td class="colsep0 rowsep0" align="center">7.2 ± 0.6 (670)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FASSIF solubility</td><td class="colsep0 rowsep0" align="left">μg/mL</td><td class="colsep0 rowsep0" align="center">125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte clearance (mL/min/g tissue)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="center">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="center">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">primate<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P450 profile IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">1A2 (ER)</td><td class="colsep0 rowsep0" align="center">>33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C9 (FCA)</td><td class="colsep0 rowsep0" align="center">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C19 (BMC)</td><td class="colsep0 rowsep0" align="center">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2D6 (MMMC)</td><td class="colsep0 rowsep0" align="center">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4 (7BQ)</td><td class="colsep0 rowsep0" align="center">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4 (DEF)</td><td class="colsep0 rowsep0" align="center">2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">This compound was used as a standard in the HWB assay: the mean pIC<sub>50</sub> excludes 3 occasions when fitted values could not be obtained.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Cynomolgous monkey.</p></div></div></div><div class="NLM_p">Our next step was to explore greater diversity at the THQ 4-position. On the basis of the results described above for compounds <b>18</b>–<b>19</b>, it was decided to do this first in compounds substituted at the THQ 6-position by <i>p</i>-CO<sub>2</sub>H phenyl and <i>p</i>-CO<sub>2</sub>Me phenyl. Para substitution of the THQ 4-anilino ring was well tolerated (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), with even quite sterically bulky groups such as <i>t</i>-butyl retaining acceptable activity (<b>30</b>). Introduction of groups of similar size but greater polarity such as the methyl sulfone (<b>31</b>, <b>32</b>) led to some loss of ApoA1 potency. Because the BET activity of <b>32</b> was comparable to the equivalent tertiary butyl <b>30</b>, it seems likely that the polarity of <b>32</b> negatively impacts its cell permeability. However, the greatest ApoA1 activity was obtained with simple 4-methyl, 4-chloro, or 4-fluoro substituents (<b>33</b>–<b>35</b>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mean Potency of <b>30</b>–<b>47</b> in ApoA1 Reporter and BET Bromodomain Assays (*Denotes Single Enantiomer, Otherwise Racemic Mixtures with <i>cis</i> Stereochemistry)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0018.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0019.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Table S2">Supporting Information Table S2</a> for standard deviation.</p></div></div><div></div></div><div class="NLM_p">Ortho and meta substitution of the 4-anilino ring was also well tolerated. For example, the 2-OMe analogue (<b>39</b>) was comparable to the 3-OMe analogue <b>38</b>.</div><div class="NLM_p">To summarize the above results, the THQ 4-position phenyl ring showed only small substituent effects on BET activity, although more significant differences were seen in cellular ApoA1 up-regulation. Compounds with the 4-chlorophenyl aniline at the THQ 4-position (such as <b>34</b>) seemed to offer the best combination of properties and potency. Incorporating this feature, the 6-position was then revisited to explore more diversely substituted phenyls.</div><div class="NLM_p">Combining the piperidine-containing 6-aryl group of <b>25</b> with the chlorophenyl aniline 4-position of <b>34</b> led to <b>40</b>, a molecule which, although potent, did not afford an advantage over <b>25</b> or <b>34</b>. Moving the acid group of <b>34</b> from the para to the meta position of the 6-aryl substitient, or replacing it with an ester at the meta position, was slightly detrimental (<b>41</b>, <b>42</b>). Replacement of the acid by a primary carboxamide (<b>43</b>) had little effect. Other positions were rather more sensitive to change, however. For instance, the addition of a small methyl substituent at the ortho position of the THQ 6-phenyl substituent led to a marked reduction of ApoA1 activity (<b>44</b>), an observation that was also found later in the BET binding assay.</div><div class="NLM_p">The THQ 2-methyl group was suspected to be important for activity because of the preference for <b>28</b> over its enantiomer <b>29</b>. To further assess its significance, an analogue of <b>21</b> lacking the 2-methyl substituent (<b>45</b>) was prepared and tested. This was weaker than <b>21</b> in all assays, confirming that the THQ 2-position methyl substituent does play a role in both ApoA1 induction and BET binding.</div><div class="NLM_p last">After this exploration, the most promising compounds were <b>33</b> and <b>34</b>, which showed potency comparable to that of <b>25</b>. Pure enantiomers of these two compounds (<b>46</b>, <b>47</b>) were prepared according to Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, <a class="ref internalNav" href="#sec2_5" aria-label="Synthetic Chemistry">Synthetic Chemistry</a>. These molecules had very similar properties, so <b>47</b> (GSK1324726A, I-BET726) was chosen as our leading molecule from this series.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthetic Chemistry</h3><div class="NLM_p">Compounds <b>9</b> and <b>13</b>–<b>15</b> were purchased. All others were synthesized using the general routes shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch6" aria-label="6">6</a>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Compounds <b>10</b>–<b>12</b> were prepared according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Aniline was condensed with crotonic acid, giving the Michael addition adduct, which was then cyclized to 2-methyl-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>50</b>) by heating in polyphosphoric acid (PPA) at 110 °C. Following acetylation under standard conditions, reductive amination in the presence of 4-methylaniline and titanium tetrachloride followed by reduction with sodium borohydride gave compounds <b>10</b> and <b>11</b> as a mixture of <i>cis</i>- and <i>trans</i>-diastereoisomers. The two isomers were easily separated by flash chromatography.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Tetrahydroquinoline Compounds <b>10</b>–<b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, reflux, 43%; (b) PPA, 110 °C, 29%; (c) AcCl, DMAP, 0 °C to RT, 86%; (d) 4-methylaniline, TiCl<sub>4</sub>, TEA, THF/DCM, 0 °C to RT then NaBH<sub>4</sub>, RT, 15%.</p></p></figure><div class="NLM_p">Compounds <b>16</b>–<b>22</b>, <b>36</b>, <b>37</b>, <b>41</b>, <b>42</b>, and <b>44</b> were synthesized according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 4-Bromoaniline was reacted with acetaldehyde in the presence of benzotriazole in toluene at room temperature. <i>N</i>-(1-(1<i>H</i>-Benzo[<i>d</i>][1,2,3]triazol-1-yl)ethyl)-4-bromoaniline (<b>52</b>) was obtained in modest yield. Reaction with <i>N</i>-vinyl formamide in the presence of a Lewis acid such as BF<sub>3</sub>·Et<sub>2</sub>O in dry THF gave the hetero-Diels–Alder adduct <b>53</b> as a racemic <i>cis</i>-mixture. The tetrahydroquinoline nitrogen atom was then substituted with an acyl chloride in the presence of pyridine, giving <b>54</b>. The formamide was deprotected using 6 N HCl in refluxing methanol to afford <b>55</b>, which reacted with phenylboronic acid under Chan–Lam–Evans conditions. Finally, R<sub>6</sub> was introduced using Suzuki coupling. Tetrahydroquinoline compounds could also be obtained from <b>54</b> using the same reagents and conditions in a different order, beginning with the installation of the R<sub>6</sub> substituent, as depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Synthesis of Tetrahydroquinoline Compounds <b>16</b>–<b>22</b>, <b>36</b>–<b>37</b>, <b>41</b>–<b>42</b>, and <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeCHO, toluene, RT, 82%; (b) <i>N</i>-vinylformamide, BF<sub>3</sub>·Et<sub>2</sub>O, THF, −5 °C, 56%; (c) MeCOCl, DCM, pyridine, 0 °C, 100%; (d) MeOH, 6 N HCl, reflux, 91%; (e) PhB(OH)<sub>2</sub>, Cu(OAc)<sub>2</sub>, TEA, DCM, RT; (f) R<sub>6</sub>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Alternative Synthesis of Tetrahydroquinoline Compounds, e.g., <b>30</b>–<b>35</b>, <b>38</b>–<b>39</b>, and <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>6</sub>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux; (b) MeOH, 6 N HCl, reflux; (c) R<sub>6</sub>PhB(OH)<sub>2</sub>, Cu(OAc)<sub>2</sub>, TEA, DCM, RT.</p></p></figure><div class="NLM_p">When the R<sub>6</sub> group bears a hydrophilic basic heterocycle such as piperidine or morpholine, compounds such as <b>23</b>–<b>26</b> and <b>40</b> could be obtained from intermediate <b>54</b> as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, beginning with Suzuki coupling with 3- or 4-formylphenylboronic acid. Reductive amination in the presence of the desired cyclic amine and sodium triacetoxyborohydride afforded intermediates of general form <b>59</b> which, after deprotection and copper-mediated Chan–Lam–Evans coupling, gave products <b>23</b>–<b>25</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Basic Tetrahydroquinoline Compounds, e.g., <b>23</b>–<b>26</b> and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3- or 4-formylPhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux; (b) NaBH(OAc)<sub>3</sub>, AcOH, cyclic II<sup>ary</sup> amines, solvent, RT; (c) MeOH, 6M HCl, reflux; (d) R<sub>4</sub>PhB(OH)<sub>2</sub>, Cu(OAc)<sub>2</sub>, TEA, DCM, RT.</p></p></figure><div class="NLM_p">Compound <b>45</b>, lacking the tetrahydroquinoline 2-position methyl substituent, was prepared according to Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. 2,3-Dihydroquinolin-4(1<i>H</i>)-one was brominated at position 6 in the presence of NBS in DCM. The tetrahydroquinoline nitrogen atom was then substituted using an acetic anhydride, giving <b>61</b>. A Suzuki coupling reaction was used to introduce the 4-methoxyophenyl substituent at position 6, affording the 6-aryl tetrahydroquinolinon-4-one. Finally, the substituent at position 4 was introduced by reductive amination with aniline in the presence of titanium tetrachloride before reduction with sodium triacetoxyborohydride, giving compound <b>45</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 2-<i>H</i> Tetrahydroquinoline Compound <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, DCM, 0 °C to RT, 86%; (b) Ac<sub>2</sub>O, 80 °C, 69%; (c) 4-MeOPhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux, 67%; (d) aniline, TiCl<sub>4</sub>, TEA, THF/DCM, 0 °C to RT then NaBH(OAc)<sub>3</sub>, AcOH, RT, 15%.</p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Enantioselective Route to Compound <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) crotonyl chloride, lithium <i>tert</i>-butoxide, THF, −20 °C, 29%; (b) 4-bromoaniline, (R-BINAP)Pd(MeCN)<sub>2</sub>(OTf)<sub>2</sub>, toluene, THF, 20 °C, 67%, ee = 92%; (c) NaBH<sub>4</sub>, MgCl<sub>2</sub>·6H<sub>2</sub>O, EtOH, H<sub>2</sub>O, −15 °C, 78%, 1 <i>cis</i>-isomer, ee = 92%; (d) AcCl, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0°C, 78%, purification by chiral chromatography, ee >99%; (e) {4-[(ethyloxy)carbonyl]phenyl}boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, EtOH, H<sub>2</sub>O, 80 °C, 92%; (f) AlCl<sub>3</sub>, Et<sub>3</sub>N, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 98%; (g) 1-bromo-4-chlorobenzene, DavePhos, Bis(dibenzylideneacetone)palladium, sodium <i>tert</i>-butoxide, toluene, 70 °C, 37% (94% based on recovered starting material); (h) 2M NaOH, EtOH, RT, 77%.</p></p></figure><div class="NLM_p last"><b>47</b> can also be prepared in an eight-step synthesis starting from isopropyl carbamate. Reaction with crotonyl chloride at −20 °C formed the but-2-enoyl carbamate <b>63</b>. An aza-Michael reaction with 4-bromoaniline was achieved stereoselectively under palladium catalyzed conditions, then cyclized to give the syn tetrahydroquinoline <b>65</b> using sodium borohydride and magnesium chloride.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a><i>N</i>-Acylation of the tetrahydroquinoline was followed by a Suzuki coupling of the 6-bromo group with {4-[(ethoxy)carbonyl]phenyl}boronic acid to give <b>67</b>. Deprotection of the 4-aminotetrahydroquinoline was achieved using aluminum chloride and triethylamine to give <b>68</b>. The mechanism of this deprotection is not fully understood but requires between 3 and 4 equiv of aluminum chloride; typically, we used 3.6 equiv to achieve full conversion. Fewer than 3 equiv of aluminum chloride gave no reaction, while 4 or more equiv of aluminum chloride, by contrast, resulted in the very rapid degradation of the starting material to a mixture of unidentified products. The Hartwig–Buchwald reaction with 1-bromo-2-chlorobenzene is sensitive to the quality of the sodium <i>tert</i>-butoxide as any acid formed by ester hydrolysis of <b>68</b> is unreactive and remains as a byproduct following the reaction. Basic ester hydrolysis completed the synthesis of <b>47</b>.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Potency and Selectivity</h3><div class="NLM_p">Knowing that compound <b>47</b> is a BET bromodomain inhibitor, we profiled it in additional binding and selectivity assays. Besides having activity in the FA assay, <b>47</b> is a potent competitor of labeled histone peptide binding to all four BET isoforms in TR-FRET format, with IC<sub>50</sub> at or below 100 nM against each (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). To confirm this, the <i>K</i><sub>d</sub> was measured by surface plasmon resonance (SPR) and determined to be 20−25 nM (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Figure S2">Supporting Information, Figure S2</a>). Isothermal titration calorimetry (ITC) results suggested that <b>47</b> binds to the tandem bromodomain of His-tagged-BRD4 (1–477) with 2:1 stoichiometry, consistent with the binding of one molecule at each bromodomain site, with high affinity (<i>K</i><sub>D</sub> 4.4 ± 0.9 nM).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Properties of Compound <b>47</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0020.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>47</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">peptide-based FRET (pIC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">BRD2</td><td class="colsep0 rowsep0" align="center">7.4 ± 0.06 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BRD3</td><td class="colsep0 rowsep0" align="center">7.1 ± 0.03 (5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BRD4</td><td class="colsep0 rowsep0" align="center">7.0 ± 0.20 (39)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BRDT</td><td class="colsep0 rowsep0" align="center">7.3 ± 0.25 (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>d</sub> by SPR (nM)</td><td class="colsep0 rowsep0" align="left">BRD2</td><td class="colsep0 rowsep0" align="center">25 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BRD3</td><td class="colsep0 rowsep0" align="center">20 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">BRD4</td><td class="colsep0 rowsep0" align="center">23 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>d</sub> by ITC (nM)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></td><td class="colsep0 rowsep0" align="left">BRD4</td><td class="colsep0 rowsep0" align="center">4.4 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CREBBP</td><td class="colsep0 rowsep0" align="center">6300 ± 500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LPS-stimulated IL6 pIC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">PBMC</td><td class="colsep0 rowsep0" align="center">7.3 ± 0.25 (20)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">HWB</td><td class="colsep0 rowsep0" align="center">6.4 ± 0.2 (12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (μg/mL)</td><td class="colsep0 rowsep0" align="left">FASSIF</td><td class="colsep0 rowsep0" align="center">106</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>47</b> was tested in a range of fluorescence thermal melting assays (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Table S3">Supporting Information Table S3</a>) and showed no significant interaction with any bromodomain tested other than the BET family and CREBBP. Consistent with this, in a panel of recombinant bromodomain acetyl-lysine site directed binding assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>), only weak activity was found against other bromodomains apart from CREBBP and EP300. To estimate the true selectivity for BRD4 over CREBBP, isothermal titration calorimetry experiments were carried out, which confirmed that, as expected, <b>47</b> binds in a 1:1 ratio with the single bromodomain of CREBBP and that the <i>K</i><sub>d</sub> was 6.3 μM, >1000-fold weaker than that for BRD4.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selectivity of <b>47</b><a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">bromodomain</th><th class="colsep0 rowsep0" align="center">modifier</th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATAD2</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATAD2B</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAZ2A</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAZ2B</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BPTF/FALZ</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD1</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD2(1)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD2(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD3(1)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD3(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD4(1)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD4(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD4(1,2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD4 (full-length, short isoform)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD1</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD7</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD9</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRDT(1)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRDT(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRPF1</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRPF3</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CECR2</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CREBBP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EP300</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GCN5</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PBRM1(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PBRM1(5)</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PCAF</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SMARCA2</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAF1(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAF1L(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIF1α/TRIM24 (BD)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIF1α/TRIM24 (PHD + BD)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIF1γ/TRIM33 (PHD + BD)</td><td class="colsep0 rowsep0" align="center"><</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WDR9(2)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Activity in BROMO<i>scan</i><sup>SM</sup> recombinant protein binding assays carried out at DiscoveRx (<a href="http://www.discoverx.com" class="extLink">http://www.discoverx.com</a>).</p></div></div></div><div class="NLM_p last">To assess its selectivity against targets unrelated to bromodomains, <b>47</b> was screened in a panel of 50 receptor, ion channel and transporter assays (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Table S4">Supporting Information, Table S4</a>). No significant activity was found at 1 or 10 μM (<25%), indicating a high degree of selectivity against those classes of nonbromodomain targets included.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Preclinical Developability Profile</h3><div class="NLM_p">Compound <b>47</b> showed an improved P450 profile over <b>28</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), with low potential to inhibit the major human CYP isoforms (IC<sub>50</sub> values >10 μM). In vitro clearances determined with liver hepatocytes were low across all species, including human (CLi <1.7 mL/min/g liver). Compound <b>47</b> had medium permeability in an artificial membrane assay. However, using singly expressed human recombinant enzymes <b>47</b> was shown to be a time-dependent inhibitor of CYP3A4 based on a 4-fold shift in IC<sub>50</sub>. Its free fraction was also relatively low.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Properties of Compound <b>47</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>47</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte clearance (mL/min/g tissue)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="center"><0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center"><0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="center"><1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">primate<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center"><0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="center"><0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P450 profile IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1A2 (ER)</td><td class="colsep0 rowsep0" align="center">>33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C9 (FCA)</td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C19 (BMC)</td><td class="colsep0 rowsep0" align="center">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2D6 (MMMC)</td><td class="colsep0 rowsep0" align="center">>33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4 (7BQ)</td><td class="colsep0 rowsep0" align="center">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4 (DEF)</td><td class="colsep0 rowsep0" align="center">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">time-dependent P450 inhibition</td><td class="colsep0 rowsep0" align="left">3A4 (DEF)</td><td class="colsep0 rowsep0" align="center">4-fold shift in IC<sub>50</sub> over 30 min (>100 μM to 24 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">permeability (nm/s)</td><td class="colsep0 rowsep0" align="left">artificial membrane</td><td class="colsep0 rowsep0" align="center">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free fraction (<i>F</i><sub>ub</sub>)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="center">0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center">0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="center">0.065</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="center">0.017</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Cynomolgus monkey.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Fluorometric assay with Cypex cDNA expressed isoforms.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Measured using rapid equilibrium dialysis at a nominal concentration of 1000 ng/mL. Assay performed using blood.</p></div></div></div><div class="NLM_p">The pharmacokinetic properties of compound <b>47</b> were investigated in four preclinical species: mouse, rat, dog, and nonhuman primate (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). It had a low-moderate clearance across the preclinical species (<30% liver blood flow). Consistent with this, <b>47</b> was stable in vitro in hepatocytes from preclinical species. The in vitro/in vivo clearance correlation across preclinical species indicates that, based on human in vitro clearance, human blood clearance could be low to moderate. The volume of distribution was low to moderate (0.5–1.0 L/kg), indicating some distribution into the tissues. Elimination half-life was moderate in dog and primate (1.8 and 2.7 h, respectively) and longer in mouse (3.6 h). Compound <b>47</b> therefore has the potential to be administered once or twice daily in human. Oral bioavailability was moderate in the rat (ca. 28%) and higher in mouse, dog, and primate (90%, 80%, and 100%, respectively). The systemic exposure in mouse was suitable for exploration of the pharmacodynamics in vivo, and exposures achieved in the rat and dog via the oral route allow for progression to safety assessment evaluation in these species.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Preclinical Pharmacokinetic Parameters for Compound <b>47</b> (Values are Mean <i>n</i> = 3, IV Infusion at 1 mg/kg, and PO Dose at 3 mg/kg unless Otherwise Stated)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="±">CLb (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> iv (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–t</sub> po (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i><sub>po</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.48 ± 0.1</td><td class="colsep0 rowsep0" align="center">3.6 ± 0.2</td><td class="colsep0 rowsep0" align="center">6028</td><td class="colsep0 rowsep0" align="center">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">26 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.4</td><td class="colsep0 rowsep0" align="center">>8</td><td class="colsep0 rowsep0" align="center">539 ± 96</td><td class="colsep0 rowsep0" align="center">28 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beagle dog</td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="center">1.8 ± 0.6</td><td class="colsep0 rowsep0" align="center">5900 ± 968</td><td class="colsep0 rowsep0" align="center">80 ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">primate<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.4</td><td class="colsep0 rowsep0" align="center">2.7 ± 0.1</td><td class="colsep0 rowsep0" align="center">10968 ± 3852</td><td class="colsep0 rowsep0" align="center">103 ± 35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Balb/c bolus IV dose at 10 mg/kg.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Terminal <i>t</i><sub>1/2</sub> estimated from <i>n</i> = 1 rat.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Cynomolgus monkey, IV infusion at 1 mg/kg, and PO dose at 2 mg/kg. Parameters are from plasma analysis.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Oral Activity</h3><div class="NLM_p">We have previously reported the activity of compound <b>47</b> in neuroblastoma assays.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Because of the links between ApoA1 up-regulation, BET inhibition, and inflammatory disease that emerged as this work was underway,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> compound <b>47</b> was assessed in an acute mouse inflammation model. After a single oral administration of compound at various concentrations followed by intraperitoneal LPS challenge, the effect on hepatic mRNA expression of the acute phase protein PAI-1 was measured. The compound showed dose-dependent inhibition of PAI-1 expression, with very significant activity already observed at the 3 mg/kg dose (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Oral activity of <b>47</b> in a murine acute LPS challenge model: PAI-1 mRNA relative to vehicle (mean ± SEM, <i>n</i> = 8). (*** <i>p</i> value <0.0001 following a <i>t</i> test comparison to the vehicle-treated group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Intravenous Activity in a Mouse Septic Shock Model</h3><div class="NLM_p">Sepsis is an acute inflammatory condition characterized by high mortality rates and a significant unmet medical need despite considerable research effort.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Therefore, compound <b>47</b> was tested in a mouse septic shock model using a therapeutic mode of treatment (dosing after induction of sepsis). An intraperitoneal injection of LPS (15–20 mg/kg) was first administered to Balb/c mice. When clinical signs were observed, compound <b>47</b> was intravenously dosed at 10 mg/kg. Only 25% of mice in the vehicle group survived, while 56% of mice treated with compound survived after 5 days (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), indicating that compound <b>47</b> is able to prevent death of diseased animals following a single administration.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Intravenous activity of <b>47</b> in a murine septic shock model (mean of two independent experiments with <i>n</i> = 8 per group in each study).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Binding Modes of Optimized Tetrahydroquinolines</h3><div class="NLM_p">In a previous publication, we showed the structure of the racemic tetrahydroquinoline <b>48</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) as an example of a fragment binding to the N-terminal bromodomain of BRD2.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The amino acids of the BET family of bromodomains are highly conserved in the acetyl-lysine pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), so it is not surprising that <b>47</b> in BRD4 inherits the general binding mode of fragment <b>48</b> in BRD2 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). This includes the key directional interactions between the THQ scaffold and the acetyl-lysine site of BRD4, namely the hydrogen bond between the <i>N</i>1-acetyl group and the side chain NH<sub>2</sub> of the conserved asparagine Asn140. The <i>N</i>1-acetyl group forms a second, shorter hydrogen bond to a water molecule, which itself hydrogen bonds to the side chain hydroxyl of Tyr97. Our analysis of fragment complexes with BRD2 suggested that the water interaction may be the stronger of the two. This water molecule is one of a chain of four conserved within bromodomain crystal structures published to date. Lying at the bottom of the acetyl-lysine pocket, these form a highly satisfied H-bonding network connecting Tyr97 to the backbone carbonyls of Pro82 and Gln85. The H-bonding interactions of the THQ template mimic the interactions made by the acetyl-lysine side chain found in X-ray structures of the BET bromodomains bound to acetylated peptides (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B).<a onclick="showRef(event, 'ref29 ref39'); return false;" href="javascript:void(0);" class="ref ref29 ref39">(29, 39)</a> The methyl group of the <i>N</i>1-acetyl of the THQ fills the small pocket between the buried water chain and the aromatic side chain of Phe83 in the same position as the terminal methyl of the acetyl lysine side chain.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Tetrahydroquinoline fragment <b>48</b>. (B) Conservation of the BET family and CREBBP bromodomain acetyl-lysine sites. Colors represent residue properties: green = hydrophobic, red = acidic, blue = basic, orange = polar, purple = proline, white = small. * denotes residue is in contact (≤4.5 Å) with compound <b>47</b> in BRD4 N-terminal bromodomain crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3uvw">3uvw</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>47</b> (cyan carbons) in the BRD4 N-terminal bromodomain (blue carbons). The conserved H-bonding network between inhibitor, protein, and conserved waters is marked in yellow. (A) Comparison with X-ray structure of fragment <b>48</b> in BRD2 N-terminal domain (orange). Black dotted line indicates the 3.5 Å distance between the C2 carbon of <b>47</b> and the side chain oxygen of Asn140. (B) Comparison to acetyl-lysine (purple carbons) taken from X-ray structure of histone H4(1-12)K5AcK8Ac in BRD4 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3uvw">3uvw</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (C) Key hydrogen-bonding interactions of <b>47</b> with BRD4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of the racemic fragment <b>48</b> in BRD2 showed that the bound enantiomer had (<i>S</i>) absolute chirality at the C2 position and that the 2-methyl group filled a small lipophilic pocket near Leu110 in the ZA loop. The C2 methyl group of <b>47</b> fulfils the same role and makes direct contact with the analogous BRD4 residue Leu94 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). The vector projecting from the C2 hydrogen points toward the side chain carbonyl oxygen of Asn140, which is only 3.5 Å away (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). Even a substituent as small as a methyl group would clash with this carbonyl oxygen, explaining the (2<i>S</i>) stereochemical requirement for activity.</div><div class="NLM_p">The unsaturated ring of the THQ is sandwiched by hydrophobic residues (mainly Pro82 and Leu92) in a narrow lipophilic region at the base of the ZA channel (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). The 6-substituent phenyl ring extends further through this channel toward solvent, passing close by Trp81 in an edge-to-face arrangement. This location explains the gross SAR seen at the 6-position in the BET binding assays. The presence of the 6-aryl ring in compounds such as <b>16</b> increases BET potency compared to analogues like <b>12</b> because of lipophilic interactions with the channel, particularly with Trp81. The crystal structure also shows that the meta and especially the para positions of the 6-aryl ring point away from the protein surface, explaining the wide range of tolerated substitutions including acidic and basic groups in compounds <b>17</b>–<b>25</b>. The carboxylate of <b>47</b> makes no direct interaction with the protein but does lie in the rough vicinity of the side chain of Lys91, although because of its flexibility this probably does not contribute much to the binding free energy. The ortho position of the 6-aryl ring offers greater opportunities for interaction with the protein. One ortho position lies close to the BRD4 WPF motif (Trp81–Pro82–Phe83), with limited room for growth (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). The opposite ortho position has more accessible space, but the SAR shows that substitution is detrimental to binding (compound <b>44</b>). This can be understood by considering the torsion angle between the THQ core and the 6-phenyl ring, which is about 30°. Ortho groups would increase this torsion angle and the width of the ligand within the ZA channel, leading to closer steric contacts against Trp81 and Leu92.</div><div class="NLM_p last">The THQ 4-position anilino linker adopts near optimal torsional angles for this group and directs its substituent chlorophenyl ring toward the hydrophobic “WPF shelf” (named because of its proximity to the conserved bromodomain WPF motif defined above). This lipophilic site has been shown to be important in other classes of BET inhibitor,<a onclick="showRef(event, 'ref30 ref31 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref33">(30, 31, 33)</a> and the poor activity of <b>26</b> and <b>27</b> which lack this substituent supports its importance in the THQ series. One edge of the chlorophenyl ring makes direct hydrophobic contacts with the WPF shelf (the 2-position with Ile146, and the 3-position with Trp81 and Pro82) but the opposite face points toward solvent (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). There is therefore plenty of space for ortho or meta substituents on this ring, explaining the rather flat substituent effects on activity at these positions. The 4-chloro group lies near Trp81 and contacts the hydrophobic side chain of Met149, although this is near the outside of the shelf and exposed to solvent, so this might make relatively small contributions to activity. Because all of the interactions made by the 4-anilino chlorophenyl ring are hydrophobic, they are not very directional, and modifications to the ring may be accommodated by relatively small sliding movements over the WPF shelf surface, as found previously in a dimethyl isoxazole series.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Comparison of Binding Mode to Selected Literature BET Inhibitors</h3><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A shows the BRD4 N-terminal bromodomain binding mode of THQ <b>47</b> superimposed on that of compound <b>1</b>.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> These different chemotypes overlay very closely, with the N1 acetyl group of <b>47</b> fulfilling a similar role to the triazole ring of <b>1</b> in its interaction with Asn140 and the conserved water network. The polycyclic cores of both inhibitors also overlay very closely, as do the chlorophenyl rings of each, which approach the WPF shelf from the same direction and make similar interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). Compound <b>3</b> binds in a very different manner, both in chemical structure and also in the directionality of the approach of its aryl ring to the WPF shelf (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) THQ <b>47</b> (cyan carbons) bound to BRD4 N-terminal bromodomain, with BRD4 molecular surface generated with modeled hydrogen atoms, aligned to <b>1</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p5o">3p5o</a>). (B) Binding mode of <b>47</b> in BRD4 N-terminal bromodomain compared to that of <b>3</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zyu">3zyu</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Binding Mode in other BET Bromodomains</h3><div class="NLM_p">X-ray structures of <b>47</b> were also solved in complex with the N-terminal and C-terminal bromodomains of BRD2 (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A,B). Both binding modes are very similar to that seen in the N-terminal bromodomain of BRD4. This is as expected, given the conservation of residues involved in direct interactions with the inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). The only differences are relatively small movements of the 4-anilino chlorophenyl group. Because of the nonpolar, weakly directional nature of the interactions between the chlorophenyl and the WPF shelf, these small movements do not translate into significant differences in potency between the BET isoforms (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison between X-ray structures of <b>47</b> in complex with BRD4 N-terminal bromodomain (cyan/blue) and (A) BRD2 N-terminal bromodomain (pink/purple), with BRD4 residue numbering, and (B) BRD2 C-terminal bromodomain (yellow/orange), with BRD2 residue numbering. (C) Comparison of X-ray structures of BRD2 N-terminal bromodomain in complex with <b>47</b> (pink/purple) and with <b>28</b> (chain A, green), with BRD2 N-terminal numbering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An X-ray structure of the N-terminal bromodomain of BRD2 was also solved in complex with <b>28</b>. The majority of the structure is well resolved in chains A and B, although the ligand is not visible in chain C. Compound <b>28</b> adopts a very similar binding mode to that of <b>47</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>C), but the electron density for the methylpiperidine is weak (<a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S3">Supporting Information Figure S3</a>) and in neither chain does this group make apparent strong interactions. This is consistent with the small effect of this substituent on binding affinity (e.g., <b>28</b> relative to <b>19</b>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The discovery and optimization of the tetrahydroquinoline series which led to <b>47</b> was accomplished without the benefit of any knowledge of the molecular target. Its molecular mechanism is now well understood. This series joins a growing list of different chemotypes which produce potent biological effects by binding to the BET family of bromodomains. We have recently shown that <b>47</b> is a potent suppressor of <i>MYCN</i> expression and survival in neuroblastoma cell lines and xenograft growth.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Here, we have described its discovery and potent anti-inflammatory effects. The THQ series offers chemical tractability and an attractive range of properties suitable for optimization and progression to preclinical development. Further publications will describe more of the medicinal chemistry and biology around this template targeting a range of therapeutic areas.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Experimental Methods (Chemistry)</h3><div class="NLM_p">All solvents were purchased from Sigma-Aldrich (Hy-Dry anhydrous solvents) and commercially available reagents were used as received. Melting points were recorded on Buchi B-545 apparatus and are uncorrected. All reactions were followed by TLC analysis (TLC plates GF254, Merck) or liquid chromatography mass spectrometry (LCMS) using a Waters ZQ instrument. NMR spectra were recorded on a Bruker NanoBay 400 MHz or a Bruker AV++ 600 MHz spectrometer and are referenced as follows. <sup>1</sup>H NMR (400 or 600 MHz), internal standard TMS at δ = 0.00. <sup>13</sup>C NMR (100.6 or 150.9 MHz), internal standard CDCl<sub>3</sub> at δ = 77.23 or DMSO-<i>d</i><sub>6</sub> at δ = 39.70. Column chromatography was performed on prepacked silica gel columns (30–90 mesh, IST) using a Biotage SP4. Mass spectra were recorded on Waters ZQ (ESI-MS) and Q-Tof 2 (HRMS) spectrometers. Mass directed auto prep was performed on a Waters 2767 with a MicroMass ZQ mass spectrometer using Supelco LCABZ++ column. Reactions performed under microwave irradiation utilized either a Biotage Initiator or CEM Discover Microwave.</div><div class="NLM_p last">Abbreviations for multiplicities observed in NMR spectra: s; singlet; br s, broad singlet; d, doublet; t, triplet; q, quadruplet; p, pentuplet; spt, septuplet; m, multiplet. The purity of all compounds was determined by LCMS and <sup>1</sup>H NMR and was always >95%. For detailed LCMS/MDAP methodology see <a class="ref internalNav" href="#notes-4" aria-label="Supplementary Methods, Supporting Information">Supplementary Methods, Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Formamide Deprotection (Method A)</h3><div class="NLM_p last">To a suspension of formamide (1 equiv) in MeOH (0.3 mol/L) was added 6 N HCl (3 equiv). The resulting mixture was stirred at reflux for 3 h, and the medium was made basic by the addition of 2N NaOH. The MeOH was evaporated under reduced pressure and the organic material extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness to afford the desired primary amine.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Chan–Lam Coupling (Method B)</h3><div class="NLM_p last">A mixture of the amine (1 equiv), phenyl boronic acid (3 equiv), anhydrous copper acetate (1.5 equiv), and triethylamine (3 equiv) in dry DCM (0.3 mol/L) was stirred at room temperature for 48–72 h. Progression of the reaction was monitored by TLC, and if necessary an additional equivalent of phenyl boronic acid and triethylamine was added and the mixture allowed to stir at room temperature for a further 12 h. This operation was repeated until the amount of the expected product exceeded the remaining proportion of the starting intermediate. The resulting mixture was poured into water, and the organic phase was extracted with DCM, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by recrystallization or chromatography on silica gel.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure for the Suzuki Coupling (Method C)</h3><div class="NLM_p last">To a solution of bromo derivative (100 mg, 0.28 mmol) in 1,2-dimethoxyethane (0.1 mol/L) was added boronic acid or the corresponding boronate ester (1.5 equiv), a 2N solution sodium carbonate in water (5 equiv), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.05 equiv), and the mixture was stirred under reflux for 20 h. The solvent was then removed under reduced pressure, and EtOAc was added to the residue. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by recrystallization or chromatography on silica gel.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure for Ester Hydrolysis (Method D)</h3><div class="NLM_p last">A solution of ester (1 equiv) in EtOH (0.1 mol/L) and 1N NaOH (2 equiv) was heated to 60 °C. After 1 h, the mixture was evaporated to dryness and the residue taken up in water. Acetic acid was added until PH 4–5, and the aqueous layer was extracted with DCM (2×). The combined organic layers were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. After concentration under reduced pressure, the title compound was obtained as a solid.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Procedure for Reductive Amination (Method E)</h3><div class="NLM_p last">To a solution of aldehyde (1 equiv) and piperidine (1.2 equiv) in solution in dichloroethane (0.1 mol/L) were added at room temperature triacetoxysodiumborohydride (1.3 equiv) and acetic acid (2.2 equiv). After stirring 2 h, the mixture was poured into a saturated aqueous solution of NaHCO<sub>3</sub>. The organic layer was extracted with DCM and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by recrystallization or chromatography on silica gel.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>cis</i>-1-(2-Methyl-4-(<i>p</i>-tolylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>10</b>) and <i>trans</i>-1-(2-Methyl-4-(<i>p</i>-tolylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>11</b>)</h3><div class="NLM_p last">To a solution of 1-acetyl-2-methyl-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>51</b>) (1 g, 4.9 mmol), 4-methylaniline (0.63 g, 5.9 mmol) and TEA (3.0 mL, 21.2 mmol) in THF (50 mL) at 0 °C was added TiCl<sub>4</sub> (1 M in CH<sub>2</sub>Cl<sub>2</sub>, 7.4 mL, 7.4 mmol). The reaction mixture was stirred for 2 h at room temperature, and TiCl<sub>4</sub> (1 M in CH<sub>2</sub>Cl<sub>2</sub>, 4.9 mL, 4.90 mmol) was added again. After 3 more hours, sodium borohydride (1.49 g, 39.36 mmol) was added portion by portion at room temperature. The reaction mixture was stirred for 18 h then poured into a 2 M aqueous solution of NaHCO<sub>3</sub>. The organic layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness to afford a mixture of two isomers <i>cis</i>/<i>trans</i>. The residue was purified by chromatography on silica gel (5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to provide the two isomers. Compound <b>10</b>: isolated as an orange oil (65 mg, 4.5%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.30 (m, 1H), 7.21 (m, 1H), 7.10 (m, 2H), 6.90 (m, 1H), 6.55 (m, 1H), 4.82 (m, 1H), 4.51 (m, 1H), 2.50 (m, 1H), 2.19 (m, 1H), 2.16 (s, 3H), 2.09 (s, 3H), 1.69 (m, 2H), 1.13 (m, 1 H), 1.10 (d, <i>J</i> = 6.6 Hz, 3H). Compound <b>11</b>: isolated as an orange oil (130 mg, 9%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.25 (m, 2H), 7.11 (m, 2H), 6.92 (m, 2H), 6.48 (m, 2H), 4.82 (m, 1H), 4.14 (m, 1H), 3.63 (m, 1H), 2.56 (m, 1H), 2.18 (s, 3H), 2.11 (s, 3H), 1.19 (m, 1H), 1.07 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method formate, 5 min): retention time 2.07 min, [M + H]<sup>+</sup> = 294.0. HRMS (M + H)<sup>+</sup> 294.18.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-((2<i>S</i>*,4<i>R</i>*)-2-Methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>12</b>)</h3><div class="NLM_p last">To a solution of 1-acetyl-2-methyl-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>51</b>) (4.06 g, 20 mmol) and aniline (3.65 mL, 40 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (300 mL) at 0 °C was added TiCl<sub>4</sub> (1 M in CH<sub>2</sub>Cl<sub>2</sub>, 30 mL, 30 mmol) over 30 min. The reaction mixture was allowed to warm to room temperature and stirred for 16 h. NaBH<sub>4</sub> (6.1 g, 160 mmol) was then added portion by portion at room temperature. The resulting mixture was stirred for 4 h and then was treated with a 10% w/w Na<sub>2</sub>CO<sub>3</sub> aqueous solution. The layers were separated, and the organic phase was extracted with CH<sub>2</sub>Cl<sub>2.</sub> The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness to afford a mixture of two isomers <i>cis</i>/<i>trans</i>. The residue was purified by chromatography on silica gel (5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>12</b> (3.2 g, 57%) as an orange oil. LCMS (method formate): retention time 1.09 min, [M + H]<sup>+</sup> = 281.24. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.22–7.33 (m, 2H), 7.16 (m, 2H), 7.09 (m, 2H), 6.65 (d, <i>J</i> = 7.6 Hz, 2H), 6.56 (t, <i>J</i> = 7.3 Hz, 1H), 6.02 (d, <i>J</i> = 7.8 Hz, 1H), 4.71 (m, 1H), 4.18 (m, 1H), 2.59 (m, 1H), 2.08 (s, 3H), 1.19 (m, 1H), 1.4 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-((2<i>S</i>*,4<i>R</i>*)-2-Methyl-6-phenyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>16</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-6-bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>) and phenylboronic acid; mp 186 °C. LCMS (method formate): retention time 1.28 min, [M + H]<sup>+</sup> = 357.28. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.48–7.58 (m, 3H), 7.38–7.47 (m, 4H), 7.28–7.35 (m, 1H), 7.10 (m, 2H), 6.73 (d, <i>J</i> = 7.8 Hz, 2H), 6.58 (t, <i>J</i> = 7.3 Hz, 1H), 6.06 (d, <i>J</i> = 7.8 Hz, 1H), 4.73 (m, 1H), 4.28 (m, 1H), 2.63 (m, 1H), 2.10 (s, 3H), 1.24 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-4-(phenylamino)-1,2,3,4-tetrahydroquinolin-6-yl)benzonitrile (<b>17</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-6-bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>) and (4-cyanophenyl)boronic acid; mp 104 °C. LCMS (method formate): retention time 1.19 min, [M + H]<sup>+</sup> = 382.26. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89 (d, <i>J</i> = 8.3 Hz, 2H), 7.73 (d, <i>J</i> = 8.3 Hz, 2H), 7.61–7.69 (m, 1H), 7.44–7.55 (m, 2H), 7.11 (d, <i>J</i> = 7.7, 7.8 Hz, 2H), 6.73 (d, <i>J</i> = 7.8 Hz, 2H), 6.55 (t, <i>J</i> = 7.8 Hz, 1H), 6.05 (d, <i>J</i> = 7.8 Hz, 1H), 4.70 (m, 1H), 4.31 (m, 1H), 2.63 (m, 1H), 2.15 (s, 3H), 1.24 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-4-(phenylamino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>18</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-6-bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>) and (4-(methoxycarbonyl)phenyl)boronic acid; mp 90 °C. LCMS (method formate): retention time 1.24 min, [M + H]<sup>+</sup> = 415.32. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (d, <i>J</i> = 8.3 Hz, 2H), 7.71 (d, <i>J</i> = 8.3 Hz, 2H), 7.63 (d, <i>J</i> = 2.2 Hz, 1H), 7.54 (d, <i>J</i> = 1.5 Hz, 1H), 7.46 (d, <i>J</i> = 8.1 Hz, 1H), 7.12 (m, 2H), 6.74 (d, <i>J</i> = 7.6 Hz, 2H), 6.59 (t, <i>J</i> = 7.8 Hz, 1H), 6.05 (d, <i>J</i> = 8.1 Hz, 1H), 4.67–4.79 (m, 1H), 4.26–4.36 (m, 1H), 3.86 (s, 3H), 2.58–2.71 (m, 1H), 2.08 (s, 3H), 1.18–1.31 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-4-(phenylamino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>19</b>)</h3><div class="NLM_p last">Method D was used to hydrolyze methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-2-methyl-4-(phenylamino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>18</b>); mp 246 °C. LCMS (method formate): retention time 0.70 min, [M – H]<sup>−</sup> = 399.38. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.20–13.44 (br s, 1H), 7.97 (d, <i>J</i> = 8.3 Hz, 2H), 7.59–7.67 (m, 3H), 7.52 (d, <i>J</i> = 1.5 Hz, 1H), 7.45 (d, <i>J</i> = 8.3 Hz, 1H), 7.11 (dd, <i>J</i> = 7.4, 8.4 Hz, 2H), 6.74 (d, <i>J</i> = 8.4 Hz, 2H), 6.59 (t, <i>J</i> = 7.4 Hz, 1H), 6.05 (d, <i>J</i> = 8.1 Hz, 1H), 4.73 (m, 1H), 4.31 (m, 1H), 2.63 (m, 1H), 2.15 (s, 3H), 1.24 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-((2<i>S</i>*,4<i>R</i>*)-2-Methyl-4-(phenylamino)-6-(4-(trifluoromethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>20</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-6-bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>) and (4-(trifluoromethyl)phenyl)boronic acid; mp 85 °C. LCMS (method formate): retention time 1.36 min, [M + H]<sup>+</sup> = 425.18. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.77 (m, 4H), 7.63 (dd, <i>J</i> = 2.1, 8.2 Hz, 1H), 7.51 (d, <i>J</i> = 1.2 Hz, 1H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.11 (dd, <i>J</i> = 7.8, 7.8 Hz, 2H), 6.73 (d, <i>J</i> = 7.8 Hz, 2H), 6.58 (t, <i>J</i> = 7.3 Hz, 1H), 6.06 (d, <i>J</i> = 7.8 Hz, 1H), 4.72 (m, 1H), 4.31 (m, 1H), 2.64 (m, 1H), 2.16 (s, 3H), 1.25 (m, 1H), 1.11 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-((2<i>S</i>*,4<i>R</i>*)-6-(4-Methoxyphenyl)-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>21</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-6-bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>) and (4-methoxyphenyl)boronic acid; mp 86 °C (becomes gummy). LCMS (method formate): retention time 1.24 min, [M + H]<sup>+</sup> = 387.18. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.42–7.52 (m, 3H), 7.33–7.41 (m, 2H), 7.10 (d, <i>J</i> = 7.7, 7.7 Hz, 2H), 6.98 (d, <i>J</i> = 8.8 Hz, 2H), 6.72 (d, <i>J</i> = 7.8 Hz, 2H), 6.58 (t, <i>J</i> = 7.2 Hz, 1H), 6.05 (d, <i>J</i> = 8.1 Hz, 1H), 4.72 (m, 1H), 4.26 (m, 1H), 3.76 (s, 3H), 2.61 (m, 1H), 2.13 (s, 3H), 1.25 (m, 1H), 1.09 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-((2<i>S</i>*,4<i>R</i>*)-6-(4-(Hydroxymethyl)phenyl)-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>22</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-6-bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>) and (4-(hydroxymethyl)phenyl)boronic acid; mp 102 °C. LCMS (method formate): retention time 1.02 min, [M + H]<sup>+</sup> = 387.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.54 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.43–7.5 (m, 3H), 7.32–7.43 (m, 3H), 7.10 (dd, <i>J</i> = 7.8, 7.8 Hz, 2H), 6.73 (d, <i>J</i> = 7.8 Hz, 2H), 6.58 (t, <i>J</i> = 7.3 Hz, 1H), 6.05 (d, <i>J</i> = 8.1 Hz, 1H), 5.17 (t, <i>J</i> = 5.8 Hz, 1H), 4.72 (m, 1H), 4.50 (d, <i>J</i> = 5.8 Hz, 2H), 4.28 (m, 1H), 2.62 (m, 1H), 2.14 (s, 3H), 1.25 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-((2<i>S</i>*,4<i>R</i>*)-2-Methyl-6-(4-(morpholinomethyl)phenyl)-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>23</b>)</h3><div class="NLM_p last"><i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-6-(4-formylphenyl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>58a</b>) was reacted with morpholine using method E. After formamide deprotection using method A, coupling of phenylboronic acid was carried out using method B; mp 80 °C. LCMS (method formate): retention time 1.18 min, [M + H]<sup>+</sup> = 456.37. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.30–7.58 (m, 7H), 7.10 (d, <i>J</i> = 7.6 Hz, 2H), 6.72 (d, <i>J</i> = 7.6 Hz, 2H), 6.58 (t, <i>J</i> = 6.8 Hz, 1H), 6.05 (d, <i>J</i> = 7.6 Hz, 1H), 4.72 (m, 1H), 4.28 (m, 1H), 3.56 (m, 4H), 3.32 (br s, 2H), 2.62 (m, 1H), 2.35 (m, 4H), 2.14 (s, 3H), 1.25 (m, 1H), 1.10 (d, <i>J</i> = 5.6 Hz, 3H).</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-((2<i>S</i>*,4<i>R</i>*)-2-Methyl-4-(phenylamino)-6-(3-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>24</b>)</h3><div class="NLM_p last">Suzuki coupling between <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>54</b>) and (3-formylphenyl)boronic acid was carried out using method C. The resulting aldehyde was coupled with piperidine using method E. After formamide deprotection using method A, phenylboronic acid was coupled using method B. LCMS (method formate): retention time 1.41 min, [M + H]<sup>+</sup> = 454.31. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.49–7.69 (m, 2H), 7.31–7.48 (m, 4H), 7.22 (d, <i>J</i> = 7.3 Hz, 1H), 7.10 (dd, <i>J</i> = 7.8, 7.8 Hz, 2H), 6.72 (d, <i>J</i> = 7.8 Hz 2H), 6.58 (t, <i>J</i> = 7.2 Hz, 1H), 6.07 (d, <i>J</i> = 8.1 Hz, 1H), 4.73 (m, 1H), 4.28 (m, 1H), 3.43 (s, 2H), 2.62 (m, 1H), 2.23–2.39 (m, 4H), 2.14 (s, 3H) 1.16–1.56 (m, 7H), 1.10 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-((2<i>S</i>*,4<i>R</i>*)-2-Methyl-4-(phenylamino)-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone Hydrochloride (<b>25</b>)</h3><div class="NLM_p last">Method B was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>27</b>) and phenylboronic acid; mp 100 °C. LCMS (method formate): retention time 1.40 min, [M + H]<sup>+</sup> = 454.41. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (br s, 1H), 7.38–7.68 (m, 7H), 7.11 (dd, <i>J</i> = 7.8, 7.8 Hz, 2H), 6.72 (d, <i>J</i> = 7.8 Hz, 2H), 6.58 (t, <i>J</i> = 7.2 Hz, 1H), 6.07 (d, <i>J</i> = 7.8 Hz, 1H), 4.72 (m, 1H), 4.28 (m, 3H), 2.88 (br s, 2H), 2.64 (m, 1H), 2.15 (s, 3H), 1.50–1.91 (m, 6H), 1.15–1.45 (m, 3H), 1.11 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>26</b>)</h3><div class="NLM_p last">Method E was used starting from <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-(4-formylphenyl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>58a</b>) and piperidine. LCMS (method formate): retention time 1.03 min, [M + H]<sup>+</sup> = 406.24. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (d, <i>J</i> = 8.3 Hz, 1H), 8.31 (s, 1H), 7.56–7.63 (m, 3H), 7.35–7.46 (m, 4H), 4.79 (m, 1H), 4.69 (m, 1H), 3.46 (s, 2H), 2.44–2.54 (m, 3H), 2.34 (m, 2H), 2.09 (s, 3H), 1.45–1.56 (m, 4H), 1.40 (m, 2H), 1.28 (m, 1H), 1.08 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-((2<i>S</i>*,4<i>R</i>*)-4-Amino-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>27</b>)</h3><div class="NLM_p last">Formamide deprotection was carried out upon <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>26</b>) using method A. LCMS (method formate): retention time 1.06 min, [M + H]<sup>+</sup> = 378.32. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.78 (br s, 1H), 7.65 (d, <i>J</i> = 8.1 Hz, 2H), 7.52 (dd, <i>J</i> = 1.7, 8.1 Hz, 1H), 7.38 (d, <i>J</i> = 8.1 Hz, 2H), 7.31 (d, <i>J</i> = 8.1 Hz, 1H), 4.62 (m, 1H), 3.59 (dd, <i>J</i> = 4.1, 11.9 Hz, 1H), 3.35 (m, 2H), 2.45 (m, 1H), 2.34 (m, 4H), 2.05 (s, 3H), 1.51 (m, 4H), 1.40 (m, 2H), 1.09 (d, <i>J</i> = 6.1 Hz, 3H), 1.05 (m, 1H). NH<sub>2</sub> not observed.</div></div><div id="sec4_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-((2<i>S</i>,4<i>R</i>)-2-Methyl-4-(phenylamino)-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>28</b>) and 1-((2<i>R</i>,4<i>S</i>)-2-Methyl-4-(phenylamino)-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>29</b>)</h3><div class="NLM_p last">Compound <b>25</b> was dissolved in EtOH and separated in its two enantiomers using column CHIRALPAK AD 250 mm × 4.6 mm 10 uM, eluting with hexane/EtOH 40/60 for 15 min at a concentration of 1 mg/mL to give <b>28</b> (retention time 4.7 min) and <b>29</b> (retention time 7.7 min).</div></div><div id="sec4_6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((4-(<i>tert</i>-butyl)phenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>30</b>)</h3><div class="NLM_p last">Method B was used to couple methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and 4-(<i>tert</i>-butyl)phenylboronic acid; mp 144 °C. LCMS (method formate): retention time 1.43 min, [M + H]<sup>+</sup> = 471.39. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (d, <i>J</i> = 8.3 Hz, 2H), 7.70 (d, <i>J</i> = 8.3 Hz, 2H), 7.63 (d, <i>J</i> = 8.1 Hz, 1H), 7.57 (br s, 1H), 7.46 (d, <i>J</i> = 8.1 Hz, 1H), 7.13 (d, <i>J</i> = 8.3 Hz, 2H), 6.68 (d, <i>J</i> = 8.3 Hz, 2H), 5.84 (d, <i>J</i> = 8.1 Hz, 1H), 4.71 (m, 1H), 4.28 (m, 1H), 3.86 (s, 3H), 2.62 (m, 1H), 2.15 (s, 3H), 1.29 (m, 1H), 1.22 (s, 9H), 1.10 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-4-((4-(methylsulfonyl)phenyl)amino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>31</b>)</h3><div class="NLM_p last">Method D was used to hydrolyze methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-2-methyl-4-((4-(methylsulfonyl)phenyl)amino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>32</b>). LCMS (method formate): retention time 0.62 min, [M – H]<sup>−</sup> = 477.39. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.00–13.65 (br s, 1H), 7.99 (d, <i>J</i> = 8.3 Hz, 2H), 7.59–7.69 (m, 5H), 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.46 (d, <i>J</i> = 1.2 Hz, 1H), 7.06 (d, <i>J</i> = 8.1 Hz, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 4.74 (m, 1H), 4.53 (m, 1H), 3.01 (m, 3H), 2.64 (m, 1H), 2.16 (s, 3H), 1.32 (m, 1H), 1.12 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-4-((4-(methylsulfonyl)phenyl)amino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>32</b>)</h3><div class="NLM_p last">Method B was used to couple methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and 4-(methylsulfonyl)phenylboronic acid. LCMS (method formate): retention time 1.04 min, [M – H]<sup>−</sup> = 491.43. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (d, <i>J</i> = 8.3 Hz, 2H), 7.70 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.62 (d, <i>J</i> = 9.0 Hz, 2H), 7.50 (d, <i>J</i> = 8.3 Hz, 1H), 7.46 (d, <i>J</i> = 1.2 Hz, 1H), 7.06 (d, <i>J</i> = 8.1 Hz, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 4.73 (m, 1H), 4.51 (m, 1H), 3.86 (s, 3H), 3.32 (s, 3H), 2.64 (m, 1H), 2.16 (s, 3H), 1.29 (m, 1H), 1.12 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-2-methyl-4-(<i>p</i>-tolylamino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>33</b>)</h3><div class="NLM_p last">Method B was used to couple methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and 4-tolylboronic acid. This was followed by hydrolysis using method D. LCMS (method formate): retention time 0.73 min, [M + H]<sup>+</sup> = 415.36. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.90–13.70 (br s, 1H),7.99 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (d, <i>J</i> = 8.3 Hz, 2H), 7.62 (dd, <i>J</i> = 1.8, 8.2 Hz, 1H), 7.53 (br s, 1H), 7.45 (d, <i>J</i> = 8.3 Hz, 1H), 6.92 (d, <i>J</i> = 8.3 Hz, 2H), 6.65 (d, <i>J</i> = 8.3 Hz, 2H), 5.84 (d, <i>J</i> = 8.1 Hz, 1H), 4.71 (m, 1H), 4.25 (m, 1H), 2.62 (m, 1H), 2.16 (s, 3H), 2.08 (s, 3H), 1.21 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>34</b>)</h3><div class="NLM_p last">Method B was used to couple methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and (4-chlorophenyl)boronic acid. This was followed by hydrolysis using method D; mp 84 °C. LCMS (method formate): retention time 1.08 min, [M – H]<sup>−</sup> = 433.15. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.76–13.15 (br s, 1H), 7.99 (d, <i>J</i> = 8.3 Hz, 2H), 7.67 (d, <i>J</i> = 8.3 Hz, 2H), 7.63 (m, 1H), 7.49 (m, 2H), 7.12 (d, <i>J</i> = 8.8 Hz, 2H), 6.74 (d, <i>J</i> = 8.8 Hz, 2H), 6.30 (d, <i>J</i> = 7.8 Hz, 1H), 4.71 (m, 1H), 4.30 (m, 1H), 2.62 (m, 1H), 2.15 (s, 3H), 1.23 (m, 1H), 1.10 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((4-fluorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>35</b>)</h3><div class="NLM_p last">Method B was used to couple methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and (4-fluorophenyl)boronic acid. LCMS (method formate): retention time 1.19 min, [M + H]<sup>+</sup> = 433.23. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.09 (d, <i>J</i> = 8.16 Hz, 2H), 7.55–7.63 (m, 5H), 7.26 (m, 1H), 6.94 (m, 2H), 6.65 (m, 2H), 4.93 (m, 1H), 4.21 (m, 1H), 3.94 (s, 3H), 2.70 (m, 1H), 2.26 (s, 3H), 1.28–1.43 (m, 1H), 1.22 (d, <i>J</i> = 6.3 Hz, 3H).</div></div><div id="sec4_6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((3-fluorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzonitrile (<b>36</b>)</h3><div class="NLM_p last">Method E was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-6-bromo-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>55</b>) and 4-(cyanophenyl)boronic acid, then method B was used with (3-fluorophenyl)boronic acid; mp 124 °C. LCMS (method formate): retention time 1.20 min, [M + H]<sup>+</sup> = 400.30. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 8.3 Hz, 2H), 7.75 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.46–7.51 (m, 2H), 7.11 (dd, <i>J</i> = 7.6, 7.6 Hz, 1H), 6.51–6.61 (m, 2H), 6.40 (d, <i>J</i> = 8.1 Hz, 1H), 6.34 (ddd, <i>J</i> = 2.0, 7.6, 7.6 Hz, 1H), 4.70 (m, 1H), 4.32 (m, 1H), 2.62 (m, 1H), 2.15 (s, 3H), 1.23 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((3-methoxyphenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzonitrile (<b>37</b>)</h3><div class="NLM_p last">Method E was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-6-bromo-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>55</b>) and 4-(cyanophenyl)boronic acid, then method B was used with (3-methoxyphenyl)boronic acid; mp 104 °C. LCMS (method formate): retention time 1.17 min, [M + H]<sup>+</sup> = 412.26. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 8.3 Hz, 2H), 7.75 (d, <i>J</i> = 8.3 Hz, 2H), 7.65 (dd, <i>J</i> = 2.0, 8.1 Hz, 1H), 7.53 (d, <i>J</i> = 1.2 Hz, 1H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.01 (t, <i>J</i> = 8.1 Hz, 1H), 6.28–6.36 (m, 2H), 6.19 (dd, <i>J</i> = 2.0, 8.1 Hz, 1H), 6.06 (d, <i>J</i> = 8.3 Hz, 1H), 4.70 (m, 1H), 4.32 (m, 1H), 3.31 (s, 3H), 2.62 (m, 1H), 2.13 (s, 3H), 1.24 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((3-methoxyphenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>38</b>)</h3><div class="NLM_p last">Method B was used starting from methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and (3-methoxyphenyl)boronic acid. This was followed by hydrolysis using method D; mp 148 °C. LCMS (method formate): retention time 0.69 min, [M + H]<sup>+</sup> = 431.31. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.99 (d, <i>J</i> = 8.1 Hz, 2H), 7.67 (d, <i>J</i> = 8.3 Hz, 2H), 7.62 (d, <i>J</i> = 8.1 Hz, 1H), 7.54 (br s, 1H), 7.45 (d, <i>J</i> = 8.3 Hz, 1H), 7.01 (dd, <i>J</i> = 8.1, 8.1 Hz, 1H), 6.29–6.36 (m, 2H), 6.19 (d, <i>J</i> = 8.1 Hz, 1H), 6.07 (d, <i>J</i> = 8.1 Hz, 1H), 4.71 (m, 1H), 4.31 (m, 1H), 3.67 (s, 3H), 2.62 (m, 1H), 2.15 (s, 3H), 1.22 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H). CO<sub>2</sub>H not observed.</div></div><div id="sec4_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((2-methoxyphenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>39</b>)</h3><div class="NLM_p last">Method B was used starting from methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) and (2-methoxyphenyl)boronic acid. This was followed by hydrolysis using method D. LCMS (method formate): retention time 0.72 min, [M + H]<sup>+</sup> = 431.34. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.05–13.82 (br s, 1H), 7.97 (d, <i>J</i> = 8.3 Hz, 2H), 7.58–7.65 (m, 3H), 7.45 (d, <i>J</i> = 8.1 Hz, 1H), 7.41 (br s, 1H), 6.90 (d, <i>J</i> = 7.8 Hz, 1H), 6.75 (t, <i>J</i> = 7.8 Hz, 1H), 6.63 (m, 2H), 5.10 (d, <i>J</i> = 8.1 Hz, 1H), 4.72 (m, 1H), 4.31 (m, 1H), 3.85 (s, 3H), 2.61 (m, 1H), 2.15 (s, 3H), 1.43 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-((2<i>S</i>*,4<i>R</i>*)-4-((4-Chlorophenyl)amino)-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>40</b>)</h3><div class="NLM_p last">Method B was used to couple 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>27</b>) and (4-chlorophenyl)boronic acid; mp 128 °C. LCMS (method formate): retention time 1.49 min, [M + H]<sup>+</sup> = 490.31. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.28–7.60 (m, 7H), 7.12 (d, <i>J</i> = 8.6 Hz, 2H), 6.73 (d, <i>J</i> = 8.6 Hz, 2H), 6.28 (d, <i>J</i> = 8.1 Hz, 1H), 4.72 (m, 1H), 4.28 (m, 1H), 3.45 (br s, 2H), 2.61 (m, 1H), 2.35 (m, 4H), 2.14 (s, 3H), 1.50 (m, 4H), 1.40 (m, 2H), 1.24 (m, 1H), 1.09 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-(1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>41</b>)</h3><div class="NLM_p last">Hydrolysis of <b>42</b> was carried out using method D; mp 152 °C. LCMS (method formate): retention time 0.79 min, [M – H]<sup>−</sup> = 433.35. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.74–13.20 (br s, 1H), 8.10 (s, 1H), 7.90 (dd, <i>J</i> = 1.2, 7.8 Hz, 1H), 7.80 (t, <i>J</i> = 7.8 Hz, 1H), 7.53–7.64 (m, 2H), 7.41–7.50 (m, 2H), 7.12 (d, <i>J</i> = 9.0 Hz, 2H), 6.74 (d, <i>J</i> = 9.0 Hz, 2H), 6.31 (d, <i>J</i> = 8.1 Hz, 1H), 4.72 (m, 1H), 4.30 (m, 1H), 2.62 (m, 1H), 2.15 (s, 3H), 1.24 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 3-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>42</b>)</h3><div class="NLM_p last">Method B was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-6-bromo-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>55</b>) and (4-chlorophenyl)boronic acid. Suzuki coupling with (3-(methoxycarbonyl)phenyl)boronic acid was then effected using method C; mp 98 °C. LCMS (method formate): retention time 1.31 min, [M – H]<sup>−</sup> = 447.34. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.07 (s, 1H), 7.92 (dd, <i>J</i> = 1.2, 7.8 Hz, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.52–7.66 (m, 2H), 7.45 (d, <i>J</i> = 9.0 Hz, 2H), 7.13 (d, <i>J</i> = 9.0 Hz, 2H), 6.74 (d, <i>J</i> = 9.1 Hz, 2H), 6.32 (d, <i>J</i> = 8.1 Hz, 1H), 4.71 (m, 1H), 4.30 (m, 1H), 3.87 (s, 3H), 2.62 (m, 1H), 2.15 (s, 3H), 1.25 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzamide (<b>43</b>)</h3><div class="NLM_p last">A solution of 4-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid (<b>34</b>) (250 mg, 0.575 mmol) in DMF (5 mL) at room temperature was treated with EDCI (220 mg, 1.15 mmol), HOBT (116 mg, 0.862 mmol), and NEt<sub>3</sub> (0.16 mL, 1.15 mmol). The resulting mixture was stirred at this temperature for 15 min then treated with a 25% w/w NH<sub>4</sub>OH aqueous solution (0.06 mL, 1.15 mmol). After continued stirring at this temperature for 16 h, more EDCI (50 mg, 0.26 mmol) and 25% w/w NH<sub>4</sub>OH aqueous solution (0.06 mL, 1.15 mmol) were added and the mixture was stirred for another 2 h, then was concentrated in vacuo. The residue was dissolved in EtOAc, and the organic phase was washed successively with a 0.5N NaOH aqueous solution, a 0.5 N HCl aqueous solution, water and brine, then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification of the residue by flash chromatography on silica gel (5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) and recrystallization in EtOH gave <b>43</b> (82 mg, 33%) as white crystals; mp 235 °C. LCMS (method formate): retention time 1.00 min, [M + H]<sup>+</sup> = 434.27. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96 (br s, 1H), 7.93 (d, <i>J</i> = 8.6 Hz, 2H), 7.63 (d, <i>J</i> = 2.0 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.46 (m, 2H), 7.35 (br s, 1H), 7.13 (d, <i>J</i> = 7.8 Hz, 2H), 6.75 (d, <i>J</i> = 7.8 Hz, 2H), 6.28 (d, <i>J</i> = 8.1 Hz, 1H), 4.72 (m, 1H), 4.31 (m, 1H), 2.62 (m, 1H), 2.15 (s, 3H), 1.23 (m, 1H), 1.10 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-((2<i>S*</i>,4<i>R*</i>)-4-((4-Chlorophenyl)amino)-2-methyl-6-(<i>o</i>-tolyl)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>44</b>)</h3><div class="NLM_p last">Method C was used starting from 1-((2<i>S*</i>,4<i>R*</i>)-6-bromo-4-((4-chlorophenyl)amino)-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56a</b>) and <i>o</i>-tolylboronic acid. LCMS (method formate): retention time 1.39 min, [M + H]<sup>+</sup> = 405.32. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.08–7.34 (m, 11H), 6.59 (d, <i>J</i> = 8.2 Hz, 1H), 4.94 (m, 1H), 4.23 (m, 1H), 2.70 (m, 1H), 2.28 (s, 3H), 2.19 (s, 3H), 1.30 (m, 1H), 1.23 (d, <i>J</i> = 6.3 Hz, 3H).</div></div><div id="sec4_6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>R</i>)-1-(6-(4-Methoxyphenyl)-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>45</b>)</h3><div class="NLM_p last">To a solution of 1-acetyl-6-(4-methoxyphenyl)-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>62</b>) (280 mg, 0.95 mmol), aniline (0.25 mL, 2.85 mmol), and NEt<sub>3</sub> (0.67 mL, 4.75 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at 0 °C was added dropwise a 1.0 M solution of titanium tetrachloride in CH<sub>2</sub>Cl<sub>2</sub> (0.95 mL, 0.95 mmol). After stirring 18 h at room temperature, the reaction mixture was poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. The residue was taken up in iPr<sub>2</sub>O, and the filtrate was evaporated to dryness and directly dissolved in AcOH. NaB(OAc)<sub>3</sub>H was added portionwise, then the reaction mixture was stirred for 18 h and basified with concentrated NaOH aqueous solution. The aqueous solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>), and the resulting solid was recrystallized in CH<sub>3</sub>CN to deliver the title compound (65 mg, 15%) as a white powder. LCMS (method formate): retention time 1.22 min, [M + H]<sup>+</sup> = 373.27. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.42–7.56 (m, 5H), 7.11 (dd, <i>J</i> = 7.9, 7.9 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 6.74 (d, <i>J</i> = 7.8 Hz, 2H), 6.57 (t, <i>J</i> = 7.3 Hz, 1H), 6.07 (d, <i>J</i> = 8.3 Hz, 1H), 4.56 (m, 1H), 4.02 (m, 1H), 3.58 (m, 1H), 3.32 (s, 3H), 2.24 (s, 3H), 2.22 (m, 1H), 1.82 (m, 1H).</div></div><div id="sec4_6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-((2<i>S</i>,4<i>R</i>)-1-Acetyl-2-methyl-4-(<i>p</i>-tolylamino)-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> can be obtained in a similar manner to compound <b>33</b> from the single enantiomer of compound <b>57a</b>, which can be obtained from the racemate as follows: A solution of methyl 4-(1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>) (103 g, 0.305 mol) in EtOH (500 mL) was treated with <span class="smallcaps smallerCapital">l</span>-(+)-lactic acid (20% w/w solution in water, 260 mL, 0.610 mmol), and the resulting mixture was refluxed for 30 min then cooled to room temperature and concentrated in vacuo. The residue was suspended in hexane (160 mL) and triturated at reflux for 10 min. The mixture was cooled to room temperature, the solid filtered off, and the trituration in hexane repeated once. The solid obtained was suspended in EtOAc (1.3 L) and triturated at reflux for 30 min to give a white precipitate. The mixture was then cooled to room temperature and left still for 16 h. The solid was filtered off and rinsed with EtOAc. The filtrate was treated with a saturated Na<sub>2</sub>CO<sub>3</sub> aqueous solution, and the resulting mixture was stirred for 30 min. The aqueous phase was extracted with AcOEt (1.5 L) and CH<sub>2</sub>Cl<sub>2</sub> (1 L), and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give 50.3 g of amine. This residue was dissolved in THF (500 mL) and treated with <span class="smallcaps smallerCapital">l</span>(−)-dibenzoyltartaric acid (26.7 g, 74.6 mmol), and the resulting mixture was refluxed for 20 min then was cooled to room temperature and left still for 72 h then at 0 °C for 30 min. The precipitate obtained was filtered off and rinsed with THF (100 mL). This precipitate was refluxed in EtOH (1.1 L), and the mixture was left at room temperature for 16 h then at 0 °C for 30 min. The solid was filtered off and dried under vacuum. It was then basified with a saturated Na<sub>2</sub>CO<sub>3</sub> aqueous solution. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 L overall), and the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give methyl 4-((2<i>S</i>,4<i>R</i>)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (28.6 g, 28%, ee >99.5%) as a white solid.</div></div><div id="sec4_6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-((2<i>S</i>,4<i>R</i>)-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic Acid (<b>47</b>)</h3><div class="NLM_p last">A solution of ethyl 4-{(2<i>S</i>,4<i>R</i>)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl}benzoate (<b>69</b>) (28.0 g, 60.5 mmol) in EtOH (380 mL) at room temperature was treated with a 2 M NaOH aqueous solution (190 mL, 60.5 mmol). The resulting mixture was stirred at this temperature for 3 h. Most of EtOH was removed in vacuo. The resulting orange emulsion was diluted with water, and the aqueous phase was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phases were washed with water, and the combined aqueous phases were acidified with a 2 N HCl aqueous solution. The aqueous phase was then extracted twice with EtOAc. The combined organic phases were dried over MgSO<sub>4</sub> and concentrated in vacuo. The residual orange foam was suspended in EtOAc, and the resulting mixture was stirred at room temperature for 15 min. The solid formed was filtered off, rinsed with EtOAc, and dried under vacuum at 50 °C to give <b>47</b> (20.2 g, 77%) as a cream solid. <sup>1</sup>H NMR, <sup>13</sup>C NMR, and chiral analysis of the product showed no evidence of epimerization, ee >99%. LCMS (method formate): retention time 1.08 min, [M – H]<sup>−</sup> = 433.15. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.92 (br s, 1H), 8.00–7.97 (m, 2H), 7.68–7.65 (m, 2H), 7.63 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 7.48 (d, <i>J</i> = 1.5 Hz, 1H), 7.46 (d, <i>J</i> = 8.1 Hz, 1H), 7.19–7.09 (m, 2H), 6.70–6.78 (m, 2H), 6.26 (d, <i>J</i> = 8.1 Hz, 1H), 4.66–4.77 (m, 1H), 4.30 (ddd, <i>J</i> = 11.8, 7.9, 4.1 Hz, 1H), 2.62 (ddd, <i>J</i> = 12.5, 8.4, 4.2 Hz, 1H), 2.15 (s, 3H), 1.27–1.20 (m, 1H), 1.10 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (150.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 168.6 (s, 1C), 167.0 (s, 1C), 147.1 (s, 1C), 143.9 (s, 1C), 137.9 (s, 1C), 136.7 (s, 1C), 135.8 (s, 1C), 130.0 (s, 2C), 129.5 (s, 1C),128.7 (s, 2C), 126.6 (s, 1C), 126.5 (s, 2C), 125.3 (s, 1C), 121.8 (s, 1C), 119.5 (s, 1C), 114.1 (s, 2C), 48.8 (s, 1C), 47.2 (s, 1C), 39.9 (s, 1C), 22.9 (s, 1C), 21.3 (s, 1C). See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S4">Supporting Information Figure S4</a> for NMR spectra. [α]<i>D</i> = +40.8° (<i>T</i> = 21.4 °C, 10 mm cell, <i>c</i> = 10 mg/mL, MeOH).</div></div><div id="sec4_6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 3-(Phenylamino)butanoic Acid (<b>49</b>)</h3><div class="NLM_p last">A solution of aniline (93.3 g, 1 mol) and crotonic acid (66 g, 0.77 mol) in toluene (600 mL) was heated to reflux. After 24 h, the reaction mixture was evaporated to dryness and the residue was purified by flash chromatography on silica gel to afford intermediate <b>49</b> as a brown oil (77.5 g, 43%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.23 (t, <i>J</i> = 7.6 Hz, 2H), 6.81 (t, <i>J</i> = 7.6 Hz, 1H), 6.73 (d, <i>J</i> = 7.6 Hz, 2H), 3.95 (m, 1H), 2.70 (m, 1H), 2.55 (m, 1H), 1.32 (d, J = 6.6 Hz, 3H).</div></div><div id="sec4_6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-Methyl-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>50</b>)</h3><div class="NLM_p last">A mixture of 3-(phenylamino)butanoic acid (<b>49</b>) (30 g, 0.168 mol) and PPA (300 mL) was heated to 110 °C. After 5 h, the reaction mixture was poured into ice and a saturated aqueous solution of NaHCO<sub>3</sub> was added until pH 7. The aqueous layer was extracted with EtOAc (3 × 1 L). The combined organic layers were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (8 g, 29%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.74 (dd, <i>J</i> = 1.5 and 7.9 Hz, 1H), 7.25 (m, 1H), 6.66 (m, 1H), 6.57 (d, <i>J</i> = 7.9 Hz, 1H), 3.70 (m, 1H), 2.55 (dd, <i>J</i> = 3.8 and 16.1 Hz, 1H), 2.44 (dd, <i>J</i> = 13.0 and 16.1 Hz, 1H), 1.27 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-Acetyl-2-methyl-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>51</b>)</h3><div class="NLM_p last">To a solution of 2-methyl-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>50</b>) (6.44 g, 40 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (150 mL) at 0 °C was added acetyl chloride (3.45 g, 45 mmol) followed by DMAP (0.48 g, 4 mmol). The mixture was stirred for 18 h at room temperature, and then 1N NaOH was added until pH 7–8. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was taken up in pentane, filtered, then washed with iPr<sub>2</sub>O to deliver intermediate <b>51</b> as an off-white powder (6.95 g, 86%). LCMS (method formate): retention time 2.12 min. [M + H]<sup>+</sup> = 204.0. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 8.01 (dd, <i>J</i> = 1.7 and 7.7 Hz, 1H), 7.57 (m, 1H), 7.39 (br s, 1H), 7.28 (m, 1H), 5.35 (br s, 1H), 3.05 (dd, <i>J</i> = 5.8 and 17.9 Hz, 1H), 2.58 (dd, <i>J</i> = 1.7 and 17.9 Hz, 1H), 2.35 (s, 3H), 1.21 (d, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-(1-(1<i>H</i>-Benzo[<i>d</i>][1,2,3]triazol-1-yl)ethyl)-4-bromoaniline (<b>52</b>)</h3><div class="NLM_p last">To a suspension of benzotriazole (139 g, 1.16 mol) in toluene (2 L) in a 3 L, four-neck flask under nitrogen atmosphere was added at room temperature a solution of 4-bromoaniline (200 g, 1.16 mol) in toluene (300 mL). Acetaldehyde (64.7 mL, 1.17 mol) in solution in toluene (200 mL) was added dropwise. The reaction mixture became progressively homogeneous and then gave a precipitate. The resulting mixture was stirred 12 h under nitrogen atmosphere then filtered. The precipitate was recrystallized in toluene to afford intermediate <b>52</b> as a white solid (304 g, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10 (d, <i>J</i> = 8.6 Hz, 1H), 8.00 (d, <i>J</i> = 8.6 Hz, 1H), 7.51 (m, 2H), 7.43 (m, 1H), 7.16 (d, <i>J</i> = 8.2 Hz, 2H), 6.63 (d, <i>J</i> = 8.2 Hz, 2H), 1.86 (d, <i>J</i> = 6.8 Hz, 3H). NH not observed.</div></div><div id="sec4_6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-6-Bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>53</b>)</h3><div class="NLM_p last">A 3 L, four-neck flask under nitrogen atmosphere was charged with <i>N</i>-vinyl formamide (66.2 g, 0.946 mol) and dry THF (400 mL). BF<sub>3</sub>·Et<sub>2</sub>O (239 mL, 1.9 mol) was added dropwise at −5 °C to the milky mixture. After 15 min, <b>52</b> (150 g, 0.473 mol) in solution in THF (1 L) was added at −5 °C. After 2 h, the mixture was slowly and carefully poured in a NaHCO<sub>3</sub> saturated aqueous solution (5 L). EtOAc (2 L) was added, and the mixture was transferred to a separatory funnel. The organic layer was separated and was washed with water (1 × 200 mL) and brine (1 × 200 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The mixture was filtered and the solid washed with EtOAc (1 × 50 mL). The filtrate was concentrated progressively until a precipitate appeared and the mixture cooled in an ice bath for 2 h. The precipitate was filtered through a Buchner funnel and washed with iPr<sub>2</sub>O (2 × 100 mL) to deliver intermediate <b>53</b> (71 g, 56%) as a solid. LCMS (method formate): retention time 0.79 min, [M + H]<sup>+</sup> = 269.05, 272.18 (1 Br). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (d, <i>J</i> = 8.8 Hz, 1H), 8.21 (s, 1H), 7.05 (dd, <i>J</i> = 2.1, 8.4 Hz, 1H), 6.97 (s, 1H), 6.44 (d, <i>J</i> = 8.8 Hz, 1H), 5.93 (s, 1H), 5.10 (m, 1H), 3.41 (m, 1H), 1.95 (m, 1H), 1.40 (m, 1H), 1.14 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>54</b>)</h3><div class="NLM_p last">Acetyl chloride (21 mL, 0.29 mol) was added dropwise at 0 °C to a solution of <b>53</b> (71 g, 0.26 mol) in a mixture of CH<sub>2</sub>Cl<sub>2</sub> (1 L) and pyridine (350 mL). After stirring 2 h at 0 °C, the mixture was poured into a mixture of crushed ice (2 kg) and concentrated HCl (450 mL). The product was extracted with CH<sub>2</sub>Cl<sub>2</sub> (1 L), washed with brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. Concentration under vacuum afforded intermediate <b>54</b> (82 g, 100%) as an off-white solid. LCMS (method formate): retention time 0.73 min, [M + H]<sup>+</sup> = 311.08, 313.04 (1 Br). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (d, <i>J</i> = 8.3 Hz, 1H), 8.27 (s, 1H), 7.49 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 7.29–7.34 (m, 2H), 4.58–4.77 (m, 2H), 2.45 (m, 1H), 2.08 (s, 3H), 1.25 (m, 1H), 1.05 (m, 3H).</div></div><div id="sec4_6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-((2<i>S</i>*,4<i>R</i>*)-4-Amino-6-bromo-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone Hydrochloride (<b>55</b>)</h3><div class="NLM_p last">Method A was used starting from <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>54</b>). Yield: 91% (oil). LCMS (method formate): retention time 0.76 min, [M + H]<sup>+</sup> = 283.285 (1 Br). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.03 (br s, 3H), 7.61 (d, <i>J</i> = 1.5 Hz, 1H), 7.58 (dd, <i>J</i> = 1.5, 8.3 Hz, 1H), 7.37 (d, <i>J</i> = 8.3 Hz, 1H), 4.56–4.72 (m, 1H), 4.13–4.30 (m, 1H), 2.74 (m, 1H), 2.04 (s, 3H), 1.25–1.41 (m, 1H), 1.06 (d, <i>J</i> = 6.36 Hz, 3H).</div></div><div id="sec4_6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-((2<i>S</i>*,4<i>R</i>*)-6-Bromo-2-methyl-4-(phenylamino)-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56</b>)</h3><div class="NLM_p last">Method B was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-6-bromo-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone hydrochloride (<b>55</b>) and phenylboronic acid. LCMS (method formate): retention time 1.20 min, [M + H]<sup>+</sup> = 359.36 (1 Br). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.45 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (d, <i>J</i> = 2.0 Hz, 1H), 7.11 (dd, <i>J</i> = 7.3, 8.4 Hz, 2H), 6.67 (d, <i>J</i> = 8.4 Hz, 2H), 6.59 (t, <i>J</i> = 7.3 Hz, 1H), 6.06 (d, <i>J</i> = 7.8 Hz, 1H), 4.67 (m, 1H), 4.22 (m, 1H), 2.58 (m, 1H), 2.08 (s, 3H), 1.19 (m, 1H), 1.06 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-((2<i>S*</i>,4<i>R*</i>)-6-Bromo-4-((4-chlorophenyl)amino)-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>56a</b>)</h3><div class="NLM_p last">Method B was used starting from 1-((2<i>S</i>*,4<i>R</i>*)-4-amino-6-bromo-2-methyl-3,4-dihydroquinolin-1(2<i>H</i>)-yl)ethanone (<b>55</b>) and (4-chlorophenyl)boronic acid. LCMS (method formate): retention time 1.28 min, [M + H]<sup>+</sup> = 393.14, 395.01 (1 Br). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.45 (dd, <i>J</i> = 1.7, 8.3 Hz, 1H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 1.7 Hz, 1H), 7.12 (d, <i>J</i> = 8.9 Hz, 2H), 6.69 (d, <i>J</i> = 8.9 Hz, 2H), 6.28 (d, <i>J</i> = 7.8 Hz, 1H), 4.67 (m, 1H), 4.23 (m, 1H), 2.58 (m, 1H), 2.07 (s, 3H), 1.17 (m, 1H), 1.06 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Methyl 4-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>57a</b>)</h3><div class="NLM_p last">Method B was used to couple (4-(methoxycarbonyl)phenyl)boronic acid to <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>54</b>) before formamide deprotection using method A; mp 250 °C. LCMS (method formate): retention time 0.89 min, [M + H]<sup>+</sup> = 339.25. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06 (d, <i>J</i> = 8.1 Hz 2H), 7.86–7.90 (m, 3H), 7.62 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.38 (d, <i>J</i> = 8.3 Hz, 1H), 4.62 (m, 1H), 3.88 (s, 3H), 3.61 (dd, <i>J</i> = 4.2, 12.0 Hz, 1H), 2.44 (m, 1H), 2.08 (s, 3H), 1.05 (d, <i>J</i> = 6.4 Hz, 3H), 1.02 (m, 1H). NH<sub>2</sub> not observed.</div></div><div id="sec4_6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-Acetyl-6-(4-formylphenyl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>58a</b>)</h3><div class="NLM_p last">Method C was used starting from <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>54</b>) and (4-formylphenyl)boronic acid; mp 86 °C. LCMS (method formate): retention time 0.78 min, [M + H]<sup>+</sup> = 337.24. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.06 (s, 1H), 8.75 (d, <i>J</i> = 8.6 Hz, 1H), 8.31 (s, 1H), 8.01 (d, <i>J</i> = 8.1 Hz, 2H), 7.93 (d, <i>J</i> = 8.1, 2H), 7.71 (dd, <i>J</i> = 1.5, 8.2 Hz, 1H), 7.58 (d, <i>J</i> = 1.5 Hz, 1H), 7.49 (d, <i>J</i> = 8.2 Hz, 1H), 4.82 (m, 1H), 4.69 (m, 1H), 2.51 (m, 1H), 2.12 (s, 3H), 1.30 (m, 1H), 1.05–1.11 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-((2<i>S*</i>,4<i>R*</i>)-1-Acetyl-2-methyl-6-(4-(piperidin-1-ylmethyl)phenyl)-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>59</b>)</h3><div class="NLM_p last">Method E was used starting from <i>N</i>-((2<i>S</i>*,4<i>R</i>*)-1-acetyl-6-(4-formylphenyl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)formamide (<b>58a</b>) and piperidine. LCMS (method formate): retention time 1.03 min, [M + H]<sup>+</sup> = 406.24. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (d, <i>J</i> = 8.3 Hz, 1H), 8.31 (s, 1H), 7.56–7.63 (m, 3H), 7.35–7.46 (m, 4H), 4.79 (m, 1H), 4.69 (m, 1H), 3.46 (s, 2H), 2.44–2.54 (m, 3H), 2.34 (m, 2H), 2.09 (s, 3H), 1.45–1.56 (m, 4H), 1.40 (m, 2H), 1.28 (m, 1H), 1.08 (d, <i>J</i> = 6.4 Hz, 3H).</div></div><div id="sec4_6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 6-Bromo-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>60</b>)</h3><div class="NLM_p last">To a solution of 2,3-dihydroquinolin-4(1<i>H</i>)-one (1.85 g, 12.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) at 0 °C was added <i>N</i>-bromosuccinimide (2.28 g, 12.8 mmol), and the mixture was stirred for 1.5 h. CH<sub>2</sub>Cl<sub>2</sub> was added to the reaction mixture, then the organic layer was separated and washed with 1N NaOH aqueous solution and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The residue was purified by flash chromatography on silica gel (0–1% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford 6-bromo-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>60</b>) (2.43 g, 86%) as a yellow solid. LCMS (method formate, 5 min): retention time 2.52 min, [M + H]<sup>+</sup> = 225.23. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.87 (d, <i>J</i> = 2.5 Hz, 1H), 7.27 (dd, <i>J</i> = 2.3 and 8.7 Hz, 1H), 6.53 (d, <i>J</i> = 8.7 Hz, 1H), 3.51 (t, <i>J</i> = 6.8 Hz, 2H), 2.62 (t, <i>J</i> = 6.8 Hz, 2H).</div></div><div id="sec4_6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 1-Acetyl-6-bromo-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>61</b>)</h3><div class="NLM_p last">A mixture of 6-bromo-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>60</b>) (1.10 g, 4.9 mmol) and acetic anhydride (11 mL) was stirred of 2 h at 80 °C and 15 h at 40 °C then concentrated under reduced pressure. The residue was recrystallized in acetonitrile to deliver <b>61</b> (0.91 g, 69%) as pale-yellow solid. LCMS (method formate, 5 min): retention time 2.44 min, [M + H]<sup>+</sup> = 268.00. <sup>1</sup>H NMR (300 MHz, DMSO) δ ppm 7.90 (s, 1H), 7.75 (m, 2H), 4.12 (t, <i>J</i> = 6.1 Hz, 2H), 2.81 (t, <i>J</i> = 6.1 Hz, 2H), 2.30 (s, 3H).</div></div><div id="sec4_6_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 1-Acetyl-6-(4-methoxyphenyl)-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>62</b>)</h3><div class="NLM_p last">To a solution of 1-acetyl-6-bromo-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>61</b>) (0.91 g, 3.4 mmol) in 1,2-dimethoxyethane (25 mL) was added (4-methoxyphenyl)boronic acid (0.67 g, 4.4 mmol), a 2.5 M solution of cesium carbonate in water (3.4 mL, 3.5 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.11 g, 0.035 mmol), and the mixture was stirred under reflux for 3.3 h. The solvent was then removed under reduced pressure, and CH<sub>2</sub>Cl<sub>2</sub> was added to the residue. The organic phase was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness. The residue was purified by flash chromatography on silica gel (2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to deliver the title compound (0.67 g, 67%) as a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 8.15 (s, 1H), 7.68 (d, <i>J</i> = 8.7 Hz, 1H), 7.48 (d, <i>J</i> = 8.7 Hz, 3H), 6.92 (d, <i>J</i> = 8.7 Hz, 2H), 4.20 (t, <i>J</i> = 6.1 Hz, 2H), 3.80 (s, 3H), 2.78 (t, <i>J</i> = 61 Hz, 2H), 2.33 (s, 3H).</div></div><div id="sec4_6_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (<i>E</i>)-Isopropyl But-2-enoylcarbamate (<b>63</b>)</h3><div class="NLM_p last">Isopropyl carbamate (30 g, 291 mmol) was charged to a 3 L Lara vessel, and dry THF (150 mL) added. (2<i>E</i>)-2-Butenoyl chloride (31.2 mL, 326 mmol) was added under nitrogen and the jacket cooled to −30 °C. When the solution temperature reached −17 °C, lithium <i>tert</i>-butoxide (655 mL, 655 mmol, 1 M in THF) was added by peristaltic pump over 2 h, keeping the reaction temperature between −10 °C and −18 °C. Once the addition was complete, the mixture was stirred for 30 min and brought to 0 °C. Et<sub>2</sub>O (450 mL) and HCl (375 mL, 1 M aqueous solution) were added and the mixture brought to 20 °C with vigorous stirring. The stirring was stopped and the layers allowed to separate and the aqueous layer to run off. Brine (375 mL) was added and the mixture stirred vigorously. The stirring was stopped, and the layers were allowed to separate and the aqueous layer to run off. The organic layer was dried (MgSO<sub>4</sub>), filtered, and evaporated to a brown oil (60 g). The mixture was loaded onto a 40+M Biotage silica column and eluted with CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (1:1 → 0:1, 10CV). The product containing fractions were evaporated to dryness and loaded on to a 1500 g Redisep Isco silica column and eluted with cyclohexane/EtOAc (0 → 40%, 17CV). The clean, product containing fractions were evaporated to an off-white solid (15.4 g, 29%). LCMS (method TFA): retention time 0.68 min, [M + H]<sup>+</sup> = 172.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.30 (d, <i>J</i> = 6.3 Hz, 6H), 1.94 (dd, <i>J</i> = 6.9, 1.6 Hz, 3H), 4.94–5.06 (m, 1H), 6.87 (dd, <i>J</i> = 15.4, 1.5 Hz, 1H), 7.14 (dq, <i>J</i> = 15.4, 6.9 Hz, 1H), 7.35 (br s, 1H).</div></div><div id="sec4_6_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (<i>S</i>)-Isopropyl (3-((4-Bromophenyl)amino)butanoyl)carbamate (<b>64</b>)</h3><div class="NLM_p last">(<i>E</i>)-Isopropyl but-2-enoylcarbamate (<b>63</b>) (9.38 g, 54.8 mmol) was stirred in toluene (281 mL) under nitrogen and ((<i>R</i>)-BINAP)ditriflatebis(acetonitrile)palladium(II) (3.35 g, 3.01 mmol) added. The catalyst formed a gummy ball, and the solution turned to an opaque yellow mixture and was stirred for 20 min. 4-Bromoaniline (14.14 g, 82 mmol) was added, the solution turned a clear light brown, and the gummy catalyst dissolved further. The mixture was stirred for 16 h. Similarly, a second batch of 1-methylethyl (2<i>E</i>)-2-butenoylcarbamate (8.51 g, 49.7 mmol) was stirred in toluene (255 mL) under nitrogen and ((<i>R</i>)-BINAP)ditriflatebis(acetonitrile)palladium(II) (3.04 g, 2.73 mmol) added. The catalyst formed a gummy ball, and the solution turned to an opaque yellow mixture and was stirred for 20 min. 4-Bromoaniline (12.83 g, 74.6 mmol) was added, the solution turned a clear light brown, and the gummy catalyst dissolved further. The mixture was stirred for 16 h. The two reaction mixtures were combined and loaded on to a 1.5 kg Isco silica Redisep column. The column was eluted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (0% → 0.5%, 19CV). The clean product containing fractions were evaporated to a pale-brown oil. The mixture was dried in a vacuum oven overnight at 40 °C to give a white solid (24.2 g, 67% overall). LCMS (method TFA) retention time = 0.91 min, [M + H]<sup>+</sup> = 342.9.. Chiral HPLC: 92% ee (method: ∼ 1 mg sample dissolved in EtOH/heptane (1 mL), 20 μL injected on 4.6 mm i.d. × 25 cm Chiralpak AD column (lot no. AD00CE-FE126)). Column eluted with 15% EtOH/heptane, <i>f</i> = 1.0 mL/min. UV detector wavelength = 215 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.26–1.35 (m, 9H), 2.90 (dd, <i>J</i> = 16.0, 6.2 Hz, 1H), 3.10 (dd, <i>J</i> = 15.9, 5.8 Hz, 1H), 3.86–3.94 (m, 1H), 3.94–4.06 (m, 1H), 4.92–5.03 (m, 1H), 6.51 (d, <i>J</i> = 8.8 Hz, 2H), 7.24 (d, <i>J</i> = 8.8 Hz, 2H), 7.44 (m, 1H).</div></div><div id="sec4_6_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Isopropyl ((2<i>S</i>,4<i>R</i>)-6-Bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate (<b>65</b>)</h3><div class="NLM_p last">(<i>S</i>)-Isopropyl (3-((4-bromophenyl)amino)butanoyl)carbamate (<b>64</b>) (17.9 g, 52.2 mmol) was taken up in EtOH (150 mL) and cooled to below −10 °C (internal temperature) in a CO<sub>2</sub>/acetone bath. Sodium borohydride (1.381 g, 36.5 mmol) was added, followed by magnesium chloride hexahydrate (11.35 g, 55.8 mmol) in water (25 mL), keeping the temperature below −5 °C. The mixture was allowed to stir at <0 °C for 1 h then warmed to room temperature and stirred for 1 h. The resulting thick suspension was poured into a mixture of citric acid (25.05 g, 130 mmol), HCl (205 mL, 205 mmol, 1 M aqueous solution), and CH<sub>2</sub>Cl<sub>2</sub> (205 mL). The biphasic mixture was stirred at room temperature for 1 h. The layers were separated and the organic layer dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield the product as a single <i>cis</i> isomer, a light-brown solid (14.1 g, 78%). LCMS (method formic): retention time = 1.13 min, [M + H]<sup>+</sup> = 327.2 (99% purity). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.14 (d, <i>J</i> = 6.3 Hz, 3H), 1.20 (d, <i>J</i> = 6.3 Hz, 3H), 1.23 (d, <i>J</i> = 6.3 Hz, 3H), 1.46 (q, <i>J</i> = 11.9 Hz, 1H), 1.88–1.97 (m, 1H) 3.40–3.51 (m, 1H), 4.69–4.79 (m, 1H), 4.78–4.88 (m, 1H), 6.48 (d, <i>J</i> = 8.6 Hz, 1H), 6.98 (s, 1H), 7.07 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 7.42 (d, <i>J</i> = 9.1 Hz, 1H).</div></div><div id="sec4_6_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Isopropyl ((2<i>S</i>,4<i>R</i>)-1-Acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate (<b>66</b>)</h3><div class="NLM_p">Isopropyl ((2<i>S</i>,4<i>R</i>)-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate (<b>65</b>) (14.1 g, 43.1 mmol) was taken up in CH<sub>2</sub>Cl<sub>2</sub> (400 mL) under nitrogen at room temperature. Pyridine (10.46 mL, 129 mmol) followed by acetyl chloride (4.60 mL, 64.6 mmol) were added and the reaction stirred for 16 h. The reaction mixture was partitioned between EtOAc (2000 mL) and a saturated NaHCO<sub>3</sub> aqueous solution (800 mL). The organic layer was extracted and washed with water (1500 mL) and brine (1500 mL) and then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield a purple solid. The crude product was taken up in the minimum of dichloromethane and applied to a Companion XL column (330 g) and eluted with 12% EtOAc in cyclohexane for 1CV, then 12–63% EtOAc over 12 CV, then held at 63% for 4CV. The appropriate fractions were collected to afford the title product as an off-white solid (12.37 g, 78%). LCMS (method formic): retention time 1.03 min, [M + H]<sup>+</sup> = 369.1. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.61 (br d, <i>J</i> = 8.6 Hz, 1H), 7.47 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 2.4 Hz, 1H), 4.83 (spt, <i>J</i> = 6.2 Hz, 1H), 4.66–4.58 (m, 1H), 4.40–4.33 (m, 1H), 2.44 (ddd, <i>J</i> = 12.7, 8.5, 4.5 Hz, 1H), 2.05 (s, 3H), 1.24 (dd, <i>J</i> = 16.3, 6.1 Hz, 6H), 1.21–1.16 (m, 2H), 1.02 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (150.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 168.4 (s, 1C), 155.7 (s, 1C), 139.2 (s, 1C), 135.4 (br s, 1C), 129.6 (s, 1C),128.1 (br s, 1C), 125.5 (s, 1C), 117.9 (s, 1C), 67.3 (s, 1C), 46.9 (br s, 1C), 46.6 (s, 1C), 39.6 (s, 1C), 22.5 (s, 1C), 22.0 (s, 2C), 21.2 (s, 1C), See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S4">Supporting Information Figure S4</a> for NMR spectra.</div><div class="NLM_p last">Separation of enantiomers: Chiralpak AD column, 20 μm particle size, internal diameter 75 mm, bed length 258 mm. Eluent 80:20 heptane:ethanol. Flow: 400 mL/min. Temperature: ambient. Injection volume: ∼44 mL containing 4 g of compound <b>66</b> in 35:65 v/v heptane:ethanol. Run time: 4.5 min. Pure fractions containing the required first eluting enantiomer from all the injections were concentrated to dryness on a rotary evaporator to give product as a solid. This was slurried in heptane, stirred for 1 h at 20–25 °C, filtered, washed on the filter with heptane, and dried under vacuum at 40 °C to give the product as a solid (89% recovery). HPLC analysis showed that the product contained <0.5% of the second eluting enantiomer. [α]<i>D</i> = +281.1° (<i>T</i> = 20.7 °C, 10 mm cell, <i>c</i> = 0.508 g/100 mL, EtOH).</div></div><div id="sec4_6_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Ethyl 4-((2<i>S</i>,4<i>R</i>)-1-Acetyl-4-((isopropoxycarbonyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>67</b>)</h3><div class="NLM_p last">Isopropyl ((2<i>S</i>,4<i>R</i>)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate (<b>66</b>) (53.47 g, 145 mmol), {4-[(ethyloxy)carbonyl]phenyl}boronic acid (29.51 g, 152 mmol), and tetrakis(triphenylphosphine)palladium (2.51 g, 2.17 mmol) were mixed in DME (500 mL) and the mixture treated with a 2N Na<sub>2</sub>CO<sub>3</sub> aqueous solution (290 mL, 580 mmol). The mixture was degassed and then heated at 105 °C under nitrogen for 16 h. The mixture was then cooled to room temperature and was partitioned between EtOAc and water. The layers were separated, and the aqueous phase was extracted twice with EtOAc. The combined organics were washed with water and then brine, dried using a hydrophobic frit, and concentrated in vacuo. The residual gray–brown solid was dissolved in EtOAc and filtered through a plug of silica. The silica was washed with EtOAc, and the combined filtrate and washings were concentrated in vacuo to give a cream solid. This material was triturated with Et<sub>2</sub>O, filtered, and the solid washed with a small volume of Et<sub>2</sub>O. The solid was partially air-dried and then dried under vacuum at 40–50 °C to give the title compound (56.2 g, 89%) as a white solid, which was used in the next step without further purification. The filtrate and washings were concentrated in vacuo. The gummy brown residue obtained was triturated with Et<sub>2</sub>O and the solvent removed in vacuo. The trituration with Et<sub>2</sub>O was repeated. The solid obtained was collected by filtration, washed with Et<sub>2</sub>O, and dried under vacuum at 40 °C to give another batch of the title compound (1.7 g, 2.7%) as a very pale-gray solid, which was used in the next step without further purification. LCMS (method formic) retention time = 1.16 min, [M + H]<sup>+</sup> = 439.16. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06 (d, <i>J</i> = 8.3 Hz, 2H), 7.80 (d, <i>J</i> = 8.3 Hz, 2H), 7.71 (d, <i>J</i> = 8.8 Hz, 1H), 7.65 (dd, <i>J</i> = 1.8, 8.8 Hz, 1H), 7.46 (m, 2H), 4.85 (spt, <i>J</i> = 6.9 Hz, 1H), 4.66 (m, 1H), 4.45 (m, 1H), 4.34 (q, <i>J</i> = 7.1 Hz, 2H), 2,47 (m, 1H), 2.10 (s, 3H), 1.35 (t, <i>J</i> = 7.1 Hz, 3H), 1.25 (t, <i>J</i> = 6.9 Hz, 6H), 1.19 (m, 1H), 1.06 (d, <i>J</i> = 6.3 Hz, 3H).</div></div><div id="sec4_6_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Ethyl 4-((2<i>S</i>,4<i>R</i>)-1-Acetyl-4-amino-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoate (<b>68</b>)</h3><div class="NLM_p last">Ethyl 4-[(2<i>S</i>,4<i>R</i>)-1-acetyl-2-methyl-4-({[(1-methylethyl)oxy]carbonyl}amino)-1,2,3,4-tetrahydro-6-quinolinyl]benzoate (<b>67</b>) (25.33g, 57.8 mmol) was added to a ice-cold suspension of AlCl<sub>3</sub> (29.24 g, 219 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (450 mL), and the resulting solution was stirred at 0 °C for 20 min. A solution of NEt<sub>3</sub> (96 mL, 693 mmol) and MeOH (50 mL) was then added over approximately 2 min (initially dropwise and then faster after first third of the solution was used). The mixture was stirred for 30 min in the ice bath, then was diluted with EtOAc, filtered through Celite, and the residue washed with EtOAc. The residue was partitioned between EtOAc and a saturated sodium NaHCO<sub>3</sub> aqueous solution. The biphasic mixture was filtered through Celite, and the residue was washed with EtOAc. The residue was further washed with acetone and the acetone washings combined with the previous biphasic mixture. Most of the organics were concentrated in vacuo, and the aqueous residue was partitioned between EtOAc and water. The layers were separated, and the aqueous phase was extracted with EtOAc. The combined organic phases were washed with brine, dried using a hydrophobic frit, and concentrated in vacuo to give the title compound (14.7 g, 72%) as a cream solid which was used in the next step without further purification. The solid residue was rewashed with MeOH, and most of the MeOH was concentrated in vacuo. The residue was partitioned between EtOAc and water, and the layers were separated. The aqueous phase was extracted with EtOAc, and the combined organic phases were dried using a hydrophobic frit and concentrated in vacuo to give the title compound (5.3 g, 26%) as a cream solid, which was used in the next step without further purification. LCMS (method formic) retention time 0.73 min, [M + H – NH<sub>2</sub>]<sup>+</sup> = 337.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06 (d, <i>J</i> = 8.3 Hz, 2H), 7.87–7.91 (m, 3H), 7.63 (dd, <i>J</i> = 2.0, 8.3 Hz, 1H), 7.39 (d, <i>J</i> = 8.3 Hz, 1H), 4.62 (m, 1H), 4.36 (q, <i>J</i> = 7.0 Hz, 2H), 3.62 (m, 1H), 2.46 (m, 1H), 2.08 (s, 3H), 1.36 (t, <i>J</i> = 7.0 Hz, 3H), 1.19 (m, 1H), 1.06 (d, <i>J</i> = 6.3 Hz, 3H). NH<sub>2</sub> not observed.</div></div><div id="sec4_6_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Ethyl 4-{(2<i>S</i>,4<i>R</i>)-1-Acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl}benzoate (<b>69</b>)</h3><div class="NLM_p last">Ethyl 4-[(2<i>S</i>,4<i>R</i>)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]benzoate (<b>68</b>) (24.6 g, 69.8 mmol), 1-bromo-4-chlorobenzene (26.7 g, 140 mmol), bis(dibenzylideneacetone)palladium (3.20 g, 5.56 mmol), and [2′-(dicyclohexylphosphanyl)-2-biphenylyl]dimethylamine (Dave-phos, 2.19 g, 5.56 mmol) were mixed in toluene (450 mL), and the mixture was treated with sodium <i>t</i>-butoxide (7.38 g, 77 mmol). The resulting mixture was degassed and stirred at 70 °C under nitrogen for 24 h, then was cooled to room temperature and filtered through Celite. The residue was washed with toluene and then with Et<sub>2</sub>O. The combined filtrate and washings were washed twice with water then twice with a 2 N HCl aqueous solution. The orange oil which precipitated was collected with the aqueous phase. The acid extracts were extracted with EtOAc, and the combined organics were washed with water and brine. This water and brine were combined with the acidic washes in order to recover the starting material (vide infra). The organic solution was further dried over MgSO<sub>4</sub> and concentrated in vacuo to give a dark-orange oil. This experiment was repeated, and the two residues hence obtained were combined for further purification. Purification of these combined residues by flash chromatography on silica gel (750 g column, 5–80% AcOEt in hexane) gave the title compound (16.5 g, 26% mean yield) as a pale-yellow foam. The impure fractions containing product were combined and concentrated in vacuo. Purification of this residue by flash chromatography on silica gel (330 g column, 5–80% AcOEt in hexane) gave the title compound (7.3 g, 11% mean yield) as a pale-brown foam. The combined acidic phases (vide supra) were basified using solid Na<sub>2</sub>CO<sub>3</sub> and then were extracted three times with EtOAc. The combined organics were dried over MgSO<sub>4</sub> and combined with the same organic phases from the parallel experiment, then were concentrated in vacuo to give <b>69</b> (28.0 g, 57% average yield) as an orange foam which partially crystallized upon standing overnight. This material could be used in a repeat of this coupling without further purification. LCMS (method formic) retention time 1.35 min, [M + H – NHPhCl]<sup>+</sup> = 337.23. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (d, <i>J</i> = 8.6 Hz, 2H), 7.69 (d, <i>J</i> = 8.6 Hz, 2H), 7.64 (dd, <i>J</i> = 2.0, 8.1 Hz, 1H), 7.47 (m, 2H), 7.12 (d, <i>J</i> = 8.8 Hz, 2H), 6.74 (d, <i>J</i> = 8.8 Hz, 2H), 6.30 (d, <i>J</i> = 8.1 Hz, 1H), 4.71 (m, 1H), 4.32 (q, <i>J</i> = 7.1 Hz, 2H), 4.28 (m, 1H), 2.62 (m, 1H), 2.15 (s, 3H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H), 1.23 (m, 1H), 1.10 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> FaSSIF Solubility</h3><div class="NLM_p last">See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>, for details of this high-throughput method to determine the solubility of compounds in fasted-state simulated intestinal fluid by precipitation.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> ApoA1 Luciferase Assay</h3><div class="NLM_p last">HepG2 cells were stably transfected with a plasmid encoding firefly luciferase under the control of the human ApoA1 promoter region (−1162, +232) and the 3′-UTR of the human ApoA-1 gene (+1037, +1091). ApoA1 potency was defined as the concentration of compound, resulting in a 70% increase in luciferase luminescence (ApoA1 Luc EC<sub>170</sub>). See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>. High correlation has been shown between ApoA1-luciferase reporter activity and ApoA1 protein secretion in HepG2 cells.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Recombinant Protein Binding Assays</h3><div class="NLM_p last">The tandem bromodomain constructs of BRD2, BRD3, and BRD4 were screened in two formats. The FA (fluorescence anisotropy) assay measures displacement of a labeled benzodiazepine analogue of <b>1</b>, as previously described.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The TR-FRET (time-resolved fluorescence resonance energy transfer) assay measures displacement of a tetra-acetylated biotinylated peptide. See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>, for full details.</div></div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> IL-6 PBMC and Whole Blood Assays</h3><div class="NLM_p last">Human whole blood and peripheral blood mononuclear cells (PBMCs) purified from whole blood were incubated with LPS and varying concentrations of test compounds for 18–24 h. Samples were prepared, and inhibition of IL-6 was measured as described in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Thermal Shift Assay (<i>T</i><sub>m</sub>)</h3><div class="NLM_p last">Thermal shifts of bromodomains were analyzed on a FluoDiaT70 instrument. The temperature of the protein sample was ramped from 26/30 to 74 °C in the presence or absence of 100 μM of the ligand. Denaturation was visualized using 1:1000 dilution of a fluorescent Sypro orange dye in a buffer of PBS, 10% glycerol. The temperature was ramped at a rate of 1 °C/min and fluorescence readings taken every 1 °C. Bromodomains tested included ATAD2, BAZ2B, BRD2 (tandem bromodomains), BRD4 (N- and C-terminal and tandem bromodomains), CREBBP, PCAF, SMARCA2, SP140, and TAF1 (tandem bromodomains). Results reported are the mean of at least two experiments.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Surface Plasmon Resonance (BIAcore) Analysis of Binding to BRD2, <b>3</b>, and <b>4</b></h3><div class="NLM_p last">BIAcore data of His6-tagged BRD2 (1–473), BRD3 (1–434), and BRD4 (1–477) was acquired and analyzed on a T100 BIAcore instrument at 25 °C. In all cases, a CM5 chip with ∼5–12kU amine coupled protein immobilized on the dextran surface was used with a running buffer of 30 mM Hepes pH 7, 150 mM NaCl, 1 mM EGTA, NaN3. Compounds were titrated as a tripling dilution starting from 10 μM. Sensorgrams and binding curves were analyzed with BIAevaluation (GE Healthcare) using a 1:1 binding model. The equilibrium <i>K</i><sub>D</sub> was calculated using response = concentration × <i>R</i><sub>max</sub>/(concentration + <i>K</i><sub>D</sub>) + offset. Example dose response fits are given in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Figure S2">Supporting Information, Figure S2</a>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Isothermal Titration Calorimetry.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></h3><div class="NLM_p">ITC titration of BRD4 was carried out using a Microcal VPITC in 50 mM Hepes, pH 7.5, 150 mM NaCl, at 25 °C. First, 9 μM His-tagged BRD4 (1–477) tandem bromodomain was placed in the cell and 200 μM ligand was titrated into this to achieve a final ligand:protein excess of ∼4:1. The data was then fitted within Origin (Microcal version) to give the following parameters: stoichiometry of 1.93, <i>K</i><sub>D</sub> of 4.4 ± 0.9 nM, Δ<i>H</i> −15.9 ± 0.08 kcal/mol, Δ<i>S</i> −15.2 cal/mol/deg.</div><div class="NLM_p last">ITC titration of CREBBP was carried out using a Microcal AutoITC200 in 50 mM Hepes, pH 7.4, 150 mM NaCl, at 25 °C. First, 44 μM of CREBBP bromodomain was placed in the cell, and 500 μM ligand was titrated into this to achieve a final ligand:protein excess of ∼2.2:1. The data was then fitted within Origin (Microcal version) to give the following parameters: stoichiometry of 1.1, <i>K</i><sub>D</sub> of 6.3 ± 0.5 μM, Δ<i>H</i> −4.35 ± 0.08 kcal/mol, Δ<i>S</i> 9.2 cal/mol/deg.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> X-ray Crystallography</h3><div class="NLM_p last">General methods for the crystallography of the N-terminal bromodomain of Brd2 have been previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The complexes of <b>28</b> and <b>47</b> were determined using <i>Escherichia coli</i> expressed His-tagged Brd2 (67–200). Specific details for each complex determined are given in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>. For the C-terminal bromodomain of Brd2, <i>E. coli</i> expressed His-tagged Brd2-BD2 (338–473) was purified to homogeneity using standard protocols in a similar manner to the N-terminal bromodomain of Brd4 using His affinity capture, Tev protease cleavage, and gel filtration.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>, for full details. Ligand OMIT maps and refinement statistics are shown in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information Figure S3 and Table S5">Supporting Information Figure S3 and Table S5</a>. Methods for the determination of the complex of <b>47</b> with the Brd4 N-terminal bromodomain and <b>48</b> with the Brd2 N-terminal bromodomain have previously been described.<a onclick="showRef(event, 'ref29 ref37'); return false;" href="javascript:void(0);" class="ref ref29 ref37">(29, 37)</a></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Cytochrome P450 Inhibition and Time-Dependent Inhibition Studies</h3><div class="NLM_p last">All cytochrome P450 inhibition studies were performed as described in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>, at GlaxoSmithKline Medicines Research Centre (Stevenage, UK).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Hepatocyte Clearance</h3><div class="NLM_p last">Intrinsic clearance studies were performed as described in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>, at GlaxoSmithKline Medicines Research Centre (Ware, UK).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Permeability Assay</h3><div class="NLM_p last">Artificial membrane permeability was measured as described in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Blood Protein Binding</h3><div class="NLM_p last">All measurements of blood protein binding were performed as described in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>, at GlaxoSmithKline Medicines Research Centre (Stevenage, UK).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Animal Studies</h3><div class="NLM_p last">All animal studies were ethically reviewed and carried out in accordance with the GSK Policy on the Care, Welfare, and Treatment of Animals and European Directive 86/609. The rat PK study was performed at GSK Stevenage, UK, the dog PK study at GSK Ware, UK, the mouse PK studies at GSK Les Ulis, France, and the primate PK study at CIT, France. For all studies, the temperature and humidity were nominally maintained at 21 °C ± 2 °C and 55% ± 10%, respectively. There were no known contaminants in the diet or water at concentrations that could interfere with the outcome of the studies. See <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Pharmacokinetics Studies</h3><div class="NLM_p last">Diluted blood samples (1:1 with water) or plasma were extracted using protein precipitation with acetonitrile containing an analytical internal standard. An aliquot of the supernatant was analyzed by reverse phase LC-MS/MS using a heat assisted electrospray interface in positive ion mode. Samples were assayed against calibration standards prepared in control blood. PK parameters were obtained from the blood or plasma concentration–time profiles using noncompartmental analysis with WinNonlin Professional 4.1a (Pharsight, Mountain View, CA).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> In Vivo Murine Efficacy Models</h3><div class="NLM_p last">The effects of single-dose administration of compound <b>47</b> on LPS-induced PAI-1 RNA expression, and in a mouse model of septic shock, were determined as described in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information, Supplementary Methods">Supporting Information, Supplementary Methods</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107"><a href="/doi/suppl/10.1021/jm5010539">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Methods, bromodomain selectivity profile of <b>47</b>, BET binding curves of <b>47</b> by SPR, X-ray ligand density maps, NMR spectra, tables showing mean, standard deviation and number of test occasions, thermal melting results for <b>47</b>, receptor, transporter, and ion channel cross-screening of <b>47</b>, X-ray data collection and refinement statistics. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5010539/suppl_file/jm5010539_si_001.pdf">jm5010539_si_001.pdf (1.19 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The X-ray coordinates have been deposited with the Protein Data Bank. The codes are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyf">4uyf</a> (BRD2 N-terminal bromodomain with <b>47</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyg">4uyg</a> (BRD2 C-terminal bromodomain with <b>47</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyh">4uyh</a> (BRD2 N-terminal bromodomain with <b>28</b>).</p><div class="testing" data-doi="10.1021/jm5010539" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bamborough</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0979687c652768276b68646b667b667c6e61496e7a62276a6664"><span class="__cf_email__" data-cfemail="3a4a5b4f56145b14585b57585548554f5d527a5d495114595557">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rab K. Prinjha</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#661407040f080203144816140f080c0e072601150d4805090b"><span class="__cf_email__" data-cfemail="96e4f7f4fff8f2f3e4b8e6e4fff8fcfef7d6f1e5fdb8f5f9fb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romain Gosmini</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Van Loc Nguyen</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jérôme Toum</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Simon</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Marie G. Brusq</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gael Krysa</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Mirguet</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alizon M. Riou-Eymard</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric V. Boursier</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lionel Trottet</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hugh Clark</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chun-wa Chung</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leanne Cutler</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuel H. Demont</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rejbinder Kaur</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonia J. Lewis</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark B. Schilling</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter E. Soden</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Taylor</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann L. Walker</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew D. Walker</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edwige Nicodème</span> - <span class="hlFld-Affiliation affiliation">†Candidate Discovery, ‡Discovery Biology, §DMPK, GlaxoSmithKline
Les Ulis, Centre de Recherches François Hyafil, GlaxoSmithKline
R&D, 25 Avenue du
Québec, 91140 Villebon-sur-Yvette, France</span>; 
    <span class="hlFld-Affiliation affiliation">∥Epinova Discovery Performance Unit, ⊥Computational & Structural
Chemistry, #Experimental
Medicine Unit, ∇Biological Sciences, ○Exploratory Development Sciences, ◆Discovery Partnerships Medicinal
Chemistry, GlaxoSmithKline Stevenage, Medicines
Research Centre, Gunnels
Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1161e7219-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i112">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the DiscoveRx Corporation for BROMO<i>scan</i><sup>SM</sup> selectivity screening. We thank Richard Upton (GlaxoSmithKline, Stevenage) for NMR support, Catherine Cartwright and James Clarke (GlaxoSmithKline, Ware) for in vitro preclinical developability profile information, and Nigel Parr and Iain Uings (GlaxoSmithKline, Stevenage) for leadership and helpful guidance given to the BET bromodomain program.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i113" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i113"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i114" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i114"> Abbreviations Used</h2><tr><td class="NLM_term">AcK</td><td class="NLM_def"><p class="first last">acetyl-lysine</p></td></tr><tr><td class="NLM_term">ApoA1</td><td class="NLM_def"><p class="first last">apolipoprotein A-1</p></td></tr><tr><td class="NLM_term">BD</td><td class="NLM_def"><p class="first last">bromodomain</p></td></tr><tr><td class="NLM_term">BET</td><td class="NLM_def"><p class="first last">bromodomain and extra-terminal</p></td></tr><tr><td class="NLM_term">BRD2/3/4</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 2/3/4</p></td></tr><tr><td class="NLM_term">BZD</td><td class="NLM_def"><p class="first last">benzodiazepine</p></td></tr><tr><td class="NLM_term">CREBBP</td><td class="NLM_def"><p class="first last">cAMP response element-binding binding protein</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">fluorescence anisotropy</p></td></tr><tr><td class="NLM_term">IL6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">NUT</td><td class="NLM_def"><p class="first last">nuclear protein in testis</p></td></tr><tr><td class="NLM_term">THQ</td><td class="NLM_def"><p class="first last">tetrahydroquinoline</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Toth, P. P.</span><span> </span><span class="NLM_article-title">Cardiology patient page. The “good cholesterol”: high-density lipoprotein</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">e89</span><span class="NLM_x">–</span> <span class="NLM_lpage">e91</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=e89-e91&author=P.+P.+Toth&title=Cardiology+patient+page.+The+%E2%80%9Cgood+cholesterol%E2%80%9D%3A+high-density+lipoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DP.%2BP.%26atitle%3DCardiology%2520patient%2520page.%2520The%2520%25E2%2580%259Cgood%2520cholesterol%25E2%2580%259D%253A%2520high-density%2520lipoprotein%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3De89%26epage%3De91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Linsel-Nitschke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tall, A. R.</span><span> </span><span class="NLM_article-title">HDL as a target in the treatment of atherosclerotic cardiovascular disease</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=193-205&author=P.+Linsel-Nitschkeauthor=A.+R.+Tall&title=HDL+as+a+target+in+the+treatment+of+atherosclerotic+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinsel-Nitschke%26aufirst%3DP.%26aulast%3DTall%26aufirst%3DA.%2BR.%26atitle%3DHDL%2520as%2520a%2520target%2520in%2520the%2520treatment%2520of%2520atherosclerotic%2520cardiovascular%2520disease%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D193%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wong, N. C.</span><span> </span><span class="NLM_article-title">Novel therapies to increase apolipoprotein AI and HDL for the treatment of atherosclerosis</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=718-728&author=N.+C.+Wong&title=Novel+therapies+to+increase+apolipoprotein+AI+and+HDL+for+the+treatment+of+atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DN.%2BC.%26atitle%3DNovel%2520therapies%2520to%2520increase%2520apolipoprotein%2520AI%2520and%2520HDL%2520for%2520the%2520treatment%2520of%2520atherosclerosis%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D718%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.+W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.+M.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Clementauthor=A.+B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+characterization+of+small+molecule+inhibitors+of+the+BET+family+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0lh-NkMAmfkWRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520small%2520molecule%2520inhibitors%2520of%2520the%2520BET%2520family%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clément, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnathan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodème, E.</span><span> </span><span class="NLM_article-title">Discovery of epigenetic regulator I-BET-762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7501</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401088k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7501-7515&author=O.+Mirguetauthor=R.+Gosminiauthor=J.+Toumauthor=C.+A.+Cl%C3%A9mentauthor=M.+Barnathanauthor=J.-M.+Brusqauthor=J.+E.+Mordauntauthor=R.+M.+Grimesauthor=M.+Croweauthor=O.+Pineauauthor=M.+Ajakaneauthor=A.+Dauganauthor=L.+Cutlerauthor=A.+C.+Haynesauthor=N.+N.+Smithersauthor=C.+Chungauthor=P.+Bamboroughauthor=I.+Uingsauthor=A.+Lewisauthor=J.+Witheringtonauthor=N.+Parrauthor=R.+K.+Prinjhaauthor=E.+Nicod%C3%A8me&title=Discovery+of+epigenetic+regulator+I-BET-762%3A+lead+optimization+to+afford+a+clinical+candidate+inhibitor+of+the+BET+bromodomains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm401088k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401088k%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DC.%2BA.%26aulast%3DBarnathan%26aufirst%3DM.%26aulast%3DBrusq%26aufirst%3DJ.-M.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DGrimes%26aufirst%3DR.%2BM.%26aulast%3DCrowe%26aufirst%3DM.%26aulast%3DPineau%26aufirst%3DO.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%2BC.%26aulast%3DSmithers%26aufirst%3DN.%2BN.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DUings%26aufirst%3DI.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicod%25C3%25A8me%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520epigenetic%2520regulator%2520I-BET-762%253A%2520lead%2520optimization%2520to%2520afford%2520a%2520clinical%2520candidate%2520inhibitor%2520of%2520the%2520BET%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7501%26epage%3D7515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span>ClinicalTrials.gov; <span class="NLM_publisher-name">National Library of Medicine</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_month">August</span><span class="NLM_day">30</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://www.clinicaltrials.gov" class="extLink">http://www.clinicaltrials.gov</a>. .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov%3B+National+Library+of+Medicine%3A+Bethesda%2C+MD%2C+August30%2C+2014%3B+http%3A%2F%2Fwww.clinicaltrials.gov.+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DClinicalTrials.gov%26pub%3DNational%2520Library%2520of%2520Medicine%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandwani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marazzi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span> </span><span class="NLM_article-title">Suppression of inflammation by a synthetic histone mimic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnature09589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21068722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1119-1123&author=E.+Nicodemeauthor=K.+L.+Jeffreyauthor=U.+Schaeferauthor=S.+Beinkeauthor=S.+Dewellauthor=C.+W.+Chungauthor=R.+Chandwaniauthor=I.+Marazziauthor=P.+Wilsonauthor=H.+Costeauthor=J.+Whiteauthor=J.+Kirilovskyauthor=C.+M.+Riceauthor=J.+M.+Loraauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=A.+Tarakhovsky&title=Suppression+of+inflammation+by+a+synthetic+histone+mimic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of inflammation by a synthetic histone mimic</span></div><div class="casAuthors">Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression.  This response, although vital for immune defense, is frequently deleterious to the host due to the exaggerated prodn. of inflammatory proteins.  The scope of inflammatory responses reflects the activation state of signaling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression.  Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a crit. step in the regulation of gene expression.  Here we present a novel pharmacol. approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins.  We describe a synthetic compd. (I-BET) that by mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis.  Our findings suggest that synthetic compds. specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxc3_PNaiuKLVg90H21EOLACvtfcHk0li-r6Gi3qiSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP&md5=0dfccd9d01b87859512bf591e1c5a93c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature09589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09589%26sid%3Dliteratum%253Aachs%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DK.%2BL.%26aulast%3DSchaefer%26aufirst%3DU.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DDewell%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChandwani%26aufirst%3DR.%26aulast%3DMarazzi%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520inflammation%2520by%2520a%2520synthetic%2520histone%2520mimic%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1119%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Florence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, D. V.</span><span> </span><span class="NLM_article-title">You bet-cha: a novel family of transcriptional regulators</span> <span class="citation_source-journal">Front Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=D1008-D1018&author=B.+Florenceauthor=D.+V.+Faller&title=You+bet-cha%3A+a+novel+family+of+transcriptional+regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlorence%26aufirst%3DB.%26aulast%3DFaller%26aufirst%3DD.%2BV.%26atitle%3DYou%2520bet-cha%253A%2520a%2520novel%2520family%2520of%2520transcriptional%2520regulators%26jtitle%3DFront%2520Biosci.%26date%3D2001%26volume%3D6%26spage%3DD1008%26epage%3DD1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Belkina, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, G. V.</span><span> </span><span class="NLM_article-title">BET domain co-regulators in obesity, inflammation and cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnrc3256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22722403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=465-477&author=A.+C.+Belkinaauthor=G.+V.+Denis&title=BET+domain+co-regulators+in+obesity%2C+inflammation+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">BET domain co-regulators in obesity, inflammation and cancer</span></div><div class="casAuthors">Belkina, Anna C.; Denis, Gerald V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helixes and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes.  Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression.  Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets.  However, small mols. that inhibit bromodomain and extraterminal (BET) proteins have been described.  We examine these developments and discuss the implications for small mol. epigenetic targeting of chromatin networks in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1x-bD67oukrVg90H21EOLACvtfcHk0li-r6Gi3qiSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D&md5=d06d88ef0d5d4d71115f40a2f901f53d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc3256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3256%26sid%3Dliteratum%253Aachs%26aulast%3DBelkina%26aufirst%3DA.%2BC.%26aulast%3DDenis%26aufirst%3DG.%2BV.%26atitle%3DBET%2520domain%2520co-regulators%2520in%2520obesity%252C%2520inflammation%2520and%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Small molecule bromodomain inhibitors: extending the druggable genome</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2FB978-0-12-396493-9.00001-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22520470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1-55&author=C.+W.+Chung&title=Small+molecule+bromodomain+inhibitors%3A+extending+the+druggable+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule bromodomain inhibitors: extending the druggable genome</span></div><div class="casAuthors">Chung, Chun-Wa</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-55</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on some of the existing knowledge for the young and rapidly evolving field of bromodomain inhibition.  Topics covered include structure and function of bromodomain, bromodomain-contg. proteins, therapeutic potential of bromodomains, and bromodomain inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI9QR6f10R97Vg90H21EOLACvtfcHk0li-r6Gi3qiSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChtr7K&md5=6a947139e3939e752fb09a749938b3a9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396493-9.00001-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396493-9.00001-7%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DSmall%2520molecule%2520bromodomain%2520inhibitors%253A%2520extending%2520the%2520druggable%2520genome%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D1%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Progress in the discovery of small-molecule inhibitors of bromodomain—histone interactions</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1177%2F1087057111421372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21956175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Slt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=1170-1185&author=C.+W.+Chungauthor=J.+Witherington&title=Progress+in+the+discovery+of+small-molecule+inhibitors+of+bromodomain%E2%80%94histone+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions</span></div><div class="casAuthors">Chung, Chun-Wa; Witherington, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1170-1185</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Bromodomains are structurally conserved protein modules present in a large no. of chromatin-assocd. proteins and in many nuclear histone acetyltransferases.  The bromodomain functions as an acetyl-lysine binding domain and has been shown to be pivotal in regulating protein-protein interactions in chromatin-mediated cellular gene transcription, cell proliferation, and viral transcriptional activation.  Structural analyses of these modules in complex with acetyl-lysine peptide ligands provide insights into the mol. basis for recognition and ligand selectivity within this epigenetic reader family.  However, there are significant challenges in configuring assays to identify inhibitors of these proteins.  This review focuses on the progress made in developing methods to identify peptidic and small-mol. ligands using biophys. label-free and biochem. approaches.  The advantage of each technique and the results reported are summarized, highlighting the potential applicably to other reader domains and the caveats in translation from simple in vitro systems to a biol. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodACR_uPDbcbVg90H21EOLACvtfcHk0lidgZ7Pky0pvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Slt7o%253D&md5=47a8a24b59135f0d4ed94d103bcb52ec</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1087057111421372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111421372%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DProgress%2520in%2520the%2520discovery%2520of%2520small-molecule%2520inhibitors%2520of%2520bromodomain%25E2%2580%2594histone%2520interactions%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26spage%3D1170%26epage%3D1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Bromodomains as therapeutic targets</span> <span class="citation_source-journal">Expert Rev. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1017%2FS1462399411001992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21933453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OhurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=e29&author=S.+Mullerauthor=P.+Filippakopoulosauthor=S.+Knapp&title=Bromodomains+as+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomains as therapeutic targets</span></div><div class="casAuthors">Muller, Susanne; Filippakopoulos, Panagis; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Reviews in Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e29/1-e29/21</span>CODEN:
                <span class="NLM_cas:coden">ERMMFS</span>;
        ISSN:<span class="NLM_cas:issn">1462-3994</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Acetylation of lysine residues is a post-translational modification with broad relevance to cellular signalling and disease biol.  Enzymes that 'write' (histone acetyltransferases, HATs) and 'erase' (histone deacetylases, HDACs) acetylation sites are an area of extensive research in current drug development, but very few potent inhibitors that modulate the 'reading process' mediated by acetyl lysines have been described.  The principal readers of ε-N-acetyl lysine (Kac) marks are bromodomains (BRDs), which are a diverse family of evolutionary conserved protein-interaction modules.  The conserved BRD fold contains a deep, largely hydrophobic acetyl lysine binding site, which represents an attractive pocket for the development of small, pharmaceutically active mols.  Proteins that contain BRDs have been implicated in the development of a large variety of diseases.  Recently, two highly potent and selective inhibitors that target BRDs of the BET (bromodomains and extra-terminal) family provided compelling data supporting targeting of these BRDs in inflammation and in an aggressive type of squamous cell carcinoma.  It is likely that BRDs will emerge alongside HATs and HDACs as interesting targets for drug development for the large no. of diseases that are caused by aberrant acetylation of lysine residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSuKacpsr6xLVg90H21EOLACvtfcHk0lidgZ7Pky0pvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OhurjI&md5=dc9383afcbe6aedc265041c21213aa0b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FS1462399411001992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399411001992%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DBromodomains%2520as%2520therapeutic%2520targets%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2011%26volume%3D13%26spage%3De29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Progress in the development and application of small molecule inhibitors of bromodomain–acetyl-lysine interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300915b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9393-9413&author=D.+S.+Hewingsauthor=T.+P.+Rooneyauthor=L.+E.+Jenningsauthor=D.+A.+Hayauthor=C.+J.+Schofieldauthor=P.+E.+Brennanauthor=S.+Knappauthor=S.+J.+Conway&title=Progress+in+the+development+and+application+of+small+molecule+inhibitors+of+bromodomain%E2%80%93acetyl-lysine+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm300915b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300915b%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520development%2520and%2520application%2520of%2520small%2520molecule%2520inhibitors%2520of%2520bromodomain%25E2%2580%2593acetyl-lysine%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9393%26epage%3D9413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Adachi, K.; Endoh, J.; Fuhie, N.; Hamada, M.; Hikawa, H.; Ishibuchi, S.; Murata, M.; Oshita, K.; Sugahara, K.; Tanaka, M.</span><span> </span><span class="NLM_article-title">Thienotriazolodiazepine compound and medicinal use thereof</span>. WO2006129623A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+Adachi&author=J.+Endoh&author=N.+Fuhie&author=M.+Hamada&author=H.+Hikawa&author=S.+Ishibuchi&author=M.+Murata&author=K.+Oshita&author=K.+Sugahara&author=M.+Tanaka&title=Thienotriazolodiazepine+compound+and+medicinal+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DThienotriazolodiazepine%2520compound%2520and%2520medicinal%2520use%2520thereof%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Miyoshi, S.; Ooike, S.; Iwata, K.; Hikawa, H.; Sugahara, K.</span><span> </span><span class="NLM_article-title">Antitumor agent</span>. WO2008-JP73864,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Miyoshi&author=S.+Ooike&author=K.+Iwata&author=H.+Hikawa&author=K.+Sugahara&title=Antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DS.%26atitle%3DAntitumor%2520agent%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span> </span><span class="NLM_article-title">Open access chemical and clinical probes to support drug discovery</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnchembio0709-436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=19536100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=436-440&author=A.+M.+Edwardsauthor=C.+Bountraauthor=D.+J.+Kerrauthor=T.+M.+Willson&title=Open+access+chemical+and+clinical+probes+to+support+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Open access chemical and clinical probes to support drug discovery</span></div><div class="casAuthors">Edwards, Aled M.; Bountra, Chas; Kerr, David J.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">436-440</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society.  Duplication could be reduced, and productivity could be increased, by performing basic biol. and clin. proofs of concept within open access industry-academia partnerships.  Chem. biologists could play a central role in this effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEVfmfLQWObLVg90H21EOLACvtfcHk0liL8PbQj5nd4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D&md5=fada9d85153aeb065c0130889be2160f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnchembio0709-436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio0709-436%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DKerr%26aufirst%3DD.%2BJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DOpen%2520access%2520chemical%2520and%2520clinical%2520probes%2520to%2520support%2520drug%2520discovery%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D436%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">French, C. A.</span><span> </span><span class="NLM_article-title">Pathogenesis of NUT midline carcinoma</span> <span class="citation_source-journal">Annu. Rev. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1146%2Fannurev-pathol-011811-132438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22017582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Kqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=247-265&author=C.+A.+French&title=Pathogenesis+of+NUT+midline+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of NUT midline carcinoma</span></div><div class="casAuthors">French, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-265</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  NUT midline carcinoma (NMC), an aggressive form of squamous cell carcinoma, is defined by the presence of acquired chromosomal rearrangements involving NUT, usually BRD4-NUT fusion genes and, less commonly, NUT-variant fusion genes involving BRD3 or still-uncharacterized genes.  Improved diagnostic tests reveal that although rare, NMCs occur in people of any age and may be indistinguishable from more common squamous cell carcinomas of adulthood.  NMCs have simple karyotypes whose hallmark is genomic instability, suggesting that NMC arises through a distinct pathogenic pathway representing a genetic shortcut to the phenotype of squamous cell carcinoma.  Mechanistically, BRD-NUT fusion proteins appear to act by blocking differentiation, possibly by sequestering histone acetyltransferase activity.  Accordingly, histone deacetylase inhibitors or BET inhibitors, the latter of which inhibit binding of BRD-NUT proteins to chromatin, induce terminal differentiation of NMC cells.  These insights provide a rationale for targeted therapy of NMC, which is almost uniformly refractory to conventional chemotherapy and radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSDatiUBVKCrVg90H21EOLACvtfcHk0liL8PbQj5nd4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Kqsbs%253D&md5=8f3773f87c158fe3f76ad4df8684f3df</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011811-132438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011811-132438%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DC.%2BA.%26atitle%3DPathogenesis%2520of%2520NUT%2520midline%2520carcinoma%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%26date%3D2012%26volume%3D7%26spage%3D247%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Selective inhibition of BET bromodomains</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnature09504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=20871596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1067-1073&author=P.+Filippakopoulosauthor=J.+Qiauthor=S.+Picaudauthor=Y.+Shenauthor=W.+B.+Smithauthor=O.+Fedorovauthor=E.+M.+Morseauthor=T.+Keatesauthor=T.+T.+Hickmanauthor=I.+Felletarauthor=M.+Philpottauthor=S.+Munroauthor=M.+R.+McKeownauthor=Y.+Wangauthor=A.+L.+Christieauthor=N.+Westauthor=M.+J.+Cameronauthor=B.+Schwartzauthor=T.+D.+Heightmanauthor=T.+N.+Laauthor=C.+A.+Frenchauthor=O.+Wiestauthor=A.+L.+Kungauthor=S.+Knappauthor=J.+E.+Bradner&title=Selective+inhibition+of+BET+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of BET bromodomains</span></div><div class="casAuthors">Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shongah; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic proteins are intently pursued targets in ligand discovery.  So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'.  Potent inhibitors of histone binding modules have not yet been described.  Here the authors report a cell-permeable small mol. (I,JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains.  High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity.  Recurrent translocation of BRD4 is obsd. in a genetically-defined, incurable subtype of human squamous carcinoma.  Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models.  These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chem. scaffold for the development of chem. probes more broadly throughout the bromodomain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ZbtmZM8m_LVg90H21EOLACvtfcHk0liL8PbQj5nd4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D&md5=bd9cadac86124d2c6c3cd5b2a92d68c2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature09504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09504%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMorse%26aufirst%3DE.%2BM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DHickman%26aufirst%3DT.%2BT.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DWest%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DLa%26aufirst%3DT.%2BN.%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DSelective%2520inhibition%2520of%2520BET%2520bromodomains%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1067%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III.</span><span> </span><span class="NLM_article-title">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">16669</span><span class="NLM_x">–</span> <span class="NLM_lpage">16674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1073%2Fpnas.1108190108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21949397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=16669-16674&author=J.+A.+Mertzauthor=A.+R.+Coneryauthor=B.+M.+Bryantauthor=P.+Sandyauthor=S.+Balasubramanianauthor=D.+A.+Meleauthor=L.+Bergeronauthor=R.+J.+Sims&title=Targeting+MYC+dependence+in+cancer+by+inhibiting+BET+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span></div><div class="casAuthors">Mertz, Jennifer A.; Conery, Andrew R.; Bryant, Barbara M.; Sandy, Peter; Balasubramanian, Srividya; Mele, Deanna A.; Bergeron, Louise; Sims, Robert J., III</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16669-16674, S16669/1-S16669/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The MYC transcription factor is a master regulator of diverse cellular functions and has been long considered a compelling therapeutic target because of its role in a range of human malignancies.  However, pharmacol. inhibition of MYC function has proven challenging because of both the diverse mechanisms driving its aberrant expression and the challenge of disrupting protein-DNA interactions.  Here, we demonstrate the rapid and potent abrogation of MYC gene transcription by representative small mol. inhibitors of the BET family of chromatin adaptors.  MYC transcriptional suppression was obsd. in the context of the natural, chromosomally translocated, and amplified gene locus.  Inhibition of BET bromodomain-promoter interactions and subsequent redn. of MYC transcript and protein levels resulted in G1 arrest and extensive apoptosis in a variety of leukemia and lymphoma cell lines.  Exogenous expression of MYC from an artificial promoter that is resistant to BET regulation significantly protected cells from cell cycle arrest and growth suppression by BET inhibitors.  MYC suppression was accompanied by deregulation of the MYC transcriptome, including potent reactivation of the p21 tumor suppressor.  Treatment with a BET inhibitor resulted in significant antitumor activity in xenograft models of Burkitt's lymphoma and acute myeloid leukemia.  These findings demonstrate that pharmacol. inhibition of MYC is achievable through targeting BET bromodomains.  Such inhibitors may have clin. utility given the widespread pathogenetic role of MYC in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UHj1YB_ikrVg90H21EOLACvtfcHk0lhdkYyvCUL6fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL&md5=b1f0fd41fa56bbfcbb1ad6c8d48f7f80</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1108190108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1108190108%26sid%3Dliteratum%253Aachs%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DMele%26aufirst%3DD.%2BA.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520MYC%2520dependence%2520in%2520cancer%2520by%2520inhibiting%2520BET%2520bromodomains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A%26date%3D2011%26volume%3D108%26spage%3D16669%26epage%3D16674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudgin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnature10509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21964340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=529-533&author=M.+A.+Dawsonauthor=R.+K.+Prinjhaauthor=A.+Dittmannauthor=G.+Giotopoulosauthor=M.+Bantscheffauthor=W.+I.+Chanauthor=S.+C.+Robsonauthor=C.+W.+Chungauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=C.+Huthmacherauthor=E.+Gudginauthor=D.+Lugoauthor=S.+Beinkeauthor=T.+D.+Chapmanauthor=E.+J.+Robertsauthor=P.+E.+Sodenauthor=K.+R.+Augerauthor=O.+Mirguetauthor=K.+Doehnerauthor=R.+Delwelauthor=A.+K.+Burnettauthor=P.+Jeffreyauthor=G.+Drewesauthor=K.+Leeauthor=B.+J.+Huntlyauthor=T.+Kouzarides&title=Inhibition+of+BET+recruitment+to+chromatin+as+an+effective+treatment+for+MLL-fusion+leukaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span></div><div class="casAuthors">Dawson, Mark A.; Prinjha, Rab K.; Dittman, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">529-533</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent chromosomal translocations involving the mixed lineage leukemia (MLL) gene initiate aggressive forms of leukemia, which are often refractory to conventional therapies.  Many MLL-fusion partners are members of the super elongation complex (SEC), a crit. regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukemia induction.  Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-assocd. factor complex (PAFc), are assocd. with the BET family of acetyl-lysine recognizing, chromatin adaptor' proteins.  These data provided the basis for therapeutic intervention in MLL-fusion leukemia, via the displacement of the BET family of proteins from chromatin.  We show that a novel small mol. inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukemic cell lines, through the induction of early cell cycle arrest and apoptosis.  I-BET151 treatment in two human leukemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes.  The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin.  In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.  Finally, the efficacy of I-BET151 against human leukemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential.  These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4FbgJpjftv7Vg90H21EOLACvtfcHk0lhdkYyvCUL6fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO&md5=dffb4b81da4ca8291c27139d0df86324</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature10509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10509%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.%2BI.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DGudgin%26aufirst%3DE.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%2BD.%26aulast%3DRoberts%26aufirst%3DE.%2BJ.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DDoehner%26aufirst%3DK.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520BET%2520recruitment%2520to%2520chromatin%2520as%2520an%2520effective%2520treatment%2520for%2520MLL-fusion%2520leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D529%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Delmore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastritis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilpatrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a therapeutic strategy to target c-Myc</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.cell.2011.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21889194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=904-917&author=J.+E.+Delmoreauthor=G.+C.+Issaauthor=M.+E.+Lemieuxauthor=P.+B.+Rahlauthor=J.+Shiauthor=H.+M.+Jacobsauthor=E.+Kastritisauthor=T.+Gilpatrickauthor=R.+M.+Paranalauthor=J.+Qiauthor=M.+Chesiauthor=A.+C.+Schinzelauthor=M.+R.+McKeownauthor=T.+P.+Heffernanauthor=C.+R.+Vakocauthor=P.+L.+Bergsagelauthor=I.+M.+Ghobrialauthor=P.+G.+Richardsonauthor=R.+A.+Youngauthor=W.+C.+Hahnauthor=K.+C.+Andersonauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=C.+S.+Mitsiades&title=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc</span></div><div class="casAuthors">Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Jun-Wei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904-917</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist.  Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation.  Using a selective small-mol. bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc.  BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes.  In exptl. models of multiple myeloma, a Myc-dependent hematol. malignancy, JQ1 produces a potent antiproliferative effect assocd. with cell-cycle arrest and cellular senescence.  Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathol. activation of c-Myc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevD1QHKmOhLVg90H21EOLACvtfcHk0ljQTlPZyPnnlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF&md5=013674b8224214a9a1c8f0b75583a5a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelmore%26aufirst%3DJ.%2BE.%26aulast%3DIssa%26aufirst%3DG.%2BC.%26aulast%3DLemieux%26aufirst%3DM.%2BE.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DH.%2BM.%26aulast%3DKastritis%26aufirst%3DE.%26aulast%3DGilpatrick%26aufirst%3DT.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520to%2520target%2520c-Myc%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D904%26epage%3D917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ott, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, D. M.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2843-2852&author=C.+J.+Ottauthor=N.+Koppauthor=L.+Birdauthor=R.+M.+Paranalauthor=J.+Qiauthor=T.+Bowmanauthor=S.+J.+Rodigauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=D.+M.+Weinstock&title=BET+bromodomain+inhibition+targets+both+c-Myc+and+IL7R+in+high-risk+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DC.%2BJ.%26aulast%3DKopp%26aufirst%3DN.%26aulast%3DBird%26aufirst%3DL.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBowman%26aufirst%3DT.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26atitle%3DBET%2520bromodomain%2520inhibition%2520targets%2520both%2520c-Myc%2520and%2520IL7R%2520in%2520high-risk%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D2843%26epage%3D2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Puissant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frumm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassil, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanthery, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nekritz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greninger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmaier, K.</span><span> </span><span class="NLM_article-title">Targeting MYCN in neuroblastoma by BET bromodomain inhibition</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=308-323&author=A.+Puissantauthor=S.+M.+Frummauthor=G.+Alexeauthor=C.+F.+Bassilauthor=J.+Qiauthor=Y.+H.+Chantheryauthor=E.+A.+Nekritzauthor=R.+Zeidauthor=W.+C.+Gustafsonauthor=P.+Greningerauthor=M.+J.+Garnettauthor=U.+McDermottauthor=C.+H.+Benesauthor=A.+L.+Kungauthor=W.+A.+Weissauthor=J.+E.+Bradnerauthor=K.+Stegmaier&title=Targeting+MYCN+in+neuroblastoma+by+BET+bromodomain+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuissant%26aufirst%3DA.%26aulast%3DFrumm%26aufirst%3DS.%2BM.%26aulast%3DAlexe%26aufirst%3DG.%26aulast%3DBassil%26aufirst%3DC.%2BF.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChanthery%26aufirst%3DY.%2BH.%26aulast%3DNekritz%26aufirst%3DE.%2BA.%26aulast%3DZeid%26aufirst%3DR.%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DU.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DStegmaier%26aufirst%3DK.%26atitle%3DTargeting%2520MYCN%2520in%2520neuroblastoma%2520by%2520BET%2520bromodomain%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D308%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delannee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudit, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2963</span><span class="NLM_x">–</span> <span class="NLM_lpage">2967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.bmcl.2012.01.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22386529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2963-2967&author=O.+Mirguetauthor=Y.+Lamotteauthor=F.+Doncheauthor=J.+Toumauthor=F.+Gellibertauthor=A.+Bouillotauthor=R.+Gosminiauthor=V.+L.+Nguyenauthor=D.+Delanneeauthor=J.+Sealauthor=F.+Blandelauthor=A.+B.+Boullayauthor=E.+Boursierauthor=S.+Martinauthor=J.+M.+Brusqauthor=G.+Krysaauthor=A.+Riouauthor=R.+Tellierauthor=A.+Costazauthor=P.+Huetauthor=Y.+Duditauthor=L.+Trottetauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=From+ApoA1+upregulation+to+BET+family+bromodomain+inhibition%3A+discovery+of+I-BET151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151</span></div><div class="casAuthors">Mirguet, Olivier; Lamotte, Yann; Donche, Frederic; Toum, Jerome; Gellibert, Francoise; Bouillot, Anne; Gosmini, Romain; Nguyen, Van-Loc; Delannee, Delphine; Seal, Jonathan; Blandel, Florence; Boullay, Anne-Benedicte; Boursier, Eric; Martin, Sandrine; Brusq, Jean-Marie; Krysa, Gael; Riou, Alizon; Tellier, Remi; Costaz, Agnes; Huet, Pascal; Dudit, Yann; Trottet, Lionel; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2963-2967</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery, synthesis, and biol. evaluation of a novel series of 7-isoxazoloquinolines is described.  Several analogs are shown to increase ApoA1 expression within the nanomolar range in the human hepatic cell line HepG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIu6f80tbgE7Vg90H21EOLACvtfcHk0ljQTlPZyPnnlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D&md5=48c9a8dc4b70bea4a86807f7a1cec5f1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.125%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DDelannee%26aufirst%3DD.%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DBlandel%26aufirst%3DF.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DRiou%26aufirst%3DA.%26aulast%3DTellier%26aufirst%3DR.%26aulast%3DCostaz%26aufirst%3DA.%26aulast%3DHuet%26aufirst%3DP.%26aulast%3DDudit%26aufirst%3DY.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DFrom%2520ApoA1%2520upregulation%2520to%2520BET%2520family%2520bromodomain%2520inhibition%253A%2520discovery%2520of%2520I-BET151%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2963%26epage%3D2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioja, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span> </span><span class="NLM_article-title">Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2968</span><span class="NLM_x">–</span> <span class="NLM_lpage">2972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.bmcl.2012.02.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22437115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2968-2972&author=J.+Sealauthor=Y.+Lamotteauthor=F.+Doncheauthor=A.+Bouillotauthor=O.+Mirguetauthor=F.+Gellibertauthor=E.+Nicodemeauthor=G.+Krysaauthor=J.+Kirilovskyauthor=S.+Beinkeauthor=S.+McClearyauthor=I.+Riojaauthor=P.+Bamboroughauthor=C.+W.+Chungauthor=L.+Gordonauthor=T.+Lewisauthor=A.+L.+Walkerauthor=L.+Cutlerauthor=D.+Lugoauthor=D.+M.+Wilsonauthor=J.+Witheringtonauthor=K.+Leeauthor=R.+K.+Prinjha&title=Identification+of+a+novel+series+of+BET+family+bromodomain+inhibitors%3A+binding+mode+and+profile+of+I-BET151+%28GSK1210151A%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)</span></div><div class="casAuthors">Seal, Jonathan; Lamotte, Yann; Donche, Frederic; Bouillot, Anne; Mirguet, Olivier; Gellibert, Francoise; Nicodeme, Edwige; Krysa, Gael; Kirilovsky, Jorge; Beinke, Soren; McCleary, Scott; Rioja, Inma; Bamborough, Paul; Chung, Chun-Wa; Gordon, Laurie; Lewis, Toni; Walker, Ann L.; Cutler, Leanne; Lugo, David; Wilson, David M.; Witherington, Jason; Lee, Kevin; Prinjha, Rab K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2968-2972</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed.  Crystallog. is used to illustrate binding modes and rationalize their SAR.  One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxemia model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJKtxBCr-pRbVg90H21EOLACvtfcHk0lgIVkhFSvyjPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D&md5=a8037c89bcb93948d663208bd1ebfd55</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.041%26sid%3Dliteratum%253Aachs%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DRioja%26aufirst%3DI.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520BET%2520family%2520bromodomain%2520inhibitors%253A%2520binding%2520mode%2520and%2520profile%2520of%2520I-BET151%2520%2528GSK1210151A%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2968%26epage%3D2972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wyspianska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nangalia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero-Nieto, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioja, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannizzaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottgens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">BET protein inhibition shows efficacy against JAK2V617F driven neoplasms</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=88-97&author=B.+Wyspianskaauthor=A.+J.+Bannisterauthor=I.+Barbieriauthor=J.+Nangaliaauthor=A.+Godfreyauthor=F.+J.+Calero-Nietoauthor=S.+Robsonauthor=I.+Riojaauthor=J.+Liauthor=M.+Wieseauthor=E.+Cannizzaroauthor=M.+A.+Dawsonauthor=B.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+R.+Greenauthor=B.+Gottgensauthor=T.+Kouzarides&title=BET+protein+inhibition+shows+efficacy+against+JAK2V617F+driven+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyspianska%26aufirst%3DB.%26aulast%3DBannister%26aufirst%3DA.%2BJ.%26aulast%3DBarbieri%26aufirst%3DI.%26aulast%3DNangalia%26aufirst%3DJ.%26aulast%3DGodfrey%26aufirst%3DA.%26aulast%3DCalero-Nieto%26aufirst%3DF.%2BJ.%26aulast%3DRobson%26aufirst%3DS.%26aulast%3DRioja%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWiese%26aufirst%3DM.%26aulast%3DCannizzaro%26aufirst%3DE.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DHuntly%26aufirst%3DB.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DGottgens%26aufirst%3DB.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DBET%2520protein%2520inhibition%2520shows%2520efficacy%2520against%2520JAK2V617F%2520driven%2520neoplasms%26jtitle%3DLeukemia%26date%3D2013%26volume%3D28%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafiane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiacchia, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimbou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, J.</span><span> </span><span class="NLM_article-title">RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span><span class="NLM_x">–</span> <span class="NLM_lpage">2589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.jacc.2010.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=20513599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2010&pages=2580-2589&author=D.+Baileyauthor=R.+Jahagirdarauthor=A.+Gordonauthor=A.+Hafianeauthor=S.+Campbellauthor=S.+Chaturauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=F.+S.+Chiacchiaauthor=J.+Johanssonauthor=L.+Krimbouauthor=N.+C.+Wongauthor=J.+Genest&title=RVX-208%3A+a+small+molecule+that+increases+apolipoprotein+A-I+and+high-density+lipoprotein+cholesterol+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208. A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span></div><div class="casAuthors">Bailey, Dana; Jahagirdar, Ravi; Gordon, Allan; Hafiane, Anouar; Campbell, Steven; Chatur, Safia; Wagner, Gregory S.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; Johansson, Jan; Krimbou, Larbi; Wong, Norman C. W.; Genest, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2580-2589</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to det. whether a novel small mol. RVX-208 affects apolipoprotein (apo)A-I and high-d. lipoprotein cholesterol (HDL-C) levels in vitro and in vivo.  Background: Increased apoA-I and HDL-C levels are potential therapeutic targets for reducing atherosclerotic disease.  Methods: HepG2 cells were treated with 0 to 60 μmol/l RVX-208 followed by assays for apoA-I and HDL-C prodn.  For in vivo studies, African green monkeys (AGMs) received 15 to 60 mg/kg/day RVX-208, and the serum was analyzed for lipoprotein levels, HDL-subparticle distribution, cholesterol efflux, and activity of lipid-modifying enzymes.  A phase I clin. trial was conducted in healthy volunteers (given 1 to 20 mg/kg/day of RVX-208) to assess safety, tolerability, and pharmacokinetics.  Results: The RVX-208 induced apoA-I mRNA and protein synthesis in HepG2 cells, leading to in- creased levels of pre-β-migrating and α-lipoprotein particles contg. apoA-I (LpA-I) in spent media.  Similarly, in AGMs, RVX-208 treatment for 63 days increased serum apoA-I and HDL-C levels (60% and 97%, resp.).  In addn., the levels of pre-β1-LpA-I and α1-LpA-I HDL-subparticles were increased as well as ATP binding cassette AI, ATP binding cassette G1, and scavenger receptor class B type I-dependent cholesterol efflux.  These changes were not mediated by cholesteryl-ester-transfer protein.  Treatment of humans for 1 wk with oral RVX-208 increased apoA-I, pre-β-HDL, and HDL functionality.  Conclusions: RVX-208 increases apoA-I and HDL-C in vitro and in vivo.  In AGMs, RVX-208 raises serum pre-β1-LpA-I and α-LpA-I levels and enhances cholesterol efflux.  Data in humans point to beneficial features of RVX-208 that might be useful for treating atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGExcnx6drLVg90H21EOLACvtfcHk0lhZ9RVF_ccoHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D&md5=aab9ac26e73704f1cd569e2ff47d0c51</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2010.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2010.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DHafiane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DChatur%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DChiacchia%26aufirst%3DF.%2BS.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DKrimbou%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DGenest%26aufirst%3DJ.%26atitle%3DRVX-208%253A%2520a%2520small%2520molecule%2520that%2520increases%2520apolipoprotein%2520A-I%2520and%2520high-density%2520lipoprotein%2520cholesterol%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2010%26volume%3D55%26spage%3D2580%26epage%3D2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujikawa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist</span> <span class="citation_source-journal">PLoS. One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83190&author=K.+G.+McLureauthor=E.+M.+Gesnerauthor=L.+Tsujikawaauthor=O.+A.+Kharenkoauthor=S.+Attwellauthor=E.+Campeauauthor=S.+Wasiakauthor=A.+Steinauthor=A.+Whiteauthor=E.+Fontanoauthor=R.+K.+Sutoauthor=N.+C.+Wongauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=P.+R.+Young&title=RVX-208%2C+an+inducer+of+ApoA-I+in+humans%2C+is+a+BET+bromodomain+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DTsujikawa%26aufirst%3DL.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DCampeau%26aufirst%3DE.%26aulast%3DWasiak%26aufirst%3DS.%26aulast%3DStein%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DFontano%26aufirst%3DE.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DRVX-208%252C%2520an%2520inducer%2520of%2520ApoA-I%2520in%2520humans%252C%2520is%2520a%2520BET%2520bromodomain%2520antagonist%26jtitle%3DPLoS.%2520One%26date%3D2013%26volume%3D8%26spage%3De83190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolven, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201320w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=576-586&author=C.+W.+Chungauthor=A.+W.+Deanauthor=J.+M.+Woolvenauthor=P.+Bamborough&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+1%3A+inhibitor+binding+modes+and+implications+for+lead+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery</span></div><div class="casAuthors">Chung, Chun-wa; Dean, Anthony W.; Woolven, James M.; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">576-586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. proteins are key epigenetic regulators of gene transcription and readers of the histone code.  However, the therapeutic benefits of modulating this target class are largely unexplored due to the lack of suitable chem. probes.  This article describes the generation of lead mols. for the BET bromodomains through screening a fragment set chosen using structural insights and computational approaches.  Anal. of 40 BRD2/fragment x-ray complexes highlights both shared and disparate interaction features that may be exploited for affinity and selectivity.  Six representative crystal structures are then exemplified in detail.  Two of the fragments are completely new bromodomain chemotypes, and three have never before been crystd. in a bromodomain, so our results significantly extend the limited public knowledge-base of crystallog. small mol./bromodomain interactions.  Certain fragments (including paracetamol) bind in a consistent mode to different bromodomains such as CREBBP, suggesting their potential to act as generic bromodomain templates.  An important implication is that the bromodomains are not only a phylogenetic family but also a system in which chem. and structural knowledge of one bromodomain gives insights transferable to others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonNb7GnZnS_rVg90H21EOLACvtfcHk0lhZ9RVF_ccoHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN&md5=5b7d7239d0de57266d94beef1ea080ae</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm201320w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201320w%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDean%26aufirst%3DA.%2BW.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25201%253A%2520inhibitor%2520binding%2520modes%2520and%2520implications%2520for%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D576%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primiano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciammetta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span> </span><span class="NLM_article-title">Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9831</span><span class="NLM_x">–</span> <span class="NLM_lpage">9837</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3010515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9831-9837&author=P.+V.+Fishauthor=P.+Filippakopoulosauthor=G.+Bishauthor=P.+E.+Brennanauthor=M.+E.+Bunnageauthor=A.+S.+Cookauthor=O.+Federovauthor=B.+S.+Gerstenbergerauthor=H.+Jonesauthor=S.+Knappauthor=B.+Marsdenauthor=K.+Nockaauthor=D.+R.+Owenauthor=M.+Philpottauthor=S.+Picaudauthor=M.+J.+Primianoauthor=M.+J.+Ralphauthor=N.+Sciammettaauthor=J.+D.+Trzupek&title=Identification+of+a+chemical+probe+for+bromo+and+extra+C-terminal+bromodomain+inhibition+through+optimization+of+a+fragment-derived+hit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit</span></div><div class="casAuthors">Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn; Brennan, Paul E.; Bunnage, Mark E.; Cook, Andrew S.; Federov, Oleg; Gerstenberger, Brian S.; Jones, Hannah; Knapp, Stefan; Marsden, Brian; Nocka, Karl; Owen, Dafydd R.; Philpott, Martin; Picaud, Sarah; Primiano, Michael J.; Ralph, Michael J.; Sciammetta, Nunzio; Trzupek, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9831-9837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs).  The significance of this subset of the epigenetic code is interrogated and interpreted by an acetyllysine-specific protein-protein interaction with bromodomain reader modules.  Selective inhibition of the bromo and extra C-terminal domain (BET) family of bromodomains with a small mol. is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti-inflammatory properties of such inhibitors.  Herein, we describe the discovery and structure-activity relationship (SAR) of a novel, small-mol. chem. probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques.  This has yielded a potent, selective compd. with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzpWnuXoLdrVg90H21EOLACvtfcHk0lhZ9RVF_ccoHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE&md5=ba864f3916bea5f793dd0b26732784f0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm3010515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010515%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DFederov%26aufirst%3DO.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPrimiano%26aufirst%3DM.%2BJ.%26aulast%3DRalph%26aufirst%3DM.%2BJ.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520chemical%2520probe%2520for%2520bromo%2520and%2520extra%2520C-terminal%2520bromodomain%2520inhibition%2520through%2520optimization%2520of%2520a%2520fragment-derived%2520hit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9831%26epage%3D9837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodrow, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201283q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=587-596&author=P.+Bamboroughauthor=H.+Dialloauthor=J.+D.+Goodacreauthor=L.+Gordonauthor=A.+Lewisauthor=J.+T.+Sealauthor=D.+M.+Wilsonauthor=M.+D.+Woodrowauthor=C.+W.+Chung&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+2%3A+optimization+of+phenylisoxazole+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides</span></div><div class="casAuthors">Bamborough, Paul; Diallo, Hawa; Goodacre, Jonathan D.; Gordon, Laurie; Lewis, Antonia; Seal, Jonathan T.; Wilson, David M.; Woodrow, Michael D.; Chung, Chun-wa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">587-596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are epigenetic reader modules that regulate gene transcription through their recognition of acetyl-lysine modified histone tails.  Inhibitors of this protein-protein interaction have the potential to modulate multiple diseases as demonstrated by the profound anti-inflammatory and antiproliferative effects of a recently disclosed class of BET compds.  While these compds. were discovered using phenotypic assays, here we present a highly efficient alternative approach to find new chem. templates, exploiting the abundant structural knowledge that exists for this target class.  A Ph di-Me isoxazole chemotype resulting from a focused fragment screen has been rapidly optimized through structure-based design, leading to a sulfonamide series showing anti-inflammatory activity in cellular assays.  This proof-of-principle expt. demonstrates the tractability of the BET family and bromodomain target class to fragment-based hit discovery and structure-based lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6lsic9qjJrVg90H21EOLACvtfcHk0ljcxueLT7DvuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF&md5=e73b16b3fddf88b43b037264b000b276</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm201283q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201283q%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DGoodacre%26aufirst%3DJ.%2BD.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DSeal%26aufirst%3DJ.%2BT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWoodrow%26aufirst%3DM.%2BD.%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520phenylisoxazole%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D587%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppusetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">3,5-Dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6761</span><span class="NLM_x">–</span> <span class="NLM_lpage">6770</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200640v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6761-6770&author=D.+S.+Hewingsauthor=M.+Wangauthor=M.+Philpottauthor=O.+Fedorovauthor=S.+Uttarkarauthor=P.+Filippakopoulosauthor=S.+Picaudauthor=C.+Vuppusettyauthor=B.+Marsdenauthor=S.+Knappauthor=S.+J.+Conwayauthor=T.+D.+Heightman&title=3%2C5-Dimethylisoxazoles+act+as+acetyl-lysine-mimetic+bromodomain+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm200640v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200640v%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DUttarkar%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DVuppusetty%26aufirst%3DC.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3D3%252C5-Dimethylisoxazoles%2520act%2520as%2520acetyl-lysine-mimetic%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6761%26epage%3D6770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3217</span><span class="NLM_x">–</span> <span class="NLM_lpage">3227</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301588r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3217-3227&author=D.+S.+Hewingsauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=S.+Picaudauthor=A.+Tumberauthor=C.+Wellsauthor=M.+M.+Olcinaauthor=K.+Freemanauthor=A.+Gillauthor=A.+J.+Ritchieauthor=D.+W.+Sheppardauthor=A.+J.+Russellauthor=E.+M.+Hammondauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=Optimization+of+3%2C5-dimethylisoxazole+derivatives+as+potent+bromodomain+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm301588r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301588r%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DFreeman%26aufirst%3DK.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DA.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DOptimization%2520of%25203%252C5-dimethylisoxazole%2520derivatives%2520as%2520potent%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3217%26epage%3D3227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellapantula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasamurthy, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birudukota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, design and optimization of isoxazole azepine BET inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml4001485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=835-840&author=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=Y.+Leblancauthor=A.+C%C3%B4t%C3%A9author=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=R.+Sankaranarayananauthor=S.+Yellapantulaauthor=N.+B.+Srinivasamurthyauthor=S.+Birudukotaauthor=B.+K.+Albrecht&title=Discovery%2C+design+and+optimization+of+isoxazole+azepine+BET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fml4001485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001485%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSankaranarayanan%26aufirst%3DR.%26aulast%3DYellapantula%26aufirst%3DS.%26aulast%3DSrinivasamurthy%26aufirst%3DN.%2BB.%26aulast%3DBirudukota%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%2520and%2520optimization%2520of%2520isoxazole%2520azepine%2520BET%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D835%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3833</span><span class="NLM_x">–</span> <span class="NLM_lpage">3851</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301793a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3833-3851&author=L.+Zhaoauthor=D.+Caoauthor=T.+Chenauthor=Y.+Wangauthor=Z.+Miaoauthor=Y.+Xuauthor=W.+Chenauthor=X.+Wangauthor=Y.+Liauthor=Z.+Duauthor=B.+Xiongauthor=J.+Liauthor=C.+Xuauthor=N.+Zhangauthor=J.+Heauthor=J.+Shen&title=Fragment-based+drug+discovery+of+2-thiazolidinones+as+inhibitors+of+the+histone+reader+BRD4+bromodomain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain</span></div><div class="casAuthors">Zhao, Lele; Cao, Danyan; Chen, Tiantian; Wang, Yingqing; Miao, Zehong; Xu, Yechun; Chen, Wuyan; Wang, Xin; Li, Yanlian; Du, Zhiyan; Xiong, Bing; Li, Jian; Xu, Chunyan; Zhang, Naixia; He, Jianhua; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3833-3851</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recognizing acetyllysine of histone is a vital process of epigenetic regulation that is mediated by a protein module called bromodomain.  To contribute novel scaffolds for developing into bromodomain inhibitors, the authors utilize a fragment-based drug discovery approach.  By successively applying docking and x-ray crystallog., they were able to identify 9 fragment hits from diffracting more than 60 crystals.  In the present work, they described four of them and carried out the integrated lead optimization for fragment I, which bears a 2-thiazolidinone core.  After several rounds of structure guided modifications, they assessed the druggability of 2-thiazolidinone by modulating in vitro pharmacokinetic studies and cellular activity assay.  The results showed that two potent of 2-thiazolidinone compds. II and III have good metabolic stability.  Also, the cellular assay confirmed the activities of 2-thiazolidinones.  Together, they hope the identified 2-thiazolidinone chemotype and other fragment hits described herein can stimulate researchers to develop more diversified bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfi2pyYq6c4LVg90H21EOLACvtfcHk0lhIOLoQ2z7TfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D&md5=8308db5d83cb72b29f261cc134514ece</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301793a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301793a%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520of%25202-thiazolidinones%2520as%2520inhibitors%2520of%2520the%2520histone%2520reader%2520BRD4%2520bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3833%26epage%3D3851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bellosta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsini, A.</span><span> </span><span class="NLM_article-title">Safety of statins: focus on clinical pharmacokinetics and drug interactions</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">III50</span><span class="NLM_x">–</span> <span class="NLM_lpage">III57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=III50-III57&author=S.+Bellostaauthor=R.+Paolettiauthor=A.+Corsini&title=Safety+of+statins%3A+focus+on+clinical+pharmacokinetics+and+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellosta%26aufirst%3DS.%26aulast%3DPaoletti%26aufirst%3DR.%26aulast%3DCorsini%26aufirst%3DA.%26atitle%3DSafety%2520of%2520statins%253A%2520focus%2520on%2520clinical%2520pharmacokinetics%2520and%2520drug%2520interactions%26jtitle%3DCirculation%26date%3D2004%26volume%3D109%26spage%3DIII50%26epage%3DIII57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wyce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbash, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy-Wilson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span> </span><span class="NLM_article-title">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span> <span class="citation_source-journal">PLoS. One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e72967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1371%2Fjournal.pone.0072967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=24009722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72967&author=A.+Wyceauthor=G.+Ganjiauthor=K.+N.+Smithemanauthor=C.-W.+Chungauthor=S.+Korenchukauthor=Y.+Baiauthor=O.+Barbashauthor=B.+Leauthor=P.+Craggsauthor=M.+T.+McCabeauthor=K.+M.+Kennedy-Wilsonauthor=L.+V.+Sanchezauthor=R.+L.+Gosminiauthor=N.+Parrauthor=C.+F.+McHughauthor=D.+Dhanakauthor=R.+K.+Prinjhaauthor=K.+R.+Augerauthor=P.+J.+Tummino&title=BET+inhibition+silences+expression+of+MYCN+and+BCL2+and+induces+cytotoxicity+in+neuroblastoma+tumor+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span></div><div class="casAuthors">Wyce, Anastasia; Ganji, Gopinath; Smitheman, Kimberly N.; Chung, Chun-Wa; Korenchuk, Susan; Bai, Yuchen; Barbash, Olena; Le, Bao Chau; Craggs, Peter D.; McCabe, Michael T.; Kennedy-Wilson, Karen M.; Sanchez, Lydia V.; Gosmini, Romain L.; Parr, Nigel; McHugh, Charles F.; Dhanak, Dashyant; Prinjha, Rab K.; Auger, Kurt R.; Tummino, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e72967</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis.  Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a no. of hematol. cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways.  However, little is currently known about the activity of BET inhibitors in solid tumor models, and whether down-regulation of MYC family genes contributes to sensitivity.  Here we provide evidence for potent BET inhibitor activity in neuroblastoma, a pediatric solid tumor assocd. with a high frequency of MYCN amplifications.  We treated a panel of neuroblastoma cell lines with a novel small mol. inhibitor of BET proteins, GSK1324726A (I-BET726), and obsd. potent growth inhibition and cytotoxicity in most cell lines irresp. of MYCN copy no. or expression level.  Gene expression analyses in neuroblastoma cell lines suggest a role of BET inhibition in apoptosis, signaling, and N-Myc-driven pathways, including the direct suppression of BCL2 and MYCN.  Reversal of MYCN or BCL2 suppression reduces the potency of I-BET726-induced cytotoxicity in a cell line-specific manner; however, neither factor fully accounts for I-BET726 sensitivity.  Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth.  Taken together, our data highlight the potential of BET inhibitors as novel therapeutics for neuroblastoma, and suggest that sensitivity is driven by pleiotropic effects on cell growth and apoptotic pathways in a context-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecB0_0elFVbVg90H21EOLACvtfcHk0lhIOLoQ2z7TfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI&md5=d39ce25a50de58f18a278a9f67935bbc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072967%26sid%3Dliteratum%253Aachs%26aulast%3DWyce%26aufirst%3DA.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DBarbash%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DB.%26aulast%3DCraggs%26aufirst%3DP.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DKennedy-Wilson%26aufirst%3DK.%2BM.%26aulast%3DSanchez%26aufirst%3DL.%2BV.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26atitle%3DBET%2520inhibition%2520silences%2520expression%2520of%2520MYCN%2520and%2520BCL2%2520and%2520induces%2520cytotoxicity%2520in%2520neuroblastoma%2520tumor%2520models%26jtitle%3DPLoS.%2520One%26date%3D2013%26volume%3D8%26spage%3De72967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Marshall, J. C.</span><span> </span><span class="NLM_article-title">Why have clinical trials in sepsis failed?</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=195-203&author=J.+C.+Marshall&title=Why+have+clinical+trials+in+sepsis+failed%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DJ.%2BC.%26atitle%3DWhy%2520have%2520clinical%2520trials%2520in%2520sepsis%2520failed%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Histone recognition and large-scale structural analysis of the human bromodomain family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.cell.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22464331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=214-231&author=P.+Filippakopoulosauthor=S.+Picaudauthor=M.+Mangosauthor=T.+Keatesauthor=J.+P.+Lambertauthor=D.+Barsyte-Lovejoyauthor=I.+Felletarauthor=R.+Volkmerauthor=S.+Mullerauthor=T.+Pawsonauthor=A.+C.+Gingrasauthor=C.+H.+Arrowsmithauthor=S.+Knapp&title=Histone+recognition+and+large-scale+structural+analysis+of+the+human+bromodomain+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Muller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-231</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks.  The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity.  Here, we present 29 high-resoln. crystal structures, covering all BRD families.  These proteins are: ASH1L, ATAD2, BAZ2B, BPTF, BRD1, BRD3(1), BRD3(2), BRD4(1), BRD4(2), BRD9, BRDT(1), CECR2, EP300, CREBBP, GCN5L2, KIAA1240, PB1(1), PB1(2), PB1(3), PB1(4), PB1(5), PB1(6), PCAF, PHIP(2), TAF1(2), WDR9(2), BRD4(1).  Comprehensive crossfamily structural anal. identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition.  Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences.  We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-contg. peptides by BRD4.  These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FSIcPoXZLVg90H21EOLACvtfcHk0liVJq0HJFUg-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D&md5=05583a01a1cd4c3b59fc59c00e4c4777</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMangos%26aufirst%3DM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DJ.%2BP.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DHistone%2520recognition%2520and%2520large-scale%2520structural%2520analysis%2520of%2520the%2520human%2520bromodomain%2520family%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D214%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Demont, E. H.; Gosmini, R.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline derivatives as bromodomain inhibitors and their preparation and use in the treatment of cancer, autoimmune and inflammatory diseases</span>. WO2010-EP66701,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+H.+Demont&author=R.+Gosmini&title=Tetrahydroquinoline+derivatives+as+bromodomain+inhibitors+and+their+preparation+and+use+in+the+treatment+of+cancer%2C+autoimmune+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26atitle%3DTetrahydroquinoline%2520derivatives%2520as%2520bromodomain%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520cancer%252C%2520autoimmune%2520and%2520inflammatory%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Damon, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugger, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of the cholesteryl ester transfer protein inhibitor torcetrapib</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/doi/10.1021/op060013i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlOit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=472-480&author=D.+B.+Damonauthor=R.+W.+Duggerauthor=S.+E.+Hubbsauthor=J.+M.+Scottauthor=R.+W.+Scott&title=Asymmetric+synthesis+of+the+cholesteryl+ester+transfer+protein+inhibitor+torcetrapib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of the Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib</span></div><div class="casAuthors">Damon, David B.; Dugger, Robert W.; Hubbs, Stephen E.; Scott, Jill M.; Scott, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">472-480</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported their efforts used to synthesize kilogram quantities of cholesteryl ester transfer protein (CETP) inhibitor, torcetrapib (I), via a mid-stage resoln.  This account describes the research conducted to develop an asym. route to I.  The first asym. center is established via coupling of (R)-3-aminopentanenitrile to 1-chloro-4-trifluoromethylbenzene.  The resulting nitrile II is converted to amide III (R = H), which is reacted with ClCO2Me to afford ester III (R = CO2Me).  This ester undergoes diastereoselective cyclization to an immonium ion to provide tetrahydroquinoline core of I.  This approach permitted a streamlined synthesis of I.  Development of the process and synthetic rationale are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMdzJ1UrCm1LVg90H21EOLACvtfcHk0liVJq0HJFUg-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlOit78%253D&md5=be8a7c3c6343c9c5f03942ceed6204f9</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fop060013i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop060013i%26sid%3Dliteratum%253Aachs%26aulast%3DDamon%26aufirst%3DD.%2BB.%26aulast%3DDugger%26aufirst%3DR.%2BW.%26aulast%3DHubbs%26aufirst%3DS.%2BE.%26aulast%3DScott%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DR.%2BW.%26atitle%3DAsymmetric%2520synthesis%2520of%2520the%2520cholesteryl%2520ester%2520transfer%2520protein%2520inhibitor%2520torcetrapib%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26spage%3D472%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 113 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michael Brand, James Clayton, Mustafa Moroglu, Matthias Schiedel, Sarah Picaud, Joseph P. Bluck, Anna Skwarska, Hannah Bolland, Anthony K. N. Chan, Corentine M. C. Laurin, Amy R. Scorah, Larissa See, Timothy P. C. Rooney, Katrina H. Andrews, Oleg Fedorov, Gabriella Perell, Prakriti Kalra, Kayla B. Vinh, Wilian A. Cortopassi, Pascal Heitel, Kirsten E. Christensen, Richard I. Cooper, Robert S. Paton, William C. K. Pomerantz, Philip C. Biggin, Ester M. Hammond, Panagis Filippakopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Stuart J. Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10102-10123. <a href="https://doi.org/10.1021/acs.jmedchem.1c00348" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00348%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DControlling%252BIntramolecular%252BInteractions%252Bin%252Bthe%252BDesign%252Bof%252BSelective%25252C%252BHigh-Affinity%252BLigands%252Bfor%252Bthe%252BCREBBP%252BBromodomain%26aulast%3DBrand%26aufirst%3DMichael%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25022021%26date%3D13072021%26volume%3D64%26issue%3D14%26spage%3D10102%26epage%3D10123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Karishma Patel, Paul D. Solomon, James L. Walshe, Daniel J. Ford, Lorna Wilkinson-White, Richard J. Payne, Jason K. K. Low, <span class="NLM_string-name hlFld-ContribAuthor">Joel P. Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">BET-Family Bromodomains Can Recognize Diacetylated Sequences from Transcription Factors Using a Conserved Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (9)
                                     , 648-662. <a href="https://doi.org/10.1021/acs.biochem.0c00816" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00816%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DBET-Family%252BBromodomains%252BCan%252BRecognize%252BDiacetylated%252BSequences%252Bfrom%252BTranscription%252BFactors%252BUsing%252Ba%252BConserved%252BMechanism%26aulast%3DPatel%26aufirst%3DKarishma%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D08102020%26date%3D13022021%26date%3D23022021%26volume%3D60%26issue%3D9%26spage%3D648%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ping Bai, Xiaoxia Lu, Yan Liu, Yu Lan, Hao Wang, Stephanie Fiedler, Robin Striar, <span class="NLM_string-name hlFld-ContribAuthor">Changning Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Positron Emission Tomography Radiotracer Selectively Targeting the BD1 Bromodomains of BET Proteins. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 282-287. <a href="https://doi.org/10.1021/acsmedchemlett.0c00650" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00650%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPositron%252BEmission%252BTomography%252BRadiotracer%252BSelectively%252BTargeting%252Bthe%252BBD1%252BBromodomains%252Bof%252BBET%252BProteins%26aulast%3DBai%26aufirst%3DPing%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14122020%26date%3D06012021%26date%3D08012021%26volume%3D12%26issue%3D2%26spage%3D282%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Corentine M. C. Laurin, Joseph P. Bluck, Anthony K. N. Chan, Michelle Keller, Andrew Boczek, Amy R. Scorah, K. F. Larissa See, Laura E. Jennings, David S. Hewings, Fern Woodhouse, Jessica K. Reynolds, Matthias Schiedel, Philip G. Humphreys, Philip C. Biggin, <span class="NLM_string-name hlFld-ContribAuthor">Stuart J. Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00618%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DFragment-Based%252BIdentification%252Bof%252BLigands%252Bfor%252BBromodomain-Containing%252BFactor%252B3%252Bof%252BTrypanosoma%252Bcruzi%26aulast%3DLaurin%26aufirst%3DCorentine%2BM.%2BC.%26date%3D2020%26date%3D2020%26date%3D31082020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jean-Rémy Marchand, Tim Knehans, Amedeo Caflisch, <span class="NLM_string-name hlFld-ContribAuthor">Andreas Vitalis</span>. </span><span class="cited-content_cbyCitation_article-title">An ABSINTH-Based Protocol for Predicting Binding Affinities between Proteins and Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (10)
                                     , 5188-5202. <a href="https://doi.org/10.1021/acs.jcim.0c00558" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00558%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAn%252BABSINTH-Based%252BProtocol%252Bfor%252BPredicting%252BBinding%252BAffinities%252Bbetween%252BProteins%252Band%252BSmall%252BMolecules%26aulast%3DMarchand%26aufirst%3DJean-R%25C3%25A9my%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19052020%26date%3D23092020%26date%3D08092020%26volume%3D60%26issue%3D10%26spage%3D5188%26epage%3D5202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher R. Wellaway, Paul Bamborough, Sharon G. Bernard, Chun-wa Chung, Peter D. Craggs, Leanne Cutler, Emmanuel H. Demont, John P. Evans, Laurie Gordon, Bhumika Karamshi, Antonia J. Lewis, Matthew J. Lindon, Darren J. Mitchell, Inmaculada Rioja, Peter E. Soden, Simon Taylor, Robert J. Watson, Rob Willis, James M. Woolven, Beata S. Wyspiańska, William J. Kerr, <span class="NLM_string-name hlFld-ContribAuthor">Rab K. Prinjha</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9020-9044. <a href="https://doi.org/10.1021/acs.jmedchem.0c00566" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00566%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ba%252BBromodomain%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252BInhibitor%252BSelective%252Bfor%252Bthe%252BN-Terminal%252BBromodomains%252BThat%252BRetains%252Ban%252BAnti-inflammatory%252Band%252BAntiproliferative%252BPhenotype%26aulast%3DWellaway%26aufirst%3DChristopher%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06042020%26date%3D03082020%26volume%3D63%26issue%3D17%26spage%3D9020%26epage%3D9044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael A. Clegg, Paul Bamborough, Chun-wa Chung, Peter D. Craggs, Laurie Gordon, Paola Grandi, Melanie Leveridge, Matthew Lindon, Gemma M. Liwicki, Anne-Marie Michon, Judit Molnar, Inmaculada Rioja, Peter E. Soden, Natalie H. Theodoulou, Thilo Werner, Nicholas C. O. Tomkinson, Rab K. Prinjha, <span class="NLM_string-name hlFld-ContribAuthor">Philip G. Humphreys</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5816-5840. <a href="https://doi.org/10.1021/acs.jmedchem.0c00075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BAtypical%252BAcetyl-lysine%252BMethyl%252BMimetics%252Bin%252Bthe%252BDevelopment%252Bof%252BSelective%252BInhibitors%252Bof%252Bthe%252BBromodomain-Containing%252BProtein%252B7%252B%252528BRD7%252529%25252FBromodomain-Containing%252BProtein%252B9%252B%252528BRD9%252529%252BBromodomains%26aulast%3DClegg%26aufirst%3DMichael%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15012020%26date%3D29052020%26date%3D15052020%26volume%3D63%26issue%3D11%26spage%3D5816%26epage%3D5840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiangjun Liu, Xiuwen Jia, Xuemeng Chen, Haotian Sun, Yue Li, Søren Kramer, <span class="NLM_string-name hlFld-ContribAuthor">Zhong Lian</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Intramolecular Desulfitative C—N Coupling: A Synthesis of Aromatic Amines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 5702-5711. <a href="https://doi.org/10.1021/acs.joc.0c00009" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00009%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNickel-Catalyzed%252BIntramolecular%252BDesulfitative%252BC%2525E2%252580%252594N%252BCoupling%25253A%252BA%252BSynthesis%252Bof%252BAromatic%252BAmines%26aulast%3DLiu%26aufirst%3DJiangjun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02012020%26date%3D06042020%26date%3D30032020%26volume%3D85%26issue%3D8%26spage%3D5702%26epage%3D5711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhaoping Pan, Xiang Li, Yujia Wang, Qinglin Jiang, Li Jiang, Min Zhang, Nan Zhang, Fengbo Wu, Bo Liu, <span class="NLM_string-name hlFld-ContribAuthor">Gu He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Thieno[2,3-d]pyrimidine-Based Hydroxamic Acid Derivatives as Bromodomain-Containing Protein 4/Histone Deacetylase Dual Inhibitors Induce Autophagic Cell Death in Colorectal Carcinoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3678-3700. <a href="https://doi.org/10.1021/acs.jmedchem.9b02178" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02178%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BThieno%25255B2%25252C3-d%25255Dpyrimidine-Based%252BHydroxamic%252BAcid%252BDerivatives%252Bas%252BBromodomain-Containing%252BProtein%252B4%25252FHistone%252BDeacetylase%252BDual%252BInhibitors%252BInduce%252BAutophagic%252BCell%252BDeath%252Bin%252BColorectal%252BCarcinoma%252BCells%26aulast%3DPan%26aufirst%3DZhaoping%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30122019%26date%3D18032020%26date%3D10032020%26volume%3D63%26issue%3D7%26spage%3D3678%26epage%3D3700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher R. Wellaway, Dominique Amans, Paul Bamborough, Heather Barnett, Rino A. Bit, Jack A. Brown, Neil R. Carlson, Chun-wa Chung, Anthony W. J. Cooper, Peter D. Craggs, Robert P. Davis, Tony W. Dean, John P. Evans, Laurie Gordon, Isobel L. Harada, David J. Hirst, Philip G. Humphreys, Katherine L. Jones, Antonia J. Lewis, Matthew J. Lindon, Dave Lugo, Mahnoor Mahmood, Scott McCleary, Patricia Medeiros, Darren J. Mitchell, Michael O’Sullivan, Armelle Le Gall, Vipulkumar K. Patel, Chris Patten, Darren L. Poole, Rishi R. Shah, Jane E. Smith, Kayleigh A. J. Stafford, Pamela J. Thomas, Mythily Vimal, Ian D. Wall, Robert J. Watson, Natalie Wellaway, Gang Yao, <span class="NLM_string-name hlFld-ContribAuthor">Rab K. Prinjha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 714-746. <a href="https://doi.org/10.1021/acs.jmedchem.9b01670" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01670%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BBromodomain%252Band%252BExtraterminal%252BInhibitor%252Bwith%252Ba%252BLow%252BPredicted%252BHuman%252BDose%252Bthrough%252BSynergistic%252BUse%252Bof%252BEncoded%252BLibrary%252BTechnology%252Band%252BFragment%252BScreening%26aulast%3DWellaway%26aufirst%3DChristopher%2BR.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D08102019%26date%3D06012020%26volume%3D63%26issue%3D2%26spage%3D714%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew J. West, James W. B. Fyfe, Julien C. Vantourout, <span class="NLM_string-name hlFld-ContribAuthor">Allan J. B. Watson</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Development and Recent Applications of the Chan–Lam Amination. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (24)
                                     , 12491-12523. <a href="https://doi.org/10.1021/acs.chemrev.9b00491" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00491%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMechanistic%252BDevelopment%252Band%252BRecent%252BApplications%252Bof%252Bthe%252BChan%2525E2%252580%252593Lam%252BAmination%26aulast%3DWest%26aufirst%3DMatthew%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05082019%26date%3D22112019%26volume%3D119%26issue%3D24%26spage%3D12491%26epage%3D12523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Miao Zhan, Xiang Pu, Bin He, Dawen Niu, <span class="NLM_string-name hlFld-ContribAuthor">Xia Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Umpolung Allylation of Imines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (18)
                                     , 5857-5860. <a href="https://doi.org/10.1021/acs.orglett.8b02536" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02536%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIntramolecular%252BUmpolung%252BAllylation%252Bof%252BImines%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07082018%26date%3D11092018%26volume%3D20%26issue%3D18%26spage%3D5857%26epage%3D5860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert P. Law, Stephen J. Atkinson, Paul Bamborough, Chun-wa Chung, Emmanuel H. Demont, Laurie J. Gordon, Matthew Lindon, Rab K. Prinjha, Allan J. B. Watson, <span class="NLM_string-name hlFld-ContribAuthor">David J. Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4317-4334. <a href="https://doi.org/10.1021/acs.jmedchem.7b01666" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01666%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTetrahydroquinoxalines%252Bas%252BBromodomain%252Band%252BExtra-Terminal%252BDomain%252B%252528BET%252529%252BInhibitors%252Bwith%252BSelectivity%252Bfor%252Bthe%252BSecond%252BBromodomain%26aulast%3DLaw%26aufirst%3DRobert%2BP.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D11112017%26date%3D03052018%26date%3D15042018%26volume%3D61%26issue%3D10%26spage%3D4317%26epage%3D4334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibraheem  Ali</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Conrad</span>, <span class="hlFld-ContribAuthor ">Eric  Verdin</span>, and <span class="hlFld-ContribAuthor ">Melanie  Ott</span>  . </span><span class="cited-content_cbyCitation_article-title">Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 1216-1252. <a href="https://doi.org/10.1021/acs.chemrev.7b00181" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00181%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DLysine%252BAcetylation%252BGoes%252BGlobal%25253A%252BFrom%252BEpigenetics%252Bto%252BMetabolism%252Band%252BTherapeutics%26aulast%3DAli%26aufirst%3DIbraheem%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31032017%26date%3D06022018%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D1216%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kwok-Ho  Chan</span>, <span class="hlFld-ContribAuthor ">Michael  Zengerle</span>, <span class="hlFld-ContribAuthor ">Andrea  Testa</span>, and <span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>  . </span><span class="cited-content_cbyCitation_article-title">Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (2)
                                     , 504-513. <a href="https://doi.org/10.1021/acs.jmedchem.6b01912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImpact%252Bof%252BTarget%252BWarhead%252Band%252BLinkage%252BVector%252Bon%252BInducing%252BProtein%252BDegradation%25253A%252BComparison%252Bof%252BBromodomain%252Band%252BExtra-Terminal%252B%252528BET%252529%252BDegraders%252BDerived%252Bfrom%252BTriazolodiazepine%252B%252528JQ1%252529%252Band%252BTetrahydroquinoline%252B%252528I-BET726%252529%252BBET%252BInhibitor%252BScaffolds%26aulast%3DChan%26aufirst%3DKwok-Ho%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D04012017%26date%3D22062017%26date%3D25012018%26date%3D08062017%26volume%3D61%26issue%3D2%26spage%3D504%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">Todd  Soltwedel</span>, <span class="hlFld-ContribAuthor ">Steven D.  Fidanze</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Hasvold</span>, <span class="hlFld-ContribAuthor ">Dachun  Liu</span>, <span class="hlFld-ContribAuthor ">Robert A.  Mantei</span>, <span class="hlFld-ContribAuthor ">John K.  Pratt</span>, <span class="hlFld-ContribAuthor ">George S.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Mai H.  Bui</span>, <span class="hlFld-ContribAuthor ">Emily J.  Faivre</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Huang</span>, <span class="hlFld-ContribAuthor ">Leiming  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Lin</span>, <span class="hlFld-ContribAuthor ">Rongqi  Wang</span>, <span class="hlFld-ContribAuthor ">Scott E.  Warder</span>, <span class="hlFld-ContribAuthor ">Denise  Wilcox</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Albert</span>, <span class="hlFld-ContribAuthor ">Terrance J.  Magoc</span>, <span class="hlFld-ContribAuthor ">Ganesh  Rajaraman</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Charles W.  Hutchins</span>, <span class="hlFld-ContribAuthor ">Jianwei J.  Shen</span>, <span class="hlFld-ContribAuthor ">Rohinton P.  Edalji</span>, <span class="hlFld-ContribAuthor ">Chaohong C.  Sun</span>, <span class="hlFld-ContribAuthor ">Ruth  Martin</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Shekman  Wong</span>, <span class="hlFld-ContribAuthor ">Guowei  Fang</span>, <span class="hlFld-ContribAuthor ">Steven W.  Elmore</span>, <span class="hlFld-ContribAuthor ">Yu  Shen</span>, and <span class="hlFld-ContribAuthor ">Warren M.  Kati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8369-8384. <a href="https://doi.org/10.1021/acs.jmedchem.7b00746" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%2525282%25252C4-Difluorophenoxy%252529-3-%2525286-methyl-7-oxo-6%25252C7-dihydro-1H-pyrrolo%25255B2%25252C3-c%25255Dpyridin-4-yl%252529phenyl%252529ethanesulfonamide%252B%252528ABBV-075%25252FMivebresib%252529%25252C%252Ba%252BPotent%252Band%252BOrally%252BAvailable%252BBromodomain%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252BFamily%252BBromodomain%252BInhibitor%26aulast%3DMcDaniel%26aufirst%3DKeith%2BF.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19052017%26date%3D12102017%26date%3D26102017%26date%3D26092017%26volume%3D60%26issue%3D20%26spage%3D8369%26epage%3D8384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Millan</span>, <span class="hlFld-ContribAuthor ">Katherine J.  Kayser-Bricker</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>, <span class="hlFld-ContribAuthor ">Adam C.  Talbot</span>, <span class="hlFld-ContribAuthor ">Shawn E. R.  Schiller</span>, <span class="hlFld-ContribAuthor ">Torsten  Herbertz</span>, <span class="hlFld-ContribAuthor ">Grace L.  Williams</span>, <span class="hlFld-ContribAuthor ">George P.  Luke</span>, <span class="hlFld-ContribAuthor ">Stephen  Hubbs</span>, <span class="hlFld-ContribAuthor ">Monica A.  Alvarez Morales</span>, <span class="hlFld-ContribAuthor ">Daniel  Cardillo</span>, <span class="hlFld-ContribAuthor ">Paul  Troccolo</span>, <span class="hlFld-ContribAuthor ">Rachel L.  Mendes</span>, and <span class="hlFld-ContribAuthor ">Crystal  McKinnon</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 847-852. <a href="https://doi.org/10.1021/acsmedchemlett.7b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BOptimization%252Bof%252BBenzopiperazines%252Bas%252BPotent%252BInhibitors%252Bof%252BBET%252BBromodomains%26aulast%3DMillan%26aufirst%3DDavid%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04052017%26date%3D14072017%26date%3D19072017%26date%3D10082017%26date%3D14072017%26volume%3D8%26issue%3D8%26spage%3D847%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Pingyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>, and <span class="hlFld-ContribAuthor ">Jia  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Bromodomain-Containing Protein 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (11)
                                     , 4533-4558. <a href="https://doi.org/10.1021/acs.jmedchem.6b01761" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01761%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDiscovery%252BTargeting%252BBromodomain-Containing%252BProtein%252B4%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D02122016%26date%3D02032017%26date%3D08062017%26date%3D14022017%26volume%3D60%26issue%3D11%26spage%3D4533%26epage%3D4558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Liu  Liu</span>, <span class="hlFld-ContribAuthor ">Donna  McEachern</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meagher</span>, <span class="hlFld-ContribAuthor ">Chao-Yie  Yang</span>, <span class="hlFld-ContribAuthor ">Xu  Ran</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Yang  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Wen</span>, <span class="hlFld-ContribAuthor ">Ting  Zhao</span>, <span class="hlFld-ContribAuthor ">Siwei  Li</span>, <span class="hlFld-ContribAuthor ">Duxin  Sun</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3887-3901. <a href="https://doi.org/10.1021/acs.jmedchem.7b00193" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252B4-%2525286-Methoxy-2-methyl-4-%252528quinolin-4-yl%252529-9H-pyrimido%25255B4%25252C5-b%25255Dindol-7-yl%252529-3%25252C5-dimethylisoxazole%252B%252528CD161%252529%252Bas%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BBET%252BBromodomain%252BInhibitor%26aulast%3DZhao%26aufirst%3DYujun%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04022017%26date%3D02052017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3887%26epage%3D3901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunzhou  Wan</span>, <span class="hlFld-ContribAuthor ">Agastya P.  Bhati</span>, <span class="hlFld-ContribAuthor ">Stefan J.  Zasada</span>, <span class="hlFld-ContribAuthor ">Ian  Wall</span>, <span class="hlFld-ContribAuthor ">Darren  Green</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, and <span class="hlFld-ContribAuthor ">Peter V.  Coveney</span>  . </span><span class="cited-content_cbyCitation_article-title">Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2017,</strong> <em>13 </em>
                                    (2)
                                     , 784-795. <a href="https://doi.org/10.1021/acs.jctc.6b00794" title="DOI URL">https://doi.org/10.1021/acs.jctc.6b00794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.6b00794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.6b00794%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DRapid%252Band%252BReliable%252BBinding%252BAffinity%252BPrediction%252Bof%252BBromodomain%252BInhibitors%25253A%252BA%252BComputational%252BStudy%26aulast%3DWan%26aufirst%3DShunzhou%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D11082016%26date%3D18012017%26date%3D14022017%26date%3D22122016%26volume%3D13%26issue%3D2%26spage%3D784%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip G.  Humphreys</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">Peter D.  Craggs</span>, <span class="hlFld-ContribAuthor ">Laurie  Gordon</span>, <span class="hlFld-ContribAuthor ">Paola  Grandi</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Hayhow</span>, <span class="hlFld-ContribAuthor ">Jameed  Hussain</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Jones</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Michon</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Renaux</span>, <span class="hlFld-ContribAuthor ">Colin J.  Suckling</span>, <span class="hlFld-ContribAuthor ">David F.  Tough</span>, and <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 695-709. <a href="https://doi.org/10.1021/acs.jmedchem.6b01566" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01566%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BCell%252BPenetrant%25252C%252Band%252BSelective%252Bp300%25252FCBP-Associated%252BFactor%252B%252528PCAF%252529%25252FGeneral%252BControl%252BNonderepressible%252B5%252B%252528GCN5%252529%252BBromodomain%252BChemical%252BProbe%26aulast%3DHumphreys%26aufirst%3DPhilip%2BG.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D27102016%26date%3D09012017%26date%3D26012017%26date%3D21122016%26volume%3D60%26issue%3D2%26spage%3D695%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vassilios  Myrianthopoulos</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Michelle-Lynn  Hall</span>, <span class="hlFld-ContribAuthor ">Stylianos  Grigoriou</span>, <span class="hlFld-ContribAuthor ">Peter Moore  Brownlee</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Catherine  Rogers</span>, <span class="hlFld-ContribAuthor ">David  Heidenreich</span>, <span class="hlFld-ContribAuthor ">Marek  Wanior</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Drosos</span>, <span class="hlFld-ContribAuthor ">Nikitia  Mexia</span>, <span class="hlFld-ContribAuthor ">Pavel  Savitsky</span>, <span class="hlFld-ContribAuthor ">Tina  Bagratuni</span>, <span class="hlFld-ContribAuthor ">Efstathios  Kastritis</span>, <span class="hlFld-ContribAuthor ">Evangelos  Terpos</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>, <span class="hlFld-ContribAuthor ">Jessica Ann  Downs</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, and <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8787-8803. <a href="https://doi.org/10.1021/acs.jmedchem.6b00355" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00355%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252Ba%252BSelective%252BLigand%252Bfor%252Bthe%252BSwitch%25252FSucrose%252BNonfermenting-Related%252BBromodomains%252Bof%252BPolybromo%252BProtein-1%252Bby%252Bthe%252BUse%252Bof%252BVirtual%252BScreening%252Band%252BHydration%252BAnalysis%26aulast%3DMyrianthopoulos%26aufirst%3DVassilios%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07032016%26date%3D27092016%26date%3D13102016%26date%3D12092016%26volume%3D59%26issue%3D19%26spage%3D8787%26epage%3D8803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Ruiz-Castillo</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12564-12649. <a href="https://doi.org/10.1021/acs.chemrev.6b00512" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DApplications%252Bof%252BPalladium-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252BReactions%26aulast%3DRuiz-Castillo%26aufirst%3DPaula%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03082016%26date%3D30092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12564%26epage%3D12649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven G.  Smith</span> and <span class="hlFld-ContribAuthor ">Ming-Ming  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">The Bromodomain: A New Target in Emerging Epigenetic Medicine. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , 598-608. <a href="https://doi.org/10.1021/acschembio.5b00831" title="DOI URL">https://doi.org/10.1021/acschembio.5b00831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00831%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DThe%252BBromodomain%25253A%252BA%252BNew%252BTarget%252Bin%252BEmerging%252BEpigenetic%252BMedicine%26aulast%3DSmith%26aufirst%3DSteven%2BG.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09102015%26date%3D23112015%26date%3D03122015%26date%3D18032016%26date%3D23112015%26volume%3D11%26issue%3D3%26spage%3D598%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie H.  Theodoulou</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Bannister</span>, <span class="hlFld-ContribAuthor ">Isabelle  Becher</span>, <span class="hlFld-ContribAuthor ">Rino A.  Bit</span>, <span class="hlFld-ContribAuthor ">Ka Hing  Che</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">Antje  Dittmann</span>, <span class="hlFld-ContribAuthor ">Gerard  Drewes</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">Laurie  Gordon</span>, <span class="hlFld-ContribAuthor ">Paola  Grandi</span>, <span class="hlFld-ContribAuthor ">Melanie  Leveridge</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Michon</span>, <span class="hlFld-ContribAuthor ">Judit  Molnar</span>, <span class="hlFld-ContribAuthor ">Samuel C.  Robson</span>, <span class="hlFld-ContribAuthor ">Nicholas C. O.  Tomkinson</span>, <span class="hlFld-ContribAuthor ">Tony  Kouzarides</span>, <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>, and <span class="hlFld-ContribAuthor ">Philip G.  Humphreys</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (4)
                                     , 1425-1439. <a href="https://doi.org/10.1021/acs.jmedchem.5b00256" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00256%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BI-BRD9%25252C%252Ba%252BSelective%252BCell%252BActive%252BChemical%252BProbe%252Bfor%252BBromodomain%252BContaining%252BProtein%252B9%252BInhibition%26aulast%3DTheodoulou%26aufirst%3DNatalie%2BH.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D30042015%26date%3D25022016%26date%3D09042015%26volume%3D59%26issue%3D4%26spage%3D1425%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqian  Xue</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhaoxuan  Liu</span>, <span class="hlFld-ContribAuthor ">Ming  Song</span>, <span class="hlFld-ContribAuthor ">Yanli  Xing</span>, <span class="hlFld-ContribAuthor ">Qiuping  Xiang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yulai  Zhou</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, and <span class="hlFld-ContribAuthor ">Yong  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (4)
                                     , 1565-1579. <a href="https://doi.org/10.1021/acs.jmedchem.5b01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBenzo%25255Bcd%25255Dindol-2%2525281H%252529-ones%252Bas%252BPotent%252Band%252BSpecific%252BBET%252BBromodomain%252BInhibitors%25253A%252BStructure-Based%252BVirtual%252BScreening%25252C%252BOptimization%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DXue%26aufirst%3DXiaoqian%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D29092015%26date%3D12012016%26date%3D25022016%26date%3D05012016%26volume%3D59%26issue%3D4%26spage%3D1565%26epage%3D1579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, and <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>  . </span><span class="cited-content_cbyCitation_article-title">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (4)
                                     , 1271-1298. <a href="https://doi.org/10.1021/acs.jmedchem.5b01514" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01514</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01514%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDisrupting%252BAcetyl-Lysine%252BRecognition%25253A%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BBromodomain%252BInhibitors%26aulast%3DRomero%26aufirst%3DF.%2BAnthony%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D29092015%26date%3D01122015%26date%3D25022016%26date%3D16112015%26volume%3D59%26issue%3D4%26spage%3D1271%26epage%3D1298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Zengerle</span>, <span class="hlFld-ContribAuthor ">Kwok-Ho  Chan</span>, and <span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (8)
                                     , 1770-1777. <a href="https://doi.org/10.1021/acschembio.5b00216" title="DOI URL">https://doi.org/10.1021/acschembio.5b00216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSelective%252BSmall%252BMolecule%252BInduced%252BDegradation%252Bof%252Bthe%252BBET%252BBromodomain%252BProtein%252BBRD4%26aulast%3DZengerle%26aufirst%3DMichael%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D25032015%26date%3D02062015%26date%3D16062015%26date%3D21082015%26date%3D02062015%26volume%3D10%26issue%3D8%26spage%3D1770%26epage%3D1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Furze</span>, <span class="hlFld-ContribAuthor ">Paola  Grandi</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Michon</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Heather  Barnett</span>, <span class="hlFld-ContribAuthor ">Hawa  Diallo</span>, <span class="hlFld-ContribAuthor ">David P.  Dixon</span>, <span class="hlFld-ContribAuthor ">Clement  Douault</span>, <span class="hlFld-ContribAuthor ">Emma J.  Jones</span>, <span class="hlFld-ContribAuthor ">Bhumika  Karamshi</span>, <span class="hlFld-ContribAuthor ">Darren J.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>, <span class="hlFld-ContribAuthor ">Christina  Rau</span>, <span class="hlFld-ContribAuthor ">Robert J.  Watson</span>, <span class="hlFld-ContribAuthor ">Thilo  Werner</span>, and <span class="hlFld-ContribAuthor ">Emmanuel H.  Demont</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 6151-6178. <a href="https://doi.org/10.1021/acs.jmedchem.5b00773" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00773%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BOptimization%252Bof%252BNaphthyridones%252Binto%252BPotent%252BATAD2%252BBromodomain%252BInhibitors%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21052015%26date%3D31072015%26date%3D13082015%26volume%3D58%26issue%3D15%26spage%3D6151%26epage%3D6178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel H.  Demont</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Furze</span>, <span class="hlFld-ContribAuthor ">Paola  Grandi</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Michon</span>, <span class="hlFld-ContribAuthor ">Chris  Wellaway</span>, <span class="hlFld-ContribAuthor ">Nathalie  Barrett</span>, <span class="hlFld-ContribAuthor ">Angela M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Peter D.  Craggs</span>, <span class="hlFld-ContribAuthor ">Hawa  Diallo</span>, <span class="hlFld-ContribAuthor ">David P.  Dixon</span>, <span class="hlFld-ContribAuthor ">Clement  Douault</span>, <span class="hlFld-ContribAuthor ">Amanda J.  Emmons</span>, <span class="hlFld-ContribAuthor ">Emma J.  Jones</span>, <span class="hlFld-ContribAuthor ">Bhumika V.  Karamshi</span>, <span class="hlFld-ContribAuthor ">Kelly  Locke</span>, <span class="hlFld-ContribAuthor ">Darren J.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Bernadette H.  Mouzon</span>, <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>, <span class="hlFld-ContribAuthor ">Andy D.  Roberts</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Robert J.  Watson</span>, and <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (14)
                                     , 5649-5673. <a href="https://doi.org/10.1021/acs.jmedchem.5b00772" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00772%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDiscovery%252Bof%252BLow-Micromolar%252BATAD2%252BBromodomain%252BInhibitors%26aulast%3DDemont%26aufirst%3DEmmanuel%2BH.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21052015%26date%3D09072015%26date%3D23072015%26volume%3D58%26issue%3D14%26spage%3D5649%26epage%3D5673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn A.  McGarry</span>, <span class="hlFld-ContribAuthor ">Alexi A.  Duenas</span>, and <span class="hlFld-ContribAuthor ">Timothy B.  Clark</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Formation of ortho-Aminobenzylamines by the Copper-Catalyzed Amination of Benzylamine Boronate Esters. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (14)
                                     , 7193-7204. <a href="https://doi.org/10.1021/acs.joc.5b01074" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01074%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSelective%252BFormation%252Bof%252Bortho-Aminobenzylamines%252Bby%252Bthe%252BCopper-Catalyzed%252BAmination%252Bof%252BBenzylamine%252BBoronate%252BEsters%26aulast%3DMcGarry%26aufirst%3DKathryn%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13052015%26date%3D01072015%26date%3D17072015%26date%3D12062015%26volume%3D80%26issue%3D14%26spage%3D7193%26epage%3D7204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Ran</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Liu  Liu</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Chao-Yie  Yang</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meagher</span>, <span class="hlFld-ContribAuthor ">Krishnapriya  Chinnaswamy</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (12)
                                     , 4927-4939. <a href="https://doi.org/10.1021/acs.jmedchem.5b00613" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252B%2525CE%2525B3-Carboline%252BAnalogues%252Bas%252BPotent%252Band%252BSpecific%252BBET%252BBromodomain%252BInhibitors%26aulast%3DRan%26aufirst%3DXu%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D14112014%26date%3D16062015%26date%3D25062015%26volume%3D58%26issue%3D12%26spage%3D4927%26epage%3D4939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lele  Zhao</span>, <span class="hlFld-ContribAuthor ">Yingqing  Wang</span>, <span class="hlFld-ContribAuthor ">Danyan  Cao</span>, <span class="hlFld-ContribAuthor ">Tiantian  Chen</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Yanlian  Li</span>, <span class="hlFld-ContribAuthor ">Yechun  Xu</span>, <span class="hlFld-ContribAuthor ">Naixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Danqi  Chen</span>, <span class="hlFld-ContribAuthor ">Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Yue-Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Guangxin  Xia</span>, <span class="hlFld-ContribAuthor ">Zhe  Shi</span>, <span class="hlFld-ContribAuthor ">Yu-Chih  Liu</span>, <span class="hlFld-ContribAuthor ">Yijyun  Lin</span>, <span class="hlFld-ContribAuthor ">Zehong  Miao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, and <span class="hlFld-ContribAuthor ">Bing  Xiong</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1281-1297. <a href="https://doi.org/10.1021/jm501504k" title="DOI URL">https://doi.org/10.1021/jm501504k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501504k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501504k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDrug%252BDiscovery%252Bof%252B2-Thiazolidinones%252Bas%252BBRD4%252BInhibitors%25253A%252B2.%252BStructure-Based%252BOptimization%26aulast%3DZhao%26aufirst%3DLele%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D30092014%26date%3D14012015%26date%3D12022015%26date%3D05012015%26volume%3D58%26issue%3D3%26spage%3D1281%26epage%3D1297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Brand</span>, <span class="hlFld-ContribAuthor ">Angelina M.  Measures</span>, <span class="hlFld-ContribAuthor ">Brian G.  Wilson</span>, <span class="hlFld-ContribAuthor ">Wilian A.  Cortopassi</span>, <span class="hlFld-ContribAuthor ">Rikki  Alexander</span>, <span class="hlFld-ContribAuthor ">Matthias  Höss</span>, <span class="hlFld-ContribAuthor ">David S.  Hewings</span>, <span class="hlFld-ContribAuthor ">Timothy P. C.  Rooney</span>, <span class="hlFld-ContribAuthor ">Robert S.  Paton</span>, and <span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     , 22-39. <a href="https://doi.org/10.1021/cb500996u" title="DOI URL">https://doi.org/10.1021/cb500996u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500996u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500996u%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSmall%252BMolecule%252BInhibitors%252Bof%252BBromodomain%2525E2%252580%252593Acetyl-lysine%252BInteractions%26aulast%3DBrand%26aufirst%3DMichael%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05122014%26date%3D30122014%26date%3D16012015%26date%3D30122014%26volume%3D10%26issue%3D1%26spage%3D22%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hussien Ahmed  Khamees</span>, <span class="hlFld-ContribAuthor ">Mahendra  Madegowda</span>, <span class="hlFld-ContribAuthor ">S  Ananda</span>, <span class="hlFld-ContribAuthor ">Y  Sangappa</span>, <span class="hlFld-ContribAuthor ">Fares Hezam  Al-Ostoot</span>, <span class="hlFld-ContribAuthor ">Nadeem  Abad</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular structure, DFT studies, in silico docking and molecular dynamics simulations of 2,6 dimethoxychalcone derivatives as BRD4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1245 </em>, 131032. <a href="https://doi.org/10.1016/j.molstruc.2021.131032" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bmolecular%252Bstructure%25252C%252BDFT%252Bstudies%25252C%252Bin%252Bsilico%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252Bof%252B2%25252C6%252Bdimethoxychalcone%252Bderivatives%252Bas%252BBRD4%252Binhibitors%26aulast%3DKhamees%26aufirst%3DHussien%2BAhmed%26date%3D2021%26volume%3D1245%26spage%3D131032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim G.  Vinogradov</span>, <span class="hlFld-ContribAuthor ">Olga V.  Turova</span>, <span class="hlFld-ContribAuthor ">Sergei G.  Zlotin</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Aza‐Diels‐Alder Reaction: Pivotal Milestones and Recent Applications to Synthesis of Nitrogen‐Containing Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (6)
                                     , 1466-1526. <a href="https://doi.org/10.1002/adsc.202001307" title="DOI URL">https://doi.org/10.1002/adsc.202001307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001307%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalytic%252BAsymmetric%252BAza%2525E2%252580%252590Diels%2525E2%252580%252590Alder%252BReaction%25253A%252BPivotal%252BMilestones%252Band%252BRecent%252BApplications%252Bto%252BSynthesis%252Bof%252BNitrogen%2525E2%252580%252590Containing%252BHeterocycles%26aulast%3DVinogradov%26aufirst%3DMaxim%2BG.%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D6%26spage%3D1466%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian J.  Groves</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Jackson</span>, <span class="hlFld-ContribAuthor ">Emma L.  Poole</span>, <span class="hlFld-ContribAuthor ">Aharon  Nachshon</span>, <span class="hlFld-ContribAuthor ">Batsheva  Rozman</span>, <span class="hlFld-ContribAuthor ">Michal  Schwartz</span>, <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>, <span class="hlFld-ContribAuthor ">David F.  Tough</span>, <span class="hlFld-ContribAuthor ">John H.  Sinclair</span>, <span class="hlFld-ContribAuthor ">Mark R.  Wills</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (9)
                                     , e2023025118. <a href="https://doi.org/10.1073/pnas.2023025118" title="DOI URL">https://doi.org/10.1073/pnas.2023025118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2023025118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2023025118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DBromodomain%252Bproteins%252Bregulate%252Bhuman%252Bcytomegalovirus%252Blatency%252Band%252Breactivation%252Ballowing%252Bepigenetic%252Btherapeutic%252Bintervention%26aulast%3DGroves%26aufirst%3DIan%2BJ.%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D9%26spage%3De2023025118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karishma  Patel</span>, <span class="hlFld-ContribAuthor ">Paul D.  Solomon</span>, <span class="hlFld-ContribAuthor ">James L.  Walshe</span>, <span class="hlFld-ContribAuthor ">Jason K. K.  Low</span>, <span class="hlFld-ContribAuthor ">Joel P.  Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">The bromodomains of
              BET
              family proteins can recognize diacetylated histone
              H2A
              .Z. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 464-476. <a href="https://doi.org/10.1002/pro.4006" title="DOI URL">https://doi.org/10.1002/pro.4006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.4006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.4006%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3DThe%252Bbromodomains%252Bof%252BBET%252Bfamily%252Bproteins%252Bcan%252Brecognize%252Bdiacetylated%252Bhistone%252BH2A%252B.Z%26aulast%3DPatel%26aufirst%3DKarishma%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D464%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian-Bo  Tong</span>, <span class="hlFld-ContribAuthor ">Ding  Luo</span>, <span class="hlFld-ContribAuthor ">Yi  Feng</span>, <span class="hlFld-ContribAuthor ">Shuai  Bian</span>, <span class="hlFld-ContribAuthor ">Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Tian-Hao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em><a href="https://doi.org/10.1007/s11030-020-10172-5" title="DOI URL">https://doi.org/10.1007/s11030-020-10172-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10172-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10172-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DStructural%252Bmodification%252Bof%252B4%25252C%252B5-dihydro-%25255B1%25252C%252B2%25252C%252B4%25255D%252Btriazolo%252B%25255B4%25252C%252B3-f%25255D%252Bpteridine%252Bderivatives%252Bas%252BBRD4%252Binhibitors%252Busing%252B2D%25252F3D-QSAR%252Band%252Bmolecular%252Bdocking%252Banalysis%26aulast%3DTong%26aufirst%3DJian-Bo%26date%3D2021%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd.  Muddassir</span>, <span class="hlFld-ContribAuthor ">Kunjal  Soni</span>, <span class="hlFld-ContribAuthor ">Chetan B.  Sangani</span>, <span class="hlFld-ContribAuthor ">Abdullah  Alarifi</span>, <span class="hlFld-ContribAuthor ">Mohd.  Afzal</span>, <span class="hlFld-ContribAuthor ">Naaser A. Y.  Abduh</span>, <span class="hlFld-ContribAuthor ">Yongtao  Duan</span>, <span class="hlFld-ContribAuthor ">Poonam  Bhadja</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 612-636. <a href="https://doi.org/10.1039/D0RA07971E" title="DOI URL">https://doi.org/10.1039/D0RA07971E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA07971E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA07971E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBromodomain%252Band%252BBET%252Bfamily%252Bproteins%252Bas%252Bepigenetic%252Btargets%252Bin%252Bcancer%252Btherapy%25253A%252Btheir%252Bdegradation%25252C%252Bpresent%252Bdrugs%25252C%252Band%252Bpossible%252BPROTACs%26aulast%3DMuddassir%26aufirst%3DMohd.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D612%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François  Danion</span>, <span class="hlFld-ContribAuthor ">Norman  van Rhijn</span>, <span class="hlFld-ContribAuthor ">Alexandre C.  Dufour</span>, <span class="hlFld-ContribAuthor ">Rachel  Legendre</span>, <span class="hlFld-ContribAuthor ">Odile  Sismeiro</span>, <span class="hlFld-ContribAuthor ">Hugo  Varet</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Olivo-Marin</span>, <span class="hlFld-ContribAuthor ">Isabelle  Mouyna</span>, <span class="hlFld-ContribAuthor ">Georgios  Chamilos</span>, <span class="hlFld-ContribAuthor ">Michael  Bromley</span>, <span class="hlFld-ContribAuthor ">Anne  Beauvais</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Latgé</span>. </span><span class="cited-content_cbyCitation_article-title">Aspergillus fumigatus, One Uninucleate Species with Disparate Offspring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fungi</span><span> <strong>2021,</strong> <em>7 </em>
                                    (1)
                                     , 30. <a href="https://doi.org/10.3390/jof7010030" title="DOI URL">https://doi.org/10.3390/jof7010030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jof7010030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjof7010030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fungi%26atitle%3DAspergillus%252Bfumigatus%25252C%252BOne%252BUninucleate%252BSpecies%252Bwith%252BDisparate%252BOffspring%26aulast%3DDanion%26aufirst%3DFran%25C3%25A7ois%26date%3D2021%26date%3D2021%26volume%3D7%26issue%3D1%26spage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Tomaselli</span>, <span class="hlFld-ContribAuthor ">Nicola  Mautone</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112750. <a href="https://doi.org/10.1016/j.ejmech.2020.112750" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112750%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bepigenetic%252Bproteolysis%252Btargeting%252Bchimeras%252B%252528Epi-PROTACs%252529%26aulast%3DTomaselli%26aufirst%3DDaniela%26date%3D2020%26volume%3D207%26spage%3D112750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annette E.  Neele</span>, <span class="hlFld-ContribAuthor ">Lisa  Willemsen</span>, <span class="hlFld-ContribAuthor ">Hung-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Kim E.  Dzobo</span>, <span class="hlFld-ContribAuthor ">Menno P.J.  de Winther</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting epigenetics as atherosclerosis treatment: an updated view. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Lipidology</span><span> <strong>2020,</strong> <em>31 </em>
                                    (6)
                                     , 324-330. <a href="https://doi.org/10.1097/MOL.0000000000000711" title="DOI URL">https://doi.org/10.1097/MOL.0000000000000711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MOL.0000000000000711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMOL.0000000000000711%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Lipidology%26atitle%3DTargeting%252Bepigenetics%252Bas%252Batherosclerosis%252Btreatment%25253A%252Ban%252Bupdated%252Bview%26aulast%3DNeele%26aufirst%3DAnnette%2BE.%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D6%26spage%3D324%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karishma  Patel</span>, <span class="hlFld-ContribAuthor ">Louise J.  Walport</span>, <span class="hlFld-ContribAuthor ">James L.  Walshe</span>, <span class="hlFld-ContribAuthor ">Paul D.  Solomon</span>, <span class="hlFld-ContribAuthor ">Jason K. K.  Low</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Tran</span>, <span class="hlFld-ContribAuthor ">Kevork S.  Mouradian</span>, <span class="hlFld-ContribAuthor ">Ana P. G.  Silva</span>, <span class="hlFld-ContribAuthor ">Lorna  Wilkinson-White</span>, <span class="hlFld-ContribAuthor ">Alexander  Norman</span>, <span class="hlFld-ContribAuthor ">Charlotte  Franck</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Matthews</span>, <span class="hlFld-ContribAuthor ">J. Mitchell  Guss</span>, <span class="hlFld-ContribAuthor ">Richard J.  Payne</span>, <span class="hlFld-ContribAuthor ">Toby  Passioura</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Suga</span>, <span class="hlFld-ContribAuthor ">Joel P.  Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic peptides can engage a single binding pocket through highly divergent modes. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2020,</strong> <em>117 </em>
                                    (43)
                                     , 26728-26738. <a href="https://doi.org/10.1073/pnas.2003086117" title="DOI URL">https://doi.org/10.1073/pnas.2003086117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2003086117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2003086117%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DCyclic%252Bpeptides%252Bcan%252Bengage%252Ba%252Bsingle%252Bbinding%252Bpocket%252Bthrough%252Bhighly%252Bdivergent%252Bmodes%26aulast%3DPatel%26aufirst%3DKarishma%26date%3D2020%26date%3D2020%26volume%3D117%26issue%3D43%26spage%3D26728%26epage%3D26738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An-cheng  Qin</span>, <span class="hlFld-ContribAuthor ">Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Yu  Song</span>, <span class="hlFld-ContribAuthor ">Yun  Gao</span>, <span class="hlFld-ContribAuthor ">Yi-Fan  Chen</span>, <span class="hlFld-ContribAuthor ">Li-na  Zhou</span>, <span class="hlFld-ContribAuthor ">Shu-sheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-sheng  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     <a href="https://doi.org/10.1038/s41419-020-03015-6" title="DOI URL">https://doi.org/10.1038/s41419-020-03015-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-020-03015-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-020-03015-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DThe%252Btherapeutic%252Beffect%252Bof%252Bthe%252BBRD4-degrading%252BPROTAC%252BA1874%252Bin%252Bhuman%252Bcolon%252Bcancer%252Bcells%26aulast%3DQin%26aufirst%3DAn-cheng%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. Jake  Slavish</span>, <span class="hlFld-ContribAuthor ">Liying  Chi</span>, <span class="hlFld-ContribAuthor ">Mi-Kyung  Yun</span>, <span class="hlFld-ContribAuthor ">Lyudmila  Tsurkan</span>, <span class="hlFld-ContribAuthor ">Nancy E.  Martinez</span>, <span class="hlFld-ContribAuthor ">Barbara  Jonchere</span>, <span class="hlFld-ContribAuthor ">Sergio C.  Chai</span>, <span class="hlFld-ContribAuthor ">Michele  Connelly</span>, <span class="hlFld-ContribAuthor ">M. Brett  Waddell</span>, <span class="hlFld-ContribAuthor ">Sourav  Das</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Neale</span>, <span class="hlFld-ContribAuthor ">Zhenmei  Li</span>, <span class="hlFld-ContribAuthor ">William R.  Shadrick</span>, <span class="hlFld-ContribAuthor ">Rachelle R.  Olsen</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Freeman</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Low</span>, <span class="hlFld-ContribAuthor ">Jeanine E.  Price</span>, <span class="hlFld-ContribAuthor ">Brandon M.  Young</span>, <span class="hlFld-ContribAuthor ">Nagakumar  Bharatham</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Boyd</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Richard E.  Lee</span>, <span class="hlFld-ContribAuthor ">Marie  Morfouace</span>, <span class="hlFld-ContribAuthor ">Martine F.  Roussel</span>, <span class="hlFld-ContribAuthor ">Taosheng  Chen</span>, <span class="hlFld-ContribAuthor ">Daniel  Savic</span>, <span class="hlFld-ContribAuthor ">R. Kiplin  Guy</span>, <span class="hlFld-ContribAuthor ">Stephen W.  White</span>, <span class="hlFld-ContribAuthor ">Anang A.  Shelat</span>, <span class="hlFld-ContribAuthor ">Philip M.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2020,</strong> <em>80 </em>
                                    (17)
                                     , 3507-3518. <a href="https://doi.org/10.1158/0008-5472.CAN-19-3934" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-19-3934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-19-3934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-19-3934%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DBromodomain-Selective%252BBET%252BInhibitors%252BAre%252BPotent%252BAntitumor%252BAgents%252Bagainst%252BMYC-Driven%252BPediatric%252BCancer%26aulast%3DSlavish%26aufirst%3DP.%2BJake%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D17%26spage%3D3507%26epage%3D3518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Stephanie  Fiedler</span>, <span class="hlFld-ContribAuthor ">Robin  Striar</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fmolb.2020.00198" title="DOI URL">https://doi.org/10.3389/fmolb.2020.00198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2020.00198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2020.00198%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DDevelopment%252Bof%252Ba%252BNovel%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BRadiotracer%252BTargeting%252BBromodomain%252Band%252BExtra-Terminal%252BDomain%252B%252528BET%252529%252BFamily%252BProteins%26aulast%3DBai%26aufirst%3DPing%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Shruti  Mathur</span>, <span class="hlFld-ContribAuthor ">Gejo  Gangadharan</span>, <span class="hlFld-ContribAuthor ">Gopinatha  Krishnappa</span>, <span class="hlFld-ContribAuthor ">Nandakumar  Dalavaikodihalli Nanjaiah</span>, <span class="hlFld-ContribAuthor ">Balasundaram  Padmanabhan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (12)
                                     , 2263-2279. <a href="https://doi.org/10.1042/BCJ20200339" title="DOI URL">https://doi.org/10.1042/BCJ20200339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200339%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DNovel%252Bpyrano%252B1%25252C3%252Boxazine%252Bbased%252Bligand%252Binhibits%252Bthe%252Bepigenetic%252Breader%252BhBRD2%252Bin%252Bglioblastoma%26aulast%3DDeshmukh%26aufirst%3DPrashant%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D12%26spage%3D2263%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Stephanie  Fiedler</span>, <span class="hlFld-ContribAuthor ">Robin  Striar</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2020,</strong> <em>84-85 </em>, 96-101. <a href="https://doi.org/10.1016/j.nucmedbio.2020.04.003" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DRadiosynthesis%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Ba%252Bnew%252Bpositron%252Bemission%252Btomography%252Bradiotracer%252Btargeting%252Bbromodomain%252Band%252Bextra-terminal%252Bdomain%252B%252528BET%252529%252Bfamily%252Bproteins%26aulast%3DBai%26aufirst%3DPing%26date%3D2020%26volume%3D84-85%26spage%3D96%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengjun  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Li</span>, <span class="hlFld-ContribAuthor ">Yong-qiang  Yang</span>, <span class="hlFld-ContribAuthor ">Shang  Cai</span>, <span class="hlFld-ContribAuthor ">Xiangwei  Lin</span>, <span class="hlFld-ContribAuthor ">Min-bin  Chen</span>, <span class="hlFld-ContribAuthor ">Hailei  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">I-BET726 suppresses human skin squamous cell carcinoma cell growth in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     <a href="https://doi.org/10.1038/s41419-020-2515-z" title="DOI URL">https://doi.org/10.1038/s41419-020-2515-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-020-2515-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-020-2515-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DI-BET726%252Bsuppresses%252Bhuman%252Bskin%252Bsquamous%252Bcell%252Bcarcinoma%252Bcell%252Bgrowth%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DLiu%26aufirst%3DZhengjun%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia Cristine  Borck</span>, <span class="hlFld-ContribAuthor ">Lian-Wang  Guo</span>, <span class="hlFld-ContribAuthor ">Jorge  Plutzky</span>. </span><span class="cited-content_cbyCitation_article-title">BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs. </span><span class="cited-content_cbyCitation_journal-name">Circulation Research</span><span> <strong>2020,</strong> <em>126 </em>
                                    (9)
                                     , 1190-1208. <a href="https://doi.org/10.1161/CIRCRESAHA.120.315929" title="DOI URL">https://doi.org/10.1161/CIRCRESAHA.120.315929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCRESAHA.120.315929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCRESAHA.120.315929%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%2520Research%26atitle%3DBET%252BEpigenetic%252BReader%252BProteins%252Bin%252BCardiovascular%252BTranscriptional%252BPrograms%26aulast%3DBorck%26aufirst%3DPatricia%2BCristine%26date%3D2020%26volume%3D126%26issue%3D9%26spage%3D1190%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.P.  Hilton-Proctor</span>, <span class="hlFld-ContribAuthor ">O.  Ilyichova</span>, <span class="hlFld-ContribAuthor ">Z.  Zheng</span>, <span class="hlFld-ContribAuthor ">I.G.  Jennings</span>, <span class="hlFld-ContribAuthor ">R.W.  Johnstone</span>, <span class="hlFld-ContribAuthor ">J.  Shortt</span>, <span class="hlFld-ContribAuthor ">S.J.  Mountford</span>, <span class="hlFld-ContribAuthor ">M.J.  Scanlon</span>, <span class="hlFld-ContribAuthor ">P.E.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted 1-methyl-4-phenylpyrrolidin-2-ones – Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112120. <a href="https://doi.org/10.1016/j.ejmech.2020.112120" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112120%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252B1-methyl-4-phenylpyrrolidin-2-ones%252B%2525E2%252580%252593%252BFragment-based%252Bdesign%252Bof%252BN-methylpyrrolidone-derived%252Bbromodomain%252Binhibitors%26aulast%3DHilton-Proctor%26aufirst%3DJ.P.%26date%3D2020%26volume%3D191%26spage%3D112120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenhai  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zheng</span>, <span class="hlFld-ContribAuthor ">Chuansheng  Li</span>, <span class="hlFld-ContribAuthor ">Zhengrong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery of Acetophenone Derivatives as BRD4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (3)
                                     , 323-329. <a href="https://doi.org/10.2174/1570180816666190329223559" title="DOI URL">https://doi.org/10.2174/1570180816666190329223559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666190329223559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666190329223559%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DDrug%252BDiscovery%252Bof%252BAcetophenone%252BDerivatives%252Bas%252BBRD4%252BInhibitors%26aulast%3DZhang%26aufirst%3DZhimin%26date%3D2020%26volume%3D17%26issue%3D3%26spage%3D323%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusuke  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yosuke  Ashikari</span>, <span class="hlFld-ContribAuthor ">Masahiro  Takumi</span>, <span class="hlFld-ContribAuthor ">Yutaka  Shimizu</span>, <span class="hlFld-ContribAuthor ">Yiyuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Higuma</span>, <span class="hlFld-ContribAuthor ">Susumu  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Hodaka  Sakaue</span>, <span class="hlFld-ContribAuthor ">Ibuki  Shite</span>, <span class="hlFld-ContribAuthor ">Kei  Maekawa</span>, <span class="hlFld-ContribAuthor ">Yoko  Aizawa</span>, <span class="hlFld-ContribAuthor ">Hiroki  Yamashita</span>, <span class="hlFld-ContribAuthor ">Yuya  Yonekura</span>, <span class="hlFld-ContribAuthor ">Marco  Colella</span>, <span class="hlFld-ContribAuthor ">Renzo  Luisi</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Takegawa</span>, <span class="hlFld-ContribAuthor ">Chiemi  Fujita</span>, <span class="hlFld-ContribAuthor ">Aiichiro  Nagaki</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Biaryls Having a Piperidylmethyl Group Based on Space Integration of Lithiation, Borylation, and Suzuki–Miyaura Coupling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (5)
                                     , 618-622. <a href="https://doi.org/10.1002/ejoc.201901729" title="DOI URL">https://doi.org/10.1002/ejoc.201901729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901729%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBiaryls%252BHaving%252Ba%252BPiperidylmethyl%252BGroup%252BBased%252Bon%252BSpace%252BIntegration%252Bof%252BLithiation%25252C%252BBorylation%25252C%252Band%252BSuzuki%2525E2%252580%252593Miyaura%252BCoupling%26aulast%3DTakahashi%26aufirst%3DYusuke%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D5%26spage%3D618%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander N.  Phillipou</span>, <span class="hlFld-ContribAuthor ">Charles S.  Lay</span>, <span class="hlFld-ContribAuthor ">Charlotte E.  Carver</span>, <span class="hlFld-ContribAuthor ">Cassie  Messenger</span>, <span class="hlFld-ContribAuthor ">John P.  Evans</span>, <span class="hlFld-ContribAuthor ">Antonia J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Laurie J.  Gordon</span>, <span class="hlFld-ContribAuthor ">Mahnoor  Mahmood</span>, <span class="hlFld-ContribAuthor ">Luke A.  Greenhough</span>, <span class="hlFld-ContribAuthor ">Douglas  Sammon</span>, <span class="hlFld-ContribAuthor ">Aaron T.  Cheng</span>, <span class="hlFld-ContribAuthor ">Syandan  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Emma J.  Jones</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Gatfield</span>, <span class="hlFld-ContribAuthor ">David J.  Brierley</span>, <span class="hlFld-ContribAuthor ">Peter D.  Craggs</span>. </span><span class="cited-content_cbyCitation_article-title">Cellular Target Engagement Approaches to Monitor Epigenetic Reader Domain Interactions. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 163-175. <a href="https://doi.org/10.1177/2472555219896278" title="DOI URL">https://doi.org/10.1177/2472555219896278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219896278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219896278%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DCellular%252BTarget%252BEngagement%252BApproaches%252Bto%252BMonitor%252BEpigenetic%252BReader%252BDomain%252BInteractions%26aulast%3DPhillipou%26aufirst%3DAlexander%2BN.%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D2%26spage%3D163%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun‐wa  Chung</span>, <span class="hlFld-ContribAuthor ">Michael M.  Hann</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein–Protein Interactions Perspective. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 479-502. <a href="https://doi.org/10.1002/9781118681121.ch20" title="DOI URL">https://doi.org/10.1002/9781118681121.ch20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch20%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BProtein%2525E2%252580%252593Protein%252BInteractions%252BPerspective%26aulast%3DChung%26aufirst%3DChun%25E2%2580%2590wa%26date%3D2020%26date%3D2020%26spage%3D479%26epage%3D502%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of BRD4 inhibitors (2013-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 57-81. <a href="https://doi.org/10.1080/13543776.2020.1702645" title="DOI URL">https://doi.org/10.1080/13543776.2020.1702645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1702645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1702645%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252BBRD4%252Binhibitors%252B%2525282013-2019%252529%26aulast%3DLu%26aufirst%3DTian%26date%3D2020%26date%3D2019%26volume%3D30%26issue%3D1%26spage%3D57%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando D.  Prieto-Martínez</span>, <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Current advances on the development of BET inhibitors: insights from computational methods. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 127-180. <a href="https://doi.org/10.1016/bs.apcsb.2020.06.002" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.06.002%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252Badvances%252Bon%252Bthe%252Bdevelopment%252Bof%252BBET%252Binhibitors%25253A%252Binsights%252Bfrom%252Bcomputational%252Bmethods%26aulast%3DPrieto-Mart%25C3%25ADnez%26aufirst%3DFernando%2BD.%26date%3D2020%26spage%3D127%26epage%3D180%26pub%3DElsevier%26date%3D2020%26volume%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria Lucia  Alonso</span>, <span class="hlFld-ContribAuthor ">Luis Emilio  Tavernelli</span>, <span class="hlFld-ContribAuthor ">Alejandro  Pezza</span>, <span class="hlFld-ContribAuthor ">Pamela  Cribb</span>, <span class="hlFld-ContribAuthor ">Carla  Ritagliati</span>, <span class="hlFld-ContribAuthor ">Esteban  Serra</span>. </span><span class="cited-content_cbyCitation_article-title">Aim for the Readers! Bromodomains As New Targets Against Chagas’ Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (36)
                                     , 6544-6563. <a href="https://doi.org/10.2174/0929867325666181031132007" title="DOI URL">https://doi.org/10.2174/0929867325666181031132007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666181031132007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666181031132007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DAim%252Bfor%252Bthe%252BReaders%252521%252BBromodomains%252BAs%252BNew%252BTargets%252BAgainst%252BChagas%2525E2%252580%252599%252BDisease%26aulast%3DAlonso%26aufirst%3DVictoria%2BLucia%26date%3D2019%26volume%3D26%26issue%3D36%26spage%3D6544%26epage%3D6563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingying  Shi</span>, <span class="hlFld-ContribAuthor ">Jingwen  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Jiaoxian  Cao</span>, <span class="hlFld-ContribAuthor ">Yiming  Li</span>, <span class="hlFld-ContribAuthor ">Fujiang  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain-Containing Protein 4: A Druggable Target. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (15)
                                     , 1517-1536. <a href="https://doi.org/10.2174/1574885514666190618113519" title="DOI URL">https://doi.org/10.2174/1574885514666190618113519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574885514666190618113519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574885514666190618113519%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DBromodomain-Containing%252BProtein%252B4%25253A%252BA%252BDruggable%252BTarget%26aulast%3DShi%26aufirst%3DYingying%26date%3D2019%26volume%3D20%26issue%3D15%26spage%3D1517%26epage%3D1536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deheng  Chen</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Ziqin  Yan</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Feilong  Zhou</span>, <span class="hlFld-ContribAuthor ">Xilin  Lyu</span>, <span class="hlFld-ContribAuthor ">Biling  Xu</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111633. <a href="https://doi.org/10.1016/j.ejmech.2019.111633" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111633%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bstructural%252Binsight%25252C%252Band%252Bbioactivities%252Bof%252BBY27%252Bas%252Ba%252Bselective%252Binhibitor%252Bof%252Bthe%252Bsecond%252Bbromodomains%252Bof%252BBET%252Bproteins%26aulast%3DChen%26aufirst%3DDeheng%26date%3D2019%26volume%3D182%26spage%3D111633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Bai</span>, <span class="hlFld-ContribAuthor ">Hsiao-Ying  Wey</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Johanna  Rokka</span>, <span class="hlFld-ContribAuthor ">Fiedler  Stephanie</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Haggarty</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron emission tomography probes targeting bromodomain and extra-terminal (BET) domains to enable
              in vivo
              neuroepigenetic imaging. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (86)
                                     , 12932-12935. <a href="https://doi.org/10.1039/C9CC06734E" title="DOI URL">https://doi.org/10.1039/C9CC06734E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC06734E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC06734E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPositron%252Bemission%252Btomography%252Bprobes%252Btargeting%252Bbromodomain%252Band%252Bextra-terminal%252B%252528BET%252529%252Bdomains%252Bto%252Benable%252Bin%252Bvivo%252Bneuroepigenetic%252Bimaging%26aulast%3DBai%26aufirst%3DPing%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D86%26spage%3D12932%26epage%3D12935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilesh  Zaware</span>, <span class="hlFld-ContribAuthor ">Ming-Ming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain biology and drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Structural & Molecular Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (10)
                                     , 870-879. <a href="https://doi.org/10.1038/s41594-019-0309-8" title="DOI URL">https://doi.org/10.1038/s41594-019-0309-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41594-019-0309-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41594-019-0309-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Structural%2520%2526%2520Molecular%2520Biology%26atitle%3DBromodomain%252Bbiology%252Band%252Bdrug%252Bdiscovery%26aulast%3DZaware%26aufirst%3DNilesh%26date%3D2019%26date%3D2019%26volume%3D26%26issue%3D10%26spage%3D870%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Amin</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Camerino</span>, <span class="hlFld-ContribAuthor ">Simon J.  Mountford</span>, <span class="hlFld-ContribAuthor ">Xiao  Ma</span>, <span class="hlFld-ContribAuthor ">David T.  Manallack</span>, <span class="hlFld-ContribAuthor ">David K.  Chalmers</span>, <span class="hlFld-ContribAuthor ">Martin  Wills</span>, <span class="hlFld-ContribAuthor ">Philip E.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">(S)-(−)-Fluorenylethylchloroformate (FLEC); preparation using asymmetric transfer hydrogenation and application to the analysis and resolution of amines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (43)
                                     , 130591. <a href="https://doi.org/10.1016/j.tet.2019.130591" title="DOI URL">https://doi.org/10.1016/j.tet.2019.130591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.130591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.130591%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D%252528S%252529-%252528%2525E2%252588%252592%252529-Fluorenylethylchloroformate%252B%252528FLEC%252529%25253B%252Bpreparation%252Busing%252Basymmetric%252Btransfer%252Bhydrogenation%252Band%252Bapplication%252Bto%252Bthe%252Banalysis%252Band%252Bresolution%252Bof%252Bamines%26aulast%3DAmin%26aufirst%3DMohammad%2BA.%26date%3D2019%26volume%3D75%26issue%3D43%26spage%3D130591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifei  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Leilei  Zhao</span>, <span class="hlFld-ContribAuthor ">Fangqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Changliang  Xu</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting the 7-methylimidazo[1,5-a]pyrazin-8(7H)-one scaffold for the development of novel chemical inhibitors for Bromodomain and Extraterminal Domain (BET) family. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>90 </em>, 103044. <a href="https://doi.org/10.1016/j.bioorg.2019.103044" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DExploiting%252Bthe%252B7-methylimidazo%25255B1%25252C5-a%25255Dpyrazin-8%2525287H%252529-one%252Bscaffold%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnovel%252Bchemical%252Binhibitors%252Bfor%252BBromodomain%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252Bfamily%26aulast%3DYang%26aufirst%3DYifei%26date%3D2019%26volume%3D90%26spage%3D103044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Conery</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomains: a new target class for drug development. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 609-628. <a href="https://doi.org/10.1038/s41573-019-0030-7" title="DOI URL">https://doi.org/10.1038/s41573-019-0030-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0030-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0030-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBromodomains%25253A%252Ba%252Bnew%252Btarget%252Bclass%252Bfor%2525C2%2525A0drug%252Bdevelopment%26aulast%3DCochran%26aufirst%3DAndrea%2BG.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David N.  Debruyne</span>, <span class="hlFld-ContribAuthor ">Ruben  Dries</span>, <span class="hlFld-ContribAuthor ">Satyaki  Sengupta</span>, <span class="hlFld-ContribAuthor ">Davide  Seruggia</span>, <span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">Bandana  Sharma</span>, <span class="hlFld-ContribAuthor ">Hao  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa  Moreau</span>, <span class="hlFld-ContribAuthor ">Michael  McLane</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Day</span>, <span class="hlFld-ContribAuthor ">Eugenio  Marco</span>, <span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Stuart H.  Orkin</span>, <span class="hlFld-ContribAuthor ">Guo-Cheng  Yuan</span>, <span class="hlFld-ContribAuthor ">Richard A.  Young</span>, <span class="hlFld-ContribAuthor ">Rani E.  George</span>. </span><span class="cited-content_cbyCitation_article-title">BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2019,</strong> <em>572 </em>
                                    (7771)
                                     , 676-680. <a href="https://doi.org/10.1038/s41586-019-1472-0" title="DOI URL">https://doi.org/10.1038/s41586-019-1472-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-019-1472-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-019-1472-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DBORIS%252Bpromotes%252Bchromatin%252Bregulatory%252Binteractions%252Bin%252Btreatment-resistant%252Bcancer%252Bcells%26aulast%3DDebruyne%26aufirst%3DDavid%2BN.%26date%3D2019%26date%3D2019%26volume%3D572%26issue%3D7771%26spage%3D676%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Joshi</span>, <span class="hlFld-ContribAuthor ">Alok R.  Singh</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Liu</span>, <span class="hlFld-ContribAuthor ">Timothy V.  Pham</span>, <span class="hlFld-ContribAuthor ">Muamera  Zulcic</span>, <span class="hlFld-ContribAuthor ">Dylan  Skola</span>, <span class="hlFld-ContribAuthor ">Hyun Bae  Chun</span>, <span class="hlFld-ContribAuthor ">Christopher K.  Glass</span>, <span class="hlFld-ContribAuthor ">Guillermo A.  Morales</span>, <span class="hlFld-ContribAuthor ">Joseph R.  Garlich</span>, <span class="hlFld-ContribAuthor ">Donald L.  Durden</span>. </span><span class="cited-content_cbyCitation_article-title">SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (6)
                                     , 1036-1044. <a href="https://doi.org/10.1158/1535-7163.MCT-18-1206" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-1206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-1206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-1206%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSF2523%25253A%252BDual%252BPI3K%25252FBRD4%252BInhibitor%252BBlocks%252BTumor%252BImmunosuppression%252Band%252BPromotes%252BAdaptive%252BImmune%252BResponses%252Bin%252BCancer%26aulast%3DJoshi%26aufirst%3DShweta%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D6%26spage%3D1036%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terezinha Ruth Marques  Rezende</span>, <span class="hlFld-ContribAuthor ">Jodieh Oliveira Santana  Varejão</span>, <span class="hlFld-ContribAuthor ">Anna Luísa Lacerda de Almeida  Sousa</span>, <span class="hlFld-ContribAuthor ">Sandra Milena Bonilla  Castañeda</span>, <span class="hlFld-ContribAuthor ">Sergio Antonio  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydroquinolines by the multicomponent Povarov reaction in water: calix[
              n
              ]arene-catalysed cascade process and mechanistic insights. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (11)
                                     , 2913-2922. <a href="https://doi.org/10.1039/C8OB02928H" title="DOI URL">https://doi.org/10.1039/C8OB02928H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02928H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02928H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTetrahydroquinolines%252Bby%252Bthe%252Bmulticomponent%252BPovarov%252Breaction%252Bin%252Bwater%25253A%252Bcalix%25255B%252Bn%252B%25255Darene-catalysed%252Bcascade%252Bprocess%252Band%252Bmechanistic%252Binsights%26aulast%3DRezende%26aufirst%3DTerezinha%2BRuth%2BMarques%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D11%26spage%3D2913%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehrosh  Pervaiz</span>, <span class="hlFld-ContribAuthor ">Pankaj  Mishra</span>, <span class="hlFld-ContribAuthor ">Stefan  Günther</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomains: Promising Targets for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 347-381. <a href="https://doi.org/10.1002/9783527809257.ch13" title="DOI URL">https://doi.org/10.1002/9783527809257.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527809257.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527809257.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DBromodomains%25253A%252BPromising%252BTargets%252Bfor%252BDrug%252BDiscovery%26aulast%3DPervaiz%26aufirst%3DMehrosh%26date%3D2019%26date%3D2019%26spage%3D347%26epage%3D381%26pub%3DWiley%26atitle%3DEpigenetic%252BDrug%252BDiscovery%26aulast%3DSippl%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingchao  Duan</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Guan</span>, <span class="hlFld-ContribAuthor ">Wenping  Qin</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhai</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Brd4 for cancer therapy: inhibitors and degraders. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 1779-1802. <a href="https://doi.org/10.1039/C8MD00198G" title="DOI URL">https://doi.org/10.1039/C8MD00198G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00198G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00198G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DTargeting%252BBrd4%252Bfor%252Bcancer%252Btherapy%25253A%252Binhibitors%252Band%252Bdegraders%26aulast%3DDuan%26aufirst%3DYingchao%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11%26spage%3D1779%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Liping  Liao</span>, <span class="hlFld-ContribAuthor ">Shijie  Fan</span>, <span class="hlFld-ContribAuthor ">Jing  Xing</span>, <span class="hlFld-ContribAuthor ">Yiqian  Xie</span>, <span class="hlFld-ContribAuthor ">Shijie  Chen</span>, <span class="hlFld-ContribAuthor ">Hong  Ding</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhiyi  Yao</span>, <span class="hlFld-ContribAuthor ">Yiran  Huang</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Oncogenesis</span><span> <strong>2018,</strong> <em>7 </em>
                                    (11)
                                     <a href="https://doi.org/10.1038/s41389-018-0093-z" title="DOI URL">https://doi.org/10.1038/s41389-018-0093-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41389-018-0093-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41389-018-0093-z%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogenesis%26atitle%3DDevelopment%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252BNitroxoline-derived%252BBET%252Binhibitors%252Bwith%252Bantitumor%252Bactivity%252Bin%252Brenal%252Bcell%252Bcarcinoma%26aulast%3DChen%26aufirst%3DWei%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Youming  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenghong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional thiophosphinamide catalyzed highly enantioselective Michael addition of acetone to (E)-2-azido β-nitrostyrenes and the subsequent reductive cyclization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (41)
                                     , 6071-6077. <a href="https://doi.org/10.1016/j.tet.2018.08.052" title="DOI URL">https://doi.org/10.1016/j.tet.2018.08.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.08.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.08.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DBifunctional%252Bthiophosphinamide%252Bcatalyzed%252Bhighly%252Benantioselective%252BMichael%252Baddition%252Bof%252Bacetone%252Bto%252B%252528E%252529-2-azido%252B%2525CE%2525B2-nitrostyrenes%252Band%252Bthe%252Bsubsequent%252Breductive%252Bcyclization%26aulast%3DZhang%26aufirst%3DHao%26date%3D2018%26volume%3D74%26issue%3D41%26spage%3D6071%26epage%3D6077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melanie  Leveridge</span>, <span class="hlFld-ContribAuthor ">Chun-Wa  Chung</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Gross</span>, <span class="hlFld-ContribAuthor ">Christopher B.  Phelps</span>, <span class="hlFld-ContribAuthor ">Darren  Green</span>. </span><span class="cited-content_cbyCitation_article-title">Integration of Lead Discovery Tactics and the Evolution of the Lead Discovery           Toolbox. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2018,</strong> <em>23 </em>
                                    (9)
                                     , 881-897. <a href="https://doi.org/10.1177/2472555218778503" title="DOI URL">https://doi.org/10.1177/2472555218778503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555218778503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555218778503%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DIntegration%252Bof%252BLead%252BDiscovery%252BTactics%252Band%252Bthe%252BEvolution%252Bof%252Bthe%252BLead%252BDiscovery%252BToolbox%26aulast%3DLeveridge%26aufirst%3DMelanie%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D9%26spage%3D881%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Lan  Zhao</span>, <span class="hlFld-ContribAuthor ">Hao-Yue  Xiang</span>, <span class="hlFld-ContribAuthor ">Chun-Hao  Yang</span>, <span class="hlFld-ContribAuthor ">Jun-An  Xiao</span>, <span class="hlFld-ContribAuthor ">Peng-Ju  Xia</span>, <span class="hlFld-ContribAuthor ">Xiao-Qing  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward Synthesis of Novel Difluorinated 2-Hydroxyl-Substituted Dihydroquinolones Through Selectfluor-triggered Annulation of 2-Aminoarylenaminones. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (32)
                                     , 9218-9221. <a href="https://doi.org/10.1002/slct.201801951" title="DOI URL">https://doi.org/10.1002/slct.201801951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201801951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201801951%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DStraightforward%252BSynthesis%252Bof%252BNovel%252BDifluorinated%252B2-Hydroxyl-Substituted%252BDihydroquinolones%252BThrough%252BSelectfluor-triggered%252BAnnulation%252Bof%252B2-Aminoarylenaminones%26aulast%3DZhao%26aufirst%3DQing-Lan%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D32%26spage%3D9218%26epage%3D9221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László  Tóth</span>, <span class="hlFld-ContribAuthor ">Attila  Mándi</span>, <span class="hlFld-ContribAuthor ">Dániel  Váradi</span>, <span class="hlFld-ContribAuthor ">Tibor  Kovács</span>, <span class="hlFld-ContribAuthor ">Anna  Szabados</span>, <span class="hlFld-ContribAuthor ">Attila  Kiss-Szikszai</span>, <span class="hlFld-ContribAuthor ">Qi  Gong</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Péter  Mátyus</span>, <span class="hlFld-ContribAuthor ">Sándor  Antus</span>, <span class="hlFld-ContribAuthor ">Tibor  Kurtán</span>. </span><span class="cited-content_cbyCitation_article-title">HPLC-ECD and TDDFT-ECD study of hexahydropyrrolo[1,2-a]quinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chirality</span><span> <strong>2018,</strong> <em>30 </em>
                                    (7)
                                     , 866-874. <a href="https://doi.org/10.1002/chir.22969" title="DOI URL">https://doi.org/10.1002/chir.22969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chir.22969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchir.22969%26sid%3Dliteratum%253Aachs%26jtitle%3DChirality%26atitle%3DHPLC-ECD%252Band%252BTDDFT-ECD%252Bstudy%252Bof%252Bhexahydropyrrolo%25255B1%25252C2-a%25255Dquinoline%252Bderivatives%26aulast%3DT%25C3%25B3th%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2018%26date%3D2018%26volume%3D30%26issue%3D7%26spage%3D866%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeena  Tahir</span>, <span class="hlFld-ContribAuthor ">Rima D.  Alharthy</span>, <span class="hlFld-ContribAuthor ">Saadia  Naseem</span>, <span class="hlFld-ContribAuthor ">Natasha  Mahmood</span>, <span class="hlFld-ContribAuthor ">Mahmood  Ahmed</span>, <span class="hlFld-ContribAuthor ">Khuram  Shahzad</span>, <span class="hlFld-ContribAuthor ">Malik Nadeem  Akhtar</span>, <span class="hlFld-ContribAuthor ">Abdul  Hameed</span>, <span class="hlFld-ContribAuthor ">Irfan  Sadiq</span>, <span class="hlFld-ContribAuthor ">Haq  Nawaz</span>, <span class="hlFld-ContribAuthor ">Muhammad  Muddassar</span>. </span><span class="cited-content_cbyCitation_article-title">Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1527. <a href="https://doi.org/10.3390/molecules23071527" title="DOI URL">https://doi.org/10.3390/molecules23071527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071527%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInvestigations%252Bof%252BStructural%252BRequirements%252Bfor%252BBRD4%252BInhibitors%252Bthrough%252BLigand-%252Band%252BStructure-Based%252B3D%252BQSAR%252BApproaches%26aulast%3DTahir%26aufirst%3DAdeena%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianju  Shao</span>, <span class="hlFld-ContribAuthor ">Yanli  Yin</span>, <span class="hlFld-ContribAuthor ">Richmond  Lee</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Zhao</span>, <span class="hlFld-ContribAuthor ">Guobi  Chai</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Photoredox Catalysis for Cascade Aerobic Decarboxylative Povarov and Oxidative Dehydrogenation Reactions of
              N
              -Aryl α-Amino Acids. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (9)
                                     , 1754-1760. <a href="https://doi.org/10.1002/adsc.201800135" title="DOI URL">https://doi.org/10.1002/adsc.201800135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800135%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSequential%252BPhotoredox%252BCatalysis%252Bfor%252BCascade%252BAerobic%252BDecarboxylative%252BPovarov%252Band%252BOxidative%252BDehydrogenation%252BReactions%252Bof%252BN%252B-Aryl%252B%2525CE%2525B1-Amino%252BAcids%26aulast%3DShao%26aufirst%3DTianju%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D9%26spage%3D1754%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqian  Xue</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Maofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiuping  Xiang</span>, <span class="hlFld-ContribAuthor ">Junjian  Wang</span>, <span class="hlFld-ContribAuthor ">Anhui  Wang</span>, <span class="hlFld-ContribAuthor ">Chenchang  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Lingjiao  Zou</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Shuang  Wu</span>, <span class="hlFld-ContribAuthor ">Yongzhi  Lu</span>, <span class="hlFld-ContribAuthor ">Hongwu  Chen</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Guohui  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 542-559. <a href="https://doi.org/10.1016/j.ejmech.2018.04.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzoxazinone-containing%252B3%25252C5-dimethylisoxazole%252Bderivatives%252Bas%252BBET%252Bbromodomain%252Binhibitors%252Bfor%252Btreatment%252Bof%252Bcastration-resistant%252Bprostate%252Bcancer%26aulast%3DXue%26aufirst%3DXiaoqian%26date%3D2018%26volume%3D152%26spage%3D542%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagakumar  Bharatham</span>, <span class="hlFld-ContribAuthor ">Peter J.  Slavish</span>, <span class="hlFld-ContribAuthor ">William R.  Shadrick</span>, <span class="hlFld-ContribAuthor ">Brandon M.  Young</span>, <span class="hlFld-ContribAuthor ">Anang A.  Shelat</span>. </span><span class="cited-content_cbyCitation_article-title">The role of ZA channel water-mediated interactions in the design of bromodomain-selective BET inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2018,</strong> <em>81 </em>, 197-210. <a href="https://doi.org/10.1016/j.jmgm.2018.03.005" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DThe%252Brole%252Bof%252BZA%252Bchannel%252Bwater-mediated%252Binteractions%252Bin%252Bthe%252Bdesign%252Bof%252Bbromodomain-selective%252BBET%252Binhibitors%26aulast%3DBharatham%26aufirst%3DNagakumar%26date%3D2018%26volume%3D81%26spage%3D197%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Pingyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 450-461. <a href="https://doi.org/10.1016/j.ejmech.2018.04.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bselective%252BBRD4%252Binhibitors%252Bcapable%252Bof%252Bblocking%252BTLR3-induced%252Bacute%252Bairway%252Binflammation%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2018%26volume%3D151%26spage%3D450%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaoyang  Sun</span>, <span class="hlFld-ContribAuthor ">Jun  Yin</span>, <span class="hlFld-ContribAuthor ">Yong  Fang</span>, <span class="hlFld-ContribAuthor ">Jian  Chen</span>, <span class="hlFld-ContribAuthor ">Kang Jin  Jeong</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Vellano</span>, <span class="hlFld-ContribAuthor ">Zhenlin  Ju</span>, <span class="hlFld-ContribAuthor ">Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Dong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yiling  Lu</span>, <span class="hlFld-ContribAuthor ">Funda  Meric-Bernstam</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Yap</span>, <span class="hlFld-ContribAuthor ">Maureen  Hattersley</span>, <span class="hlFld-ContribAuthor ">Mark J.  O'Connor</span>, <span class="hlFld-ContribAuthor ">Huawei  Chen</span>, <span class="hlFld-ContribAuthor ">Stephen  Fawell</span>, <span class="hlFld-ContribAuthor ">Shiaw-Yih  Lin</span>, <span class="hlFld-ContribAuthor ">Guang  Peng</span>, <span class="hlFld-ContribAuthor ">Gordon B.  Mills</span>. </span><span class="cited-content_cbyCitation_article-title">BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2018,</strong> <em>33 </em>
                                    (3)
                                     , 401-416.e8. <a href="https://doi.org/10.1016/j.ccell.2018.01.019" title="DOI URL">https://doi.org/10.1016/j.ccell.2018.01.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccell.2018.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccell.2018.01.019%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DBRD4%252BInhibition%252BIs%252BSynthetic%252BLethal%252Bwith%252BPARP%252BInhibitors%252Bthrough%252Bthe%252BInduction%252Bof%252BHomologous%252BRecombination%252BDeficiency%26aulast%3DSun%26aufirst%3DChaoyang%26date%3D2018%26volume%3D33%26issue%3D3%26spage%3D401%26epage%3D416.e8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Xianghong  Guan</span>, <span class="hlFld-ContribAuthor ">Jiewei  Jiang</span>, <span class="hlFld-ContribAuthor ">Gunda I.  Georg</span>. </span><span class="cited-content_cbyCitation_article-title">BRDT Inhibitors for Male Contraceptive Drug Discovery: Current Status. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 287-315. <a href="https://doi.org/10.1007/978-981-13-0773-7_11" title="DOI URL">https://doi.org/10.1007/978-981-13-0773-7_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-0773-7_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-0773-7_11%26sid%3Dliteratum%253Aachs%26atitle%3DBRDT%252BInhibitors%252Bfor%252BMale%252BContraceptive%252BDrug%252BDiscovery%25253A%252BCurrent%252BStatus%26aulast%3DMiao%26aufirst%3DZhenyuan%26date%3D2018%26date%3D2018%26spage%3D287%26epage%3D315%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BProtein-Protein%252BInteractions%252Bby%252BSmall%252BMolecules%26aulast%3DSheng%26aufirst%3DChunquan%26date%3D2018%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William R.  Shadrick</span>, <span class="hlFld-ContribAuthor ">Peter J.  Slavish</span>, <span class="hlFld-ContribAuthor ">Sergio C.  Chai</span>, <span class="hlFld-ContribAuthor ">Brett  Waddell</span>, <span class="hlFld-ContribAuthor ">Michele  Connelly</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Low</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Brandon M.  Young</span>, <span class="hlFld-ContribAuthor ">Nagakumar  Bharatham</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Vincent A.  Boyd</span>, <span class="hlFld-ContribAuthor ">Marie  Morfouace</span>, <span class="hlFld-ContribAuthor ">Martine F.  Roussel</span>, <span class="hlFld-ContribAuthor ">Taosheng  Chen</span>, <span class="hlFld-ContribAuthor ">Richard E.  Lee</span>, <span class="hlFld-ContribAuthor ">R.  Kiplin Guy</span>, <span class="hlFld-ContribAuthor ">Anang A.  Shelat</span>, <span class="hlFld-ContribAuthor ">Philip M.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (1)
                                     , 25-36. <a href="https://doi.org/10.1016/j.bmc.2017.10.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Ba%252Bwater%252Bnetwork%252Bto%252Bachieve%252Benthalpy-driven%25252C%252Bbromodomain-selective%252BBET%252Binhibitors%26aulast%3DShadrick%26aufirst%3DWilliam%2BR.%26date%3D2018%26volume%3D26%26issue%3D1%26spage%3D25%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tan Boon  Toh</span>, <span class="hlFld-ContribAuthor ">Jhin Jieh  Lim</span>, <span class="hlFld-ContribAuthor ">Edward Kai-Hua  Chow</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetics in cancer stem cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-017-0596-9" title="DOI URL">https://doi.org/10.1186/s12943-017-0596-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-017-0596-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-017-0596-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DEpigenetics%252Bin%252Bcancer%252Bstem%252Bcells%26aulast%3DToh%26aufirst%3DTan%2BBoon%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophie E.  van der Krieken</span>, <span class="hlFld-ContribAuthor ">Herman E.  Popeijus</span>, <span class="hlFld-ContribAuthor ">Ronald P.  Mensink</span>, <span class="hlFld-ContribAuthor ">Jogchum  Plat</span>. </span><span class="cited-content_cbyCitation_article-title">Link Between ER-Stress, PPAR-Alpha Activation, and BET Inhibition in Relation to Apolipoprotein A-I Transcription in HepG2 Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2017,</strong> <em>118 </em>
                                    (8)
                                     , 2161-2167. <a href="https://doi.org/10.1002/jcb.25858" title="DOI URL">https://doi.org/10.1002/jcb.25858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.25858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.25858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DLink%252BBetween%252BER-Stress%25252C%252BPPAR-Alpha%252BActivation%25252C%252Band%252BBET%252BInhibition%252Bin%252BRelation%252Bto%252BApolipoprotein%252BA-I%252BTranscription%252Bin%252BHepG2%252BCells%26aulast%3Dvan%2Bder%2BKrieken%26aufirst%3DSophie%2BE.%26date%3D2017%26date%3D2017%26volume%3D118%26issue%3D8%26spage%3D2161%26epage%3D2167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahong  Yao</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">What structural modifications can be used for BRD4 inhibitors for their use in leukemia therapy?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (9)
                                     , 839-842. <a href="https://doi.org/10.4155/fmc-2017-0084" title="DOI URL">https://doi.org/10.4155/fmc-2017-0084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0084%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DWhat%252Bstructural%252Bmodifications%252Bcan%252Bbe%252Bused%252Bfor%252BBRD4%252Binhibitors%252Bfor%252Btheir%252Buse%252Bin%252Bleukemia%252Btherapy%25253F%26aulast%3DYao%26aufirst%3DDahong%26date%3D2017%26volume%3D9%26issue%3D9%26spage%3D839%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongya  Sun</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhifeng  Chen</span>, <span class="hlFld-ContribAuthor ">Yiqian  Xie</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Limin  Chen</span>, <span class="hlFld-ContribAuthor ">Hong  Ding</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (9)
                                     , 2003-2009. <a href="https://doi.org/10.1016/j.bmcl.2017.03.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252BBRD4%252Binhibitors%252Bby%252Bhigh-throughput%252Bscreening%25252C%252Bcrystallography%25252C%252Band%252Bcell-based%252Bassays%26aulast%3DSun%26aufirst%3DZhongya%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D2003%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathéo  Berthet</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Isabelle  Parrot</span>. </span><span class="cited-content_cbyCitation_article-title">MgI
              2
              ‐chemoselective cleavage for removal of amino acid protecting groups: A fresh vision for peptide synthesis. </span><span class="cited-content_cbyCitation_journal-name">Peptide Science</span><span> <strong>2017,</strong> <em>108 </em>
                                    (2)
                                     , e22908. <a href="https://doi.org/10.1002/bip.22908" title="DOI URL">https://doi.org/10.1002/bip.22908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.22908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.22908%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptide%2520Science%26atitle%3DMgI%252B2%252B%2525E2%252580%252590chemoselective%252Bcleavage%252Bfor%252Bremoval%252Bof%252Bamino%252Bacid%252Bprotecting%252Bgroups%25253A%252BA%252Bfresh%252Bvision%252Bfor%252Bpeptide%252Bsynthesis%26aulast%3DBerthet%26aufirst%3DMath%25C3%25A9o%26date%3D2017%26date%3D2017%26volume%3D108%26issue%3D2%26spage%3De22908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Jeffers</span>, <span class="hlFld-ContribAuthor ">Chunlin  Yang</span>, <span class="hlFld-ContribAuthor ">Sherri  Huang</span>, <span class="hlFld-ContribAuthor ">William J.  Sullivan</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Microbiology and Molecular Biology Reviews</span><span> <strong>2017,</strong> <em>81 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/MMBR.00047-16" title="DOI URL">https://doi.org/10.1128/MMBR.00047-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/MMBR.00047-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FMMBR.00047-16%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%2520and%2520Molecular%2520Biology%2520Reviews%26atitle%3DBromodomains%252Bin%252BProtozoan%252BParasites%25253A%252BEvolution%25252C%252BFunction%25252C%252Band%252BOpportunities%252Bfor%252BDrug%252BDevelopment%26aulast%3DJeffers%26aufirst%3DVictoria%26date%3D2017%26volume%3D81%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dequina A.  Nicholas</span>, <span class="hlFld-ContribAuthor ">Guillaume  Andrieu</span>, <span class="hlFld-ContribAuthor ">Katherine J.  Strissel</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Nikolajczyk</span>, <span class="hlFld-ContribAuthor ">Gerald V.  Denis</span>. </span><span class="cited-content_cbyCitation_article-title">BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2017,</strong> <em>74 </em>
                                    (2)
                                     , 231-243. <a href="https://doi.org/10.1007/s00018-016-2320-0" title="DOI URL">https://doi.org/10.1007/s00018-016-2320-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-016-2320-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-016-2320-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DBET%252Bbromodomain%252Bproteins%252Band%252Bepigenetic%252Bregulation%252Bof%252Binflammation%25253A%252Bimplications%252Bfor%252Btype%252B2%252Bdiabetes%252Band%252Bbreast%252Bcancer%26aulast%3DNicholas%26aufirst%3DDequina%2BA.%26date%3D2017%26date%3D2016%26volume%3D74%26issue%3D2%26spage%3D231%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Elisa  Pasqua</span>, <span class="hlFld-ContribAuthor ">B.  Wilding</span>, <span class="hlFld-ContribAuthor ">M.D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">K.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 202-280. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12395-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12395-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12395-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12395-9%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BProtein%252BSynthesis%25252C%252BFolding%25252C%252Band%252BDegradation%252BPathways%252Bin%252BCancer%26aulast%3DPasqua%26aufirst%3DA%2BElisa%26date%3D2017%26spage%3D202%26epage%3D280%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhifeng  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Shien  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqian  Xie</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Liyan  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong  Ding</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Kunqian  Yu</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1322-1331. <a href="https://doi.org/10.1039/C7MD00083A" title="DOI URL">https://doi.org/10.1039/C7MD00083A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00083A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00083A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bnovel%252Btrimethoxy-ring%252BBRD4%252Bbromodomain%252Binhibitors%25253A%252BAlphaScreen%252Bassay%25252C%252Bcrystallography%252Band%252Bcell-based%252Bassay%26aulast%3DChen%26aufirst%3DZhifeng%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1322%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke  Li</span>, <span class="hlFld-ContribAuthor ">Juxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Kailin  Wu</span>, <span class="hlFld-ContribAuthor ">Daijun  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenyong  Han</span>, <span class="hlFld-ContribAuthor ">Nanwei  Wan</span>, <span class="hlFld-ContribAuthor ">Baodong  Cui</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective synthesis of 1,2,3,4-tetrahydroquinoline-4-ols and 2,3-dihydroquinolin-4(1H)-ones via a sequential asymmetric hydroxylation/diastereoselective oxidation process using Rhodococcus equi ZMU-LK19. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (17)
                                     , 3580-3584. <a href="https://doi.org/10.1039/C7OB00151G" title="DOI URL">https://doi.org/10.1039/C7OB00151G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00151G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00151G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEnantioselective%252Bsynthesis%252Bof%252B1%25252C2%25252C3%25252C4-tetrahydroquinoline-4-ols%252Band%252B2%25252C3-dihydroquinolin-4%2525281H%252529-ones%252Bvia%252Ba%252Bsequential%252Basymmetric%252Bhydroxylation%25252Fdiastereoselective%252Boxidation%252Bprocess%252Busing%252BRhodococcus%252Bequi%252BZMU-LK19%26aulast%3DLi%26aufirst%3DKe%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D17%26spage%3D3580%26epage%3D3584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjun  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Guofeng  Meng</span>, <span class="hlFld-ContribAuthor ">Hong  Lin</span>, <span class="hlFld-ContribAuthor ">Sharon  Wu</span>, <span class="hlFld-ContribAuthor ">Jamie  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Xu</span>, <span class="hlFld-ContribAuthor ">David  Tough</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Inmaculada  Rioja</span>, <span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongkang  Mei</span>, <span class="hlFld-ContribAuthor ">Rab  Prinjha</span>, <span class="hlFld-ContribAuthor ">Zhong  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells. </span><span class="cited-content_cbyCitation_journal-name">Stem Cell Research</span><span> <strong>2016,</strong> <em>17 </em>
                                    (2)
                                     , 212-221. <a href="https://doi.org/10.1016/j.scr.2016.07.006" title="DOI URL">https://doi.org/10.1016/j.scr.2016.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.scr.2016.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.scr.2016.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cell%2520Research%26atitle%3DBET%252Bbromodomain%252Binhibition%252Bpromotes%252Bneurogenesis%252Bwhile%252Binhibiting%252Bgliogenesis%252Bin%252Bneural%252Bprogenitor%252Bcells%26aulast%3DLi%26aufirst%3DJingjun%26date%3D2016%26volume%3D17%26issue%3D2%26spage%3D212%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carles  Galdeano</span>, <span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>. </span><span class="cited-content_cbyCitation_article-title">Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (13)
                                     , 1655-1680. <a href="https://doi.org/10.4155/fmc-2016-0059" title="DOI URL">https://doi.org/10.4155/fmc-2016-0059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0059%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelectivity%252Bon-target%252Bof%252Bbromodomain%252Bchemical%252Bprobes%252Bby%252Bstructure-guided%252Bmedicinal%252Bchemistry%252Band%252Bchemical%252Bbiology%26aulast%3DGaldeano%26aufirst%3DCarles%26date%3D2016%26volume%3D8%26issue%3D13%26spage%3D1655%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean  Gilham</span>, <span class="hlFld-ContribAuthor ">Sylwia  Wasiak</span>, <span class="hlFld-ContribAuthor ">Laura M.  Tsujikawa</span>, <span class="hlFld-ContribAuthor ">Christopher  Halliday</span>, <span class="hlFld-ContribAuthor ">Karen  Norek</span>, <span class="hlFld-ContribAuthor ">Reena G.  Patel</span>, <span class="hlFld-ContribAuthor ">Ewelina  Kulikowski</span>, <span class="hlFld-ContribAuthor ">Jan  Johansson</span>, <span class="hlFld-ContribAuthor ">Michael  Sweeney</span>, <span class="hlFld-ContribAuthor ">Norman C.W.  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease. </span><span class="cited-content_cbyCitation_journal-name">Atherosclerosis</span><span> <strong>2016,</strong> <em>247 </em>, 48-57. <a href="https://doi.org/10.1016/j.atherosclerosis.2016.01.036" title="DOI URL">https://doi.org/10.1016/j.atherosclerosis.2016.01.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.atherosclerosis.2016.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.atherosclerosis.2016.01.036%26sid%3Dliteratum%253Aachs%26jtitle%3DAtherosclerosis%26atitle%3DRVX-208%25252C%252Ba%252BBET-inhibitor%252Bfor%252Btreating%252Batherosclerotic%252Bcardiovascular%252Bdisease%25252C%252Braises%252BApoA-I%25252FHDL%252Band%252Brepresses%252Bpathways%252Bthat%252Bcontribute%252Bto%252Bcardiovascular%252Bdisease%26aulast%3DGilham%26aufirst%3DDean%26date%3D2016%26volume%3D247%26spage%3D48%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamel  Meslamani</span>, <span class="hlFld-ContribAuthor ">Steven G.  Smith</span>, <span class="hlFld-ContribAuthor ">Roberto  Sanchez</span>, <span class="hlFld-ContribAuthor ">Ming-Ming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Structural features and inhibitors of bromodomains. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2016,</strong> <em>19 </em>, 3-15. <a href="https://doi.org/10.1016/j.ddtec.2016.09.001" title="DOI URL">https://doi.org/10.1016/j.ddtec.2016.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2016.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2016.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DStructural%252Bfeatures%252Band%252Binhibitors%252Bof%252Bbromodomains%26aulast%3DMeslamani%26aufirst%3DJamel%26date%3D2016%26volume%3D19%26spage%3D3%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.G.  Smith</span>, <span class="hlFld-ContribAuthor ">M.-M.  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">The Bromodomain as an Acetyl-Lysine Reader Domain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 97-111. <a href="https://doi.org/10.1016/B978-0-12-802389-1.00005-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-802389-1.00005-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802389-1.00005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802389-1.00005-8%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BBromodomain%252Bas%252Ban%252BAcetyl-Lysine%252BReader%2525C2%2525A0Domain%26aulast%3DSmith%26aufirst%3DS.G.%26date%3D2016%26spage%3D97%26epage%3D111%26pub%3DElsevier%26atitle%3DChromatin%252BSignaling%252Band%252BDiseases%26date%3D2016%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oakley B.  Cox</span>, <span class="hlFld-ContribAuthor ">Tobias  Krojer</span>, <span class="hlFld-ContribAuthor ">Patrick  Collins</span>, <span class="hlFld-ContribAuthor ">Octovia  Monteiro</span>, <span class="hlFld-ContribAuthor ">Romain  Talon</span>, <span class="hlFld-ContribAuthor ">Anthony  Bradley</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Jahangir  Amin</span>, <span class="hlFld-ContribAuthor ">Brian D.  Marsden</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>, <span class="hlFld-ContribAuthor ">Frank  von Delft</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>. </span><span class="cited-content_cbyCitation_article-title">A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 2322-2330. <a href="https://doi.org/10.1039/C5SC03115J" title="DOI URL">https://doi.org/10.1039/C5SC03115J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5SC03115J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5SC03115J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DA%252Bpoised%252Bfragment%252Blibrary%252Benables%252Brapid%252Bsynthetic%252Bexpansion%252Byielding%252Bthe%252Bfirst%252Breported%252Binhibitors%252Bof%252BPHIP%2525282%252529%25252C%252Ban%252Batypical%252Bbromodomain%26aulast%3DCox%26aufirst%3DOakley%2BB.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D2322%26epage%3D2330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm5010539&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm5010539%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=113&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some examples of BET bromodomain inhibitors, <b>1</b>–<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Tetrahydroquinoline Compounds <b>10</b>–<b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, reflux, 43%; (b) PPA, 110 °C, 29%; (c) AcCl, DMAP, 0 °C to RT, 86%; (d) 4-methylaniline, TiCl<sub>4</sub>, TEA, THF/DCM, 0 °C to RT then NaBH<sub>4</sub>, RT, 15%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Synthesis of Tetrahydroquinoline Compounds <b>16</b>–<b>22</b>, <b>36</b>–<b>37</b>, <b>41</b>–<b>42</b>, and <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeCHO, toluene, RT, 82%; (b) <i>N</i>-vinylformamide, BF<sub>3</sub>·Et<sub>2</sub>O, THF, −5 °C, 56%; (c) MeCOCl, DCM, pyridine, 0 °C, 100%; (d) MeOH, 6 N HCl, reflux, 91%; (e) PhB(OH)<sub>2</sub>, Cu(OAc)<sub>2</sub>, TEA, DCM, RT; (f) R<sub>6</sub>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Alternative Synthesis of Tetrahydroquinoline Compounds, e.g., <b>30</b>–<b>35</b>, <b>38</b>–<b>39</b>, and <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>6</sub>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux; (b) MeOH, 6 N HCl, reflux; (c) R<sub>6</sub>PhB(OH)<sub>2</sub>, Cu(OAc)<sub>2</sub>, TEA, DCM, RT.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Basic Tetrahydroquinoline Compounds, e.g., <b>23</b>–<b>26</b> and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3- or 4-formylPhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux; (b) NaBH(OAc)<sub>3</sub>, AcOH, cyclic II<sup>ary</sup> amines, solvent, RT; (c) MeOH, 6M HCl, reflux; (d) R<sub>4</sub>PhB(OH)<sub>2</sub>, Cu(OAc)<sub>2</sub>, TEA, DCM, RT.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 2-<i>H</i> Tetrahydroquinoline Compound <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, DCM, 0 °C to RT, 86%; (b) Ac<sub>2</sub>O, 80 °C, 69%; (c) 4-MeOPhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux, 67%; (d) aniline, TiCl<sub>4</sub>, TEA, THF/DCM, 0 °C to RT then NaBH(OAc)<sub>3</sub>, AcOH, RT, 15%.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Enantioselective Route to Compound <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) crotonyl chloride, lithium <i>tert</i>-butoxide, THF, −20 °C, 29%; (b) 4-bromoaniline, (R-BINAP)Pd(MeCN)<sub>2</sub>(OTf)<sub>2</sub>, toluene, THF, 20 °C, 67%, ee = 92%; (c) NaBH<sub>4</sub>, MgCl<sub>2</sub>·6H<sub>2</sub>O, EtOH, H<sub>2</sub>O, −15 °C, 78%, 1 <i>cis</i>-isomer, ee = 92%; (d) AcCl, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0°C, 78%, purification by chiral chromatography, ee >99%; (e) {4-[(ethyloxy)carbonyl]phenyl}boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, EtOH, H<sub>2</sub>O, 80 °C, 92%; (f) AlCl<sub>3</sub>, Et<sub>3</sub>N, MeOH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 98%; (g) 1-bromo-4-chlorobenzene, DavePhos, Bis(dibenzylideneacetone)palladium, sodium <i>tert</i>-butoxide, toluene, 70 °C, 37% (94% based on recovered starting material); (h) 2M NaOH, EtOH, RT, 77%.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Oral activity of <b>47</b> in a murine acute LPS challenge model: PAI-1 mRNA relative to vehicle (mean ± SEM, <i>n</i> = 8). (*** <i>p</i> value <0.0001 following a <i>t</i> test comparison to the vehicle-treated group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Intravenous activity of <b>47</b> in a murine septic shock model (mean of two independent experiments with <i>n</i> = 8 per group in each study).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Tetrahydroquinoline fragment <b>48</b>. (B) Conservation of the BET family and CREBBP bromodomain acetyl-lysine sites. Colors represent residue properties: green = hydrophobic, red = acidic, blue = basic, orange = polar, purple = proline, white = small. * denotes residue is in contact (≤4.5 Å) with compound <b>47</b> in BRD4 N-terminal bromodomain crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3uvw">3uvw</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>47</b> (cyan carbons) in the BRD4 N-terminal bromodomain (blue carbons). The conserved H-bonding network between inhibitor, protein, and conserved waters is marked in yellow. (A) Comparison with X-ray structure of fragment <b>48</b> in BRD2 N-terminal domain (orange). Black dotted line indicates the 3.5 Å distance between the C2 carbon of <b>47</b> and the side chain oxygen of Asn140. (B) Comparison to acetyl-lysine (purple carbons) taken from X-ray structure of histone H4(1-12)K5AcK8Ac in BRD4 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3uvw">3uvw</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (C) Key hydrogen-bonding interactions of <b>47</b> with BRD4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) THQ <b>47</b> (cyan carbons) bound to BRD4 N-terminal bromodomain, with BRD4 molecular surface generated with modeled hydrogen atoms, aligned to <b>1</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p5o">3p5o</a>). (B) Binding mode of <b>47</b> in BRD4 N-terminal bromodomain compared to that of <b>3</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zyu">3zyu</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/medium/jm-2014-010539_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison between X-ray structures of <b>47</b> in complex with BRD4 N-terminal bromodomain (cyan/blue) and (A) BRD2 N-terminal bromodomain (pink/purple), with BRD4 residue numbering, and (B) BRD2 C-terminal bromodomain (yellow/orange), with BRD2 residue numbering. (C) Comparison of X-ray structures of BRD2 N-terminal bromodomain in complex with <b>47</b> (pink/purple) and with <b>28</b> (chain A, green), with BRD2 N-terminal numbering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm5010539/20141006/images/large/jm-2014-010539_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010539&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i115">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Toth, P. P.</span><span> </span><span class="NLM_article-title">Cardiology patient page. The “good cholesterol”: high-density lipoprotein</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">e89</span><span class="NLM_x">–</span> <span class="NLM_lpage">e91</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=e89-e91&author=P.+P.+Toth&title=Cardiology+patient+page.+The+%E2%80%9Cgood+cholesterol%E2%80%9D%3A+high-density+lipoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DP.%2BP.%26atitle%3DCardiology%2520patient%2520page.%2520The%2520%25E2%2580%259Cgood%2520cholesterol%25E2%2580%259D%253A%2520high-density%2520lipoprotein%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3De89%26epage%3De91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Linsel-Nitschke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tall, A. R.</span><span> </span><span class="NLM_article-title">HDL as a target in the treatment of atherosclerotic cardiovascular disease</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=193-205&author=P.+Linsel-Nitschkeauthor=A.+R.+Tall&title=HDL+as+a+target+in+the+treatment+of+atherosclerotic+cardiovascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinsel-Nitschke%26aufirst%3DP.%26aulast%3DTall%26aufirst%3DA.%2BR.%26atitle%3DHDL%2520as%2520a%2520target%2520in%2520the%2520treatment%2520of%2520atherosclerotic%2520cardiovascular%2520disease%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D193%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wong, N. C.</span><span> </span><span class="NLM_article-title">Novel therapies to increase apolipoprotein AI and HDL for the treatment of atherosclerosis</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=718-728&author=N.+C.+Wong&title=Novel+therapies+to+increase+apolipoprotein+AI+and+HDL+for+the+treatment+of+atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DN.%2BC.%26atitle%3DNovel%2520therapies%2520to%2520increase%2520apolipoprotein%2520AI%2520and%2520HDL%2520for%2520the%2520treatment%2520of%2520atherosclerosis%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D718%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.+W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.+M.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Clementauthor=A.+B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+characterization+of+small+molecule+inhibitors+of+the+BET+family+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0lgt4s_-vntuGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520small%2520molecule%2520inhibitors%2520of%2520the%2520BET%2520family%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clément, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnathan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineau, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodème, E.</span><span> </span><span class="NLM_article-title">Discovery of epigenetic regulator I-BET-762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7501</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401088k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7501-7515&author=O.+Mirguetauthor=R.+Gosminiauthor=J.+Toumauthor=C.+A.+Cl%C3%A9mentauthor=M.+Barnathanauthor=J.-M.+Brusqauthor=J.+E.+Mordauntauthor=R.+M.+Grimesauthor=M.+Croweauthor=O.+Pineauauthor=M.+Ajakaneauthor=A.+Dauganauthor=L.+Cutlerauthor=A.+C.+Haynesauthor=N.+N.+Smithersauthor=C.+Chungauthor=P.+Bamboroughauthor=I.+Uingsauthor=A.+Lewisauthor=J.+Witheringtonauthor=N.+Parrauthor=R.+K.+Prinjhaauthor=E.+Nicod%C3%A8me&title=Discovery+of+epigenetic+regulator+I-BET-762%3A+lead+optimization+to+afford+a+clinical+candidate+inhibitor+of+the+BET+bromodomains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm401088k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401088k%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DC.%2BA.%26aulast%3DBarnathan%26aufirst%3DM.%26aulast%3DBrusq%26aufirst%3DJ.-M.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DGrimes%26aufirst%3DR.%2BM.%26aulast%3DCrowe%26aufirst%3DM.%26aulast%3DPineau%26aufirst%3DO.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DHaynes%26aufirst%3DA.%2BC.%26aulast%3DSmithers%26aufirst%3DN.%2BN.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DUings%26aufirst%3DI.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicod%25C3%25A8me%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520epigenetic%2520regulator%2520I-BET-762%253A%2520lead%2520optimization%2520to%2520afford%2520a%2520clinical%2520candidate%2520inhibitor%2520of%2520the%2520BET%2520bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7501%26epage%3D7515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span>ClinicalTrials.gov; <span class="NLM_publisher-name">National Library of Medicine</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_month">August</span><span class="NLM_day">30</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://www.clinicaltrials.gov" class="extLink">http://www.clinicaltrials.gov</a>. .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov%3B+National+Library+of+Medicine%3A+Bethesda%2C+MD%2C+August30%2C+2014%3B+http%3A%2F%2Fwww.clinicaltrials.gov.+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DClinicalTrials.gov%26pub%3DNational%2520Library%2520of%2520Medicine%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandwani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marazzi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span> </span><span class="NLM_article-title">Suppression of inflammation by a synthetic histone mimic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnature09589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21068722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1119-1123&author=E.+Nicodemeauthor=K.+L.+Jeffreyauthor=U.+Schaeferauthor=S.+Beinkeauthor=S.+Dewellauthor=C.+W.+Chungauthor=R.+Chandwaniauthor=I.+Marazziauthor=P.+Wilsonauthor=H.+Costeauthor=J.+Whiteauthor=J.+Kirilovskyauthor=C.+M.+Riceauthor=J.+M.+Loraauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=A.+Tarakhovsky&title=Suppression+of+inflammation+by+a+synthetic+histone+mimic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of inflammation by a synthetic histone mimic</span></div><div class="casAuthors">Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression.  This response, although vital for immune defense, is frequently deleterious to the host due to the exaggerated prodn. of inflammatory proteins.  The scope of inflammatory responses reflects the activation state of signaling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression.  Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a crit. step in the regulation of gene expression.  Here we present a novel pharmacol. approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins.  We describe a synthetic compd. (I-BET) that by mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis.  Our findings suggest that synthetic compds. specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxc3_PNaiuKLVg90H21EOLACvtfcHk0ljBx0W_2ZrGzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP&md5=0dfccd9d01b87859512bf591e1c5a93c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature09589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09589%26sid%3Dliteratum%253Aachs%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DK.%2BL.%26aulast%3DSchaefer%26aufirst%3DU.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DDewell%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DChandwani%26aufirst%3DR.%26aulast%3DMarazzi%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520inflammation%2520by%2520a%2520synthetic%2520histone%2520mimic%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1119%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Florence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, D. V.</span><span> </span><span class="NLM_article-title">You bet-cha: a novel family of transcriptional regulators</span> <span class="citation_source-journal">Front Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=D1008-D1018&author=B.+Florenceauthor=D.+V.+Faller&title=You+bet-cha%3A+a+novel+family+of+transcriptional+regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlorence%26aufirst%3DB.%26aulast%3DFaller%26aufirst%3DD.%2BV.%26atitle%3DYou%2520bet-cha%253A%2520a%2520novel%2520family%2520of%2520transcriptional%2520regulators%26jtitle%3DFront%2520Biosci.%26date%3D2001%26volume%3D6%26spage%3DD1008%26epage%3DD1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Belkina, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, G. V.</span><span> </span><span class="NLM_article-title">BET domain co-regulators in obesity, inflammation and cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnrc3256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22722403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=465-477&author=A.+C.+Belkinaauthor=G.+V.+Denis&title=BET+domain+co-regulators+in+obesity%2C+inflammation+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">BET domain co-regulators in obesity, inflammation and cancer</span></div><div class="casAuthors">Belkina, Anna C.; Denis, Gerald V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The bromodomain is a highly conserved motif of 110 amino acids that is bundled into four anti-parallel α-helixes and found in proteins that interact with chromatin, such as transcription factors, histone acetylases and nucleosome remodelling complexes.  Bromodomain proteins are chromatin 'readers'; they recruit chromatin-regulating enzymes, including 'writers' and 'erasers' of histone modification, to target promoters and to regulate gene expression.  Conventional wisdom held that complexes involved in chromatin dynamics are not 'druggable' targets.  However, small mols. that inhibit bromodomain and extraterminal (BET) proteins have been described.  We examine these developments and discuss the implications for small mol. epigenetic targeting of chromatin networks in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1x-bD67oukrVg90H21EOLACvtfcHk0lilsrzPNoypvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFyks7s%253D&md5=d06d88ef0d5d4d71115f40a2f901f53d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc3256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3256%26sid%3Dliteratum%253Aachs%26aulast%3DBelkina%26aufirst%3DA.%2BC.%26aulast%3DDenis%26aufirst%3DG.%2BV.%26atitle%3DBET%2520domain%2520co-regulators%2520in%2520obesity%252C%2520inflammation%2520and%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Small molecule bromodomain inhibitors: extending the druggable genome</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2FB978-0-12-396493-9.00001-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22520470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1-55&author=C.+W.+Chung&title=Small+molecule+bromodomain+inhibitors%3A+extending+the+druggable+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule bromodomain inhibitors: extending the druggable genome</span></div><div class="casAuthors">Chung, Chun-Wa</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-55</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on some of the existing knowledge for the young and rapidly evolving field of bromodomain inhibition.  Topics covered include structure and function of bromodomain, bromodomain-contg. proteins, therapeutic potential of bromodomains, and bromodomain inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI9QR6f10R97Vg90H21EOLACvtfcHk0lilsrzPNoypvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChtr7K&md5=6a947139e3939e752fb09a749938b3a9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-396493-9.00001-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-396493-9.00001-7%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DSmall%2520molecule%2520bromodomain%2520inhibitors%253A%2520extending%2520the%2520druggable%2520genome%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D1%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Progress in the discovery of small-molecule inhibitors of bromodomain—histone interactions</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1177%2F1087057111421372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21956175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Slt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=1170-1185&author=C.+W.+Chungauthor=J.+Witherington&title=Progress+in+the+discovery+of+small-molecule+inhibitors+of+bromodomain%E2%80%94histone+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions</span></div><div class="casAuthors">Chung, Chun-Wa; Witherington, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1170-1185</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Bromodomains are structurally conserved protein modules present in a large no. of chromatin-assocd. proteins and in many nuclear histone acetyltransferases.  The bromodomain functions as an acetyl-lysine binding domain and has been shown to be pivotal in regulating protein-protein interactions in chromatin-mediated cellular gene transcription, cell proliferation, and viral transcriptional activation.  Structural analyses of these modules in complex with acetyl-lysine peptide ligands provide insights into the mol. basis for recognition and ligand selectivity within this epigenetic reader family.  However, there are significant challenges in configuring assays to identify inhibitors of these proteins.  This review focuses on the progress made in developing methods to identify peptidic and small-mol. ligands using biophys. label-free and biochem. approaches.  The advantage of each technique and the results reported are summarized, highlighting the potential applicably to other reader domains and the caveats in translation from simple in vitro systems to a biol. context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodACR_uPDbcbVg90H21EOLACvtfcHk0ljHnmbz8jBYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Slt7o%253D&md5=47a8a24b59135f0d4ed94d103bcb52ec</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1087057111421372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057111421372%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DProgress%2520in%2520the%2520discovery%2520of%2520small-molecule%2520inhibitors%2520of%2520bromodomain%25E2%2580%2594histone%2520interactions%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2011%26volume%3D16%26spage%3D1170%26epage%3D1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Bromodomains as therapeutic targets</span> <span class="citation_source-journal">Expert Rev. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1017%2FS1462399411001992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21933453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OhurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=e29&author=S.+Mullerauthor=P.+Filippakopoulosauthor=S.+Knapp&title=Bromodomains+as+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomains as therapeutic targets</span></div><div class="casAuthors">Muller, Susanne; Filippakopoulos, Panagis; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Reviews in Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e29/1-e29/21</span>CODEN:
                <span class="NLM_cas:coden">ERMMFS</span>;
        ISSN:<span class="NLM_cas:issn">1462-3994</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Acetylation of lysine residues is a post-translational modification with broad relevance to cellular signalling and disease biol.  Enzymes that 'write' (histone acetyltransferases, HATs) and 'erase' (histone deacetylases, HDACs) acetylation sites are an area of extensive research in current drug development, but very few potent inhibitors that modulate the 'reading process' mediated by acetyl lysines have been described.  The principal readers of ε-N-acetyl lysine (Kac) marks are bromodomains (BRDs), which are a diverse family of evolutionary conserved protein-interaction modules.  The conserved BRD fold contains a deep, largely hydrophobic acetyl lysine binding site, which represents an attractive pocket for the development of small, pharmaceutically active mols.  Proteins that contain BRDs have been implicated in the development of a large variety of diseases.  Recently, two highly potent and selective inhibitors that target BRDs of the BET (bromodomains and extra-terminal) family provided compelling data supporting targeting of these BRDs in inflammation and in an aggressive type of squamous cell carcinoma.  It is likely that BRDs will emerge alongside HATs and HDACs as interesting targets for drug development for the large no. of diseases that are caused by aberrant acetylation of lysine residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSuKacpsr6xLVg90H21EOLACvtfcHk0ljHnmbz8jBYfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OhurjI&md5=dc9383afcbe6aedc265041c21213aa0b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FS1462399411001992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1462399411001992%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DBromodomains%2520as%2520therapeutic%2520targets%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Med.%26date%3D2011%26volume%3D13%26spage%3De29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Progress in the development and application of small molecule inhibitors of bromodomain–acetyl-lysine interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300915b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9393-9413&author=D.+S.+Hewingsauthor=T.+P.+Rooneyauthor=L.+E.+Jenningsauthor=D.+A.+Hayauthor=C.+J.+Schofieldauthor=P.+E.+Brennanauthor=S.+Knappauthor=S.+J.+Conway&title=Progress+in+the+development+and+application+of+small+molecule+inhibitors+of+bromodomain%E2%80%93acetyl-lysine+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm300915b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300915b%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520development%2520and%2520application%2520of%2520small%2520molecule%2520inhibitors%2520of%2520bromodomain%25E2%2580%2593acetyl-lysine%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9393%26epage%3D9413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Adachi, K.; Endoh, J.; Fuhie, N.; Hamada, M.; Hikawa, H.; Ishibuchi, S.; Murata, M.; Oshita, K.; Sugahara, K.; Tanaka, M.</span><span> </span><span class="NLM_article-title">Thienotriazolodiazepine compound and medicinal use thereof</span>. WO2006129623A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+Adachi&author=J.+Endoh&author=N.+Fuhie&author=M.+Hamada&author=H.+Hikawa&author=S.+Ishibuchi&author=M.+Murata&author=K.+Oshita&author=K.+Sugahara&author=M.+Tanaka&title=Thienotriazolodiazepine+compound+and+medicinal+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DThienotriazolodiazepine%2520compound%2520and%2520medicinal%2520use%2520thereof%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Miyoshi, S.; Ooike, S.; Iwata, K.; Hikawa, H.; Sugahara, K.</span><span> </span><span class="NLM_article-title">Antitumor agent</span>. WO2008-JP73864,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+Miyoshi&author=S.+Ooike&author=K.+Iwata&author=H.+Hikawa&author=K.+Sugahara&title=Antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DS.%26atitle%3DAntitumor%2520agent%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span> </span><span class="NLM_article-title">Open access chemical and clinical probes to support drug discovery</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnchembio0709-436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=19536100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=436-440&author=A.+M.+Edwardsauthor=C.+Bountraauthor=D.+J.+Kerrauthor=T.+M.+Willson&title=Open+access+chemical+and+clinical+probes+to+support+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Open access chemical and clinical probes to support drug discovery</span></div><div class="casAuthors">Edwards, Aled M.; Bountra, Chas; Kerr, David J.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">436-440</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society.  Duplication could be reduced, and productivity could be increased, by performing basic biol. and clin. proofs of concept within open access industry-academia partnerships.  Chem. biologists could play a central role in this effort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEVfmfLQWObLVg90H21EOLACvtfcHk0lipaTU_4Eq_hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVags7g%253D&md5=fada9d85153aeb065c0130889be2160f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnchembio0709-436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio0709-436%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DKerr%26aufirst%3DD.%2BJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DOpen%2520access%2520chemical%2520and%2520clinical%2520probes%2520to%2520support%2520drug%2520discovery%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D436%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">French, C. A.</span><span> </span><span class="NLM_article-title">Pathogenesis of NUT midline carcinoma</span> <span class="citation_source-journal">Annu. Rev. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1146%2Fannurev-pathol-011811-132438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22017582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Kqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=247-265&author=C.+A.+French&title=Pathogenesis+of+NUT+midline+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of NUT midline carcinoma</span></div><div class="casAuthors">French, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-265</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  NUT midline carcinoma (NMC), an aggressive form of squamous cell carcinoma, is defined by the presence of acquired chromosomal rearrangements involving NUT, usually BRD4-NUT fusion genes and, less commonly, NUT-variant fusion genes involving BRD3 or still-uncharacterized genes.  Improved diagnostic tests reveal that although rare, NMCs occur in people of any age and may be indistinguishable from more common squamous cell carcinomas of adulthood.  NMCs have simple karyotypes whose hallmark is genomic instability, suggesting that NMC arises through a distinct pathogenic pathway representing a genetic shortcut to the phenotype of squamous cell carcinoma.  Mechanistically, BRD-NUT fusion proteins appear to act by blocking differentiation, possibly by sequestering histone acetyltransferase activity.  Accordingly, histone deacetylase inhibitors or BET inhibitors, the latter of which inhibit binding of BRD-NUT proteins to chromatin, induce terminal differentiation of NMC cells.  These insights provide a rationale for targeted therapy of NMC, which is almost uniformly refractory to conventional chemotherapy and radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSDatiUBVKCrVg90H21EOLACvtfcHk0lipaTU_4Eq_hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Kqsbs%253D&md5=8f3773f87c158fe3f76ad4df8684f3df</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011811-132438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011811-132438%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DC.%2BA.%26atitle%3DPathogenesis%2520of%2520NUT%2520midline%2520carcinoma%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%26date%3D2012%26volume%3D7%26spage%3D247%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Selective inhibition of BET bromodomains</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnature09504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=20871596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1067-1073&author=P.+Filippakopoulosauthor=J.+Qiauthor=S.+Picaudauthor=Y.+Shenauthor=W.+B.+Smithauthor=O.+Fedorovauthor=E.+M.+Morseauthor=T.+Keatesauthor=T.+T.+Hickmanauthor=I.+Felletarauthor=M.+Philpottauthor=S.+Munroauthor=M.+R.+McKeownauthor=Y.+Wangauthor=A.+L.+Christieauthor=N.+Westauthor=M.+J.+Cameronauthor=B.+Schwartzauthor=T.+D.+Heightmanauthor=T.+N.+Laauthor=C.+A.+Frenchauthor=O.+Wiestauthor=A.+L.+Kungauthor=S.+Knappauthor=J.+E.+Bradner&title=Selective+inhibition+of+BET+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of BET bromodomains</span></div><div class="casAuthors">Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shongah; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic proteins are intently pursued targets in ligand discovery.  So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'.  Potent inhibitors of histone binding modules have not yet been described.  Here the authors report a cell-permeable small mol. (I,JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains.  High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity.  Recurrent translocation of BRD4 is obsd. in a genetically-defined, incurable subtype of human squamous carcinoma.  Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models.  These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chem. scaffold for the development of chem. probes more broadly throughout the bromodomain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ZbtmZM8m_LVg90H21EOLACvtfcHk0lghPLEmaFMm4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D&md5=bd9cadac86124d2c6c3cd5b2a92d68c2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnature09504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09504%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMorse%26aufirst%3DE.%2BM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DHickman%26aufirst%3DT.%2BT.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DWest%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DLa%26aufirst%3DT.%2BN.%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DSelective%2520inhibition%2520of%2520BET%2520bromodomains%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1067%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III.</span><span> </span><span class="NLM_article-title">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">16669</span><span class="NLM_x">–</span> <span class="NLM_lpage">16674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1073%2Fpnas.1108190108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21949397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=16669-16674&author=J.+A.+Mertzauthor=A.+R.+Coneryauthor=B.+M.+Bryantauthor=P.+Sandyauthor=S.+Balasubramanianauthor=D.+A.+Meleauthor=L.+Bergeronauthor=R.+J.+Sims&title=Targeting+MYC+dependence+in+cancer+by+inhibiting+BET+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MYC dependence in cancer by inhibiting BET bromodomains</span></div><div class="casAuthors">Mertz, Jennifer A.; Conery, Andrew R.; Bryant, Barbara M.; Sandy, Peter; Balasubramanian, Srividya; Mele, Deanna A.; Bergeron, Louise; Sims, Robert J., III</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16669-16674, S16669/1-S16669/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The MYC transcription factor is a master regulator of diverse cellular functions and has been long considered a compelling therapeutic target because of its role in a range of human malignancies.  However, pharmacol. inhibition of MYC function has proven challenging because of both the diverse mechanisms driving its aberrant expression and the challenge of disrupting protein-DNA interactions.  Here, we demonstrate the rapid and potent abrogation of MYC gene transcription by representative small mol. inhibitors of the BET family of chromatin adaptors.  MYC transcriptional suppression was obsd. in the context of the natural, chromosomally translocated, and amplified gene locus.  Inhibition of BET bromodomain-promoter interactions and subsequent redn. of MYC transcript and protein levels resulted in G1 arrest and extensive apoptosis in a variety of leukemia and lymphoma cell lines.  Exogenous expression of MYC from an artificial promoter that is resistant to BET regulation significantly protected cells from cell cycle arrest and growth suppression by BET inhibitors.  MYC suppression was accompanied by deregulation of the MYC transcriptome, including potent reactivation of the p21 tumor suppressor.  Treatment with a BET inhibitor resulted in significant antitumor activity in xenograft models of Burkitt's lymphoma and acute myeloid leukemia.  These findings demonstrate that pharmacol. inhibition of MYC is achievable through targeting BET bromodomains.  Such inhibitors may have clin. utility given the widespread pathogenetic role of MYC in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UHj1YB_ikrVg90H21EOLACvtfcHk0lghPLEmaFMm4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWksrnL&md5=b1f0fd41fa56bbfcbb1ad6c8d48f7f80</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1108190108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1108190108%26sid%3Dliteratum%253Aachs%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DMele%26aufirst%3DD.%2BA.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520MYC%2520dependence%2520in%2520cancer%2520by%2520inhibiting%2520BET%2520bromodomains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A%26date%3D2011%26volume%3D108%26spage%3D16669%26epage%3D16674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudgin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1038%2Fnature10509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21964340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=529-533&author=M.+A.+Dawsonauthor=R.+K.+Prinjhaauthor=A.+Dittmannauthor=G.+Giotopoulosauthor=M.+Bantscheffauthor=W.+I.+Chanauthor=S.+C.+Robsonauthor=C.+W.+Chungauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=C.+Huthmacherauthor=E.+Gudginauthor=D.+Lugoauthor=S.+Beinkeauthor=T.+D.+Chapmanauthor=E.+J.+Robertsauthor=P.+E.+Sodenauthor=K.+R.+Augerauthor=O.+Mirguetauthor=K.+Doehnerauthor=R.+Delwelauthor=A.+K.+Burnettauthor=P.+Jeffreyauthor=G.+Drewesauthor=K.+Leeauthor=B.+J.+Huntlyauthor=T.+Kouzarides&title=Inhibition+of+BET+recruitment+to+chromatin+as+an+effective+treatment+for+MLL-fusion+leukaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span></div><div class="casAuthors">Dawson, Mark A.; Prinjha, Rab K.; Dittman, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">529-533</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent chromosomal translocations involving the mixed lineage leukemia (MLL) gene initiate aggressive forms of leukemia, which are often refractory to conventional therapies.  Many MLL-fusion partners are members of the super elongation complex (SEC), a crit. regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukemia induction.  Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-assocd. factor complex (PAFc), are assocd. with the BET family of acetyl-lysine recognizing, chromatin adaptor' proteins.  These data provided the basis for therapeutic intervention in MLL-fusion leukemia, via the displacement of the BET family of proteins from chromatin.  We show that a novel small mol. inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukemic cell lines, through the induction of early cell cycle arrest and apoptosis.  I-BET151 treatment in two human leukemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes.  The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin.  In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.  Finally, the efficacy of I-BET151 against human leukemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential.  These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4FbgJpjftv7Vg90H21EOLACvtfcHk0lghPLEmaFMm4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO&md5=dffb4b81da4ca8291c27139d0df86324</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature10509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10509%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.%2BI.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DGudgin%26aufirst%3DE.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%2BD.%26aulast%3DRoberts%26aufirst%3DE.%2BJ.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DDoehner%26aufirst%3DK.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520BET%2520recruitment%2520to%2520chromatin%2520as%2520an%2520effective%2520treatment%2520for%2520MLL-fusion%2520leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D529%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Delmore, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issa, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastritis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilpatrick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghobrial, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition as a therapeutic strategy to target c-Myc</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">904</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.cell.2011.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=21889194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2011&pages=904-917&author=J.+E.+Delmoreauthor=G.+C.+Issaauthor=M.+E.+Lemieuxauthor=P.+B.+Rahlauthor=J.+Shiauthor=H.+M.+Jacobsauthor=E.+Kastritisauthor=T.+Gilpatrickauthor=R.+M.+Paranalauthor=J.+Qiauthor=M.+Chesiauthor=A.+C.+Schinzelauthor=M.+R.+McKeownauthor=T.+P.+Heffernanauthor=C.+R.+Vakocauthor=P.+L.+Bergsagelauthor=I.+M.+Ghobrialauthor=P.+G.+Richardsonauthor=R.+A.+Youngauthor=W.+C.+Hahnauthor=K.+C.+Andersonauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=C.+S.+Mitsiades&title=BET+bromodomain+inhibition+as+a+therapeutic+strategy+to+target+c-Myc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc</span></div><div class="casAuthors">Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E.; Rahl, Peter B.; Shi, Jun-Wei; Jacobs, Hannah M.; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M.; Qi, Jun; Chesi, Marta; Schinzel, Anna C.; McKeown, Michael R.; Heffernan, Timothy P.; Vakoc, Christopher R.; Bergsagel, P. Leif; Ghobrial, Irene M.; Richardson, Paul G.; Young, Richard A.; Hahn, William C.; Anderson, Kenneth C.; Kung, Andrew L.; Bradner, James E.; Mitsiades, Constantine S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">904-917</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: MYC contributes to the pathogenesis of a majority of human cancers, yet strategies to modulate the function of the c-Myc oncoprotein do not exist.  Toward this objective, we have targeted MYC transcription by interfering with chromatin-dependent signal transduction to RNA polymerase, specifically by inhibiting the acetyl-lysine recognition domains (bromodomains) of putative coactivator proteins implicated in transcriptional initiation and elongation.  Using a selective small-mol. bromodomain inhibitor, JQ1, we identify BET bromodomain proteins as regulatory factors for c-Myc.  BET inhibition by JQ1 downregulates MYC transcription, followed by genome-wide downregulation of Myc-dependent target genes.  In exptl. models of multiple myeloma, a Myc-dependent hematol. malignancy, JQ1 produces a potent antiproliferative effect assocd. with cell-cycle arrest and cellular senescence.  Efficacy of JQ1 in three murine models of multiple myeloma establishes the therapeutic rationale for BET bromodomain inhibition in this disease and other malignancies characterized by pathol. activation of c-Myc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpevD1QHKmOhLVg90H21EOLACvtfcHk0ljD2rXh-B7BYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2ht7fF&md5=013674b8224214a9a1c8f0b75583a5a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelmore%26aufirst%3DJ.%2BE.%26aulast%3DIssa%26aufirst%3DG.%2BC.%26aulast%3DLemieux%26aufirst%3DM.%2BE.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DH.%2BM.%26aulast%3DKastritis%26aufirst%3DE.%26aulast%3DGilpatrick%26aufirst%3DT.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26atitle%3DBET%2520bromodomain%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520to%2520target%2520c-Myc%26jtitle%3DCell%26date%3D2011%26volume%3D146%26spage%3D904%26epage%3D917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ott, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranal, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, D. M.</span><span> </span><span class="NLM_article-title">BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=2843-2852&author=C.+J.+Ottauthor=N.+Koppauthor=L.+Birdauthor=R.+M.+Paranalauthor=J.+Qiauthor=T.+Bowmanauthor=S.+J.+Rodigauthor=A.+L.+Kungauthor=J.+E.+Bradnerauthor=D.+M.+Weinstock&title=BET+bromodomain+inhibition+targets+both+c-Myc+and+IL7R+in+high-risk+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DC.%2BJ.%26aulast%3DKopp%26aufirst%3DN.%26aulast%3DBird%26aufirst%3DL.%26aulast%3DParanal%26aufirst%3DR.%2BM.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBowman%26aufirst%3DT.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DWeinstock%26aufirst%3DD.%2BM.%26atitle%3DBET%2520bromodomain%2520inhibition%2520targets%2520both%2520c-Myc%2520and%2520IL7R%2520in%2520high-risk%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D2843%26epage%3D2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Puissant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frumm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassil, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanthery, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nekritz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greninger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmaier, K.</span><span> </span><span class="NLM_article-title">Targeting MYCN in neuroblastoma by BET bromodomain inhibition</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=308-323&author=A.+Puissantauthor=S.+M.+Frummauthor=G.+Alexeauthor=C.+F.+Bassilauthor=J.+Qiauthor=Y.+H.+Chantheryauthor=E.+A.+Nekritzauthor=R.+Zeidauthor=W.+C.+Gustafsonauthor=P.+Greningerauthor=M.+J.+Garnettauthor=U.+McDermottauthor=C.+H.+Benesauthor=A.+L.+Kungauthor=W.+A.+Weissauthor=J.+E.+Bradnerauthor=K.+Stegmaier&title=Targeting+MYCN+in+neuroblastoma+by+BET+bromodomain+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuissant%26aufirst%3DA.%26aulast%3DFrumm%26aufirst%3DS.%2BM.%26aulast%3DAlexe%26aufirst%3DG.%26aulast%3DBassil%26aufirst%3DC.%2BF.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChanthery%26aufirst%3DY.%2BH.%26aulast%3DNekritz%26aufirst%3DE.%2BA.%26aulast%3DZeid%26aufirst%3DR.%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DU.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DStegmaier%26aufirst%3DK.%26atitle%3DTargeting%2520MYCN%2520in%2520neuroblastoma%2520by%2520BET%2520bromodomain%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D308%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delannee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudit, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2963</span><span class="NLM_x">–</span> <span class="NLM_lpage">2967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.bmcl.2012.01.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22386529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2963-2967&author=O.+Mirguetauthor=Y.+Lamotteauthor=F.+Doncheauthor=J.+Toumauthor=F.+Gellibertauthor=A.+Bouillotauthor=R.+Gosminiauthor=V.+L.+Nguyenauthor=D.+Delanneeauthor=J.+Sealauthor=F.+Blandelauthor=A.+B.+Boullayauthor=E.+Boursierauthor=S.+Martinauthor=J.+M.+Brusqauthor=G.+Krysaauthor=A.+Riouauthor=R.+Tellierauthor=A.+Costazauthor=P.+Huetauthor=Y.+Duditauthor=L.+Trottetauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=From+ApoA1+upregulation+to+BET+family+bromodomain+inhibition%3A+discovery+of+I-BET151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151</span></div><div class="casAuthors">Mirguet, Olivier; Lamotte, Yann; Donche, Frederic; Toum, Jerome; Gellibert, Francoise; Bouillot, Anne; Gosmini, Romain; Nguyen, Van-Loc; Delannee, Delphine; Seal, Jonathan; Blandel, Florence; Boullay, Anne-Benedicte; Boursier, Eric; Martin, Sandrine; Brusq, Jean-Marie; Krysa, Gael; Riou, Alizon; Tellier, Remi; Costaz, Agnes; Huet, Pascal; Dudit, Yann; Trottet, Lionel; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2963-2967</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery, synthesis, and biol. evaluation of a novel series of 7-isoxazoloquinolines is described.  Several analogs are shown to increase ApoA1 expression within the nanomolar range in the human hepatic cell line HepG2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIu6f80tbgE7Vg90H21EOLACvtfcHk0ljD2rXh-B7BYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1elsbY%253D&md5=48c9a8dc4b70bea4a86807f7a1cec5f1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.125%26sid%3Dliteratum%253Aachs%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DDelannee%26aufirst%3DD.%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DBlandel%26aufirst%3DF.%26aulast%3DBoullay%26aufirst%3DA.%2BB.%26aulast%3DBoursier%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DRiou%26aufirst%3DA.%26aulast%3DTellier%26aufirst%3DR.%26aulast%3DCostaz%26aufirst%3DA.%26aulast%3DHuet%26aufirst%3DP.%26aulast%3DDudit%26aufirst%3DY.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DFrom%2520ApoA1%2520upregulation%2520to%2520BET%2520family%2520bromodomain%2520inhibition%253A%2520discovery%2520of%2520I-BET151%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2963%26epage%3D2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Seal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamotte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioja, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span> </span><span class="NLM_article-title">Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2968</span><span class="NLM_x">–</span> <span class="NLM_lpage">2972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.bmcl.2012.02.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22437115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2968-2972&author=J.+Sealauthor=Y.+Lamotteauthor=F.+Doncheauthor=A.+Bouillotauthor=O.+Mirguetauthor=F.+Gellibertauthor=E.+Nicodemeauthor=G.+Krysaauthor=J.+Kirilovskyauthor=S.+Beinkeauthor=S.+McClearyauthor=I.+Riojaauthor=P.+Bamboroughauthor=C.+W.+Chungauthor=L.+Gordonauthor=T.+Lewisauthor=A.+L.+Walkerauthor=L.+Cutlerauthor=D.+Lugoauthor=D.+M.+Wilsonauthor=J.+Witheringtonauthor=K.+Leeauthor=R.+K.+Prinjha&title=Identification+of+a+novel+series+of+BET+family+bromodomain+inhibitors%3A+binding+mode+and+profile+of+I-BET151+%28GSK1210151A%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)</span></div><div class="casAuthors">Seal, Jonathan; Lamotte, Yann; Donche, Frederic; Bouillot, Anne; Mirguet, Olivier; Gellibert, Francoise; Nicodeme, Edwige; Krysa, Gael; Kirilovsky, Jorge; Beinke, Soren; McCleary, Scott; Rioja, Inma; Bamborough, Paul; Chung, Chun-Wa; Gordon, Laurie; Lewis, Toni; Walker, Ann L.; Cutler, Leanne; Lugo, David; Wilson, David M.; Witherington, Jason; Lee, Kevin; Prinjha, Rab K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2968-2972</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed.  Crystallog. is used to illustrate binding modes and rationalize their SAR.  One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxemia model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJKtxBCr-pRbVg90H21EOLACvtfcHk0lhub5nT6f43YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOqsr8%253D&md5=a8037c89bcb93948d663208bd1ebfd55</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.041%26sid%3Dliteratum%253Aachs%26aulast%3DSeal%26aufirst%3DJ.%26aulast%3DLamotte%26aufirst%3DY.%26aulast%3DDonche%26aufirst%3DF.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DRioja%26aufirst%3DI.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DT.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520BET%2520family%2520bromodomain%2520inhibitors%253A%2520binding%2520mode%2520and%2520profile%2520of%2520I-BET151%2520%2528GSK1210151A%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2968%26epage%3D2972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wyspianska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nangalia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero-Nieto, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioja, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannizzaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottgens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">BET protein inhibition shows efficacy against JAK2V617F driven neoplasms</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=88-97&author=B.+Wyspianskaauthor=A.+J.+Bannisterauthor=I.+Barbieriauthor=J.+Nangaliaauthor=A.+Godfreyauthor=F.+J.+Calero-Nietoauthor=S.+Robsonauthor=I.+Riojaauthor=J.+Liauthor=M.+Wieseauthor=E.+Cannizzaroauthor=M.+A.+Dawsonauthor=B.+Huntlyauthor=R.+K.+Prinjhaauthor=A.+R.+Greenauthor=B.+Gottgensauthor=T.+Kouzarides&title=BET+protein+inhibition+shows+efficacy+against+JAK2V617F+driven+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyspianska%26aufirst%3DB.%26aulast%3DBannister%26aufirst%3DA.%2BJ.%26aulast%3DBarbieri%26aufirst%3DI.%26aulast%3DNangalia%26aufirst%3DJ.%26aulast%3DGodfrey%26aufirst%3DA.%26aulast%3DCalero-Nieto%26aufirst%3DF.%2BJ.%26aulast%3DRobson%26aufirst%3DS.%26aulast%3DRioja%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWiese%26aufirst%3DM.%26aulast%3DCannizzaro%26aufirst%3DE.%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DHuntly%26aufirst%3DB.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DGottgens%26aufirst%3DB.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DBET%2520protein%2520inhibition%2520shows%2520efficacy%2520against%2520JAK2V617F%2520driven%2520neoplasms%26jtitle%3DLeukemia%26date%3D2013%26volume%3D28%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bailey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahagirdar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafiane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiacchia, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimbou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, J.</span><span> </span><span class="NLM_article-title">RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2580</span><span class="NLM_x">–</span> <span class="NLM_lpage">2589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.jacc.2010.02.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=20513599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2010&pages=2580-2589&author=D.+Baileyauthor=R.+Jahagirdarauthor=A.+Gordonauthor=A.+Hafianeauthor=S.+Campbellauthor=S.+Chaturauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=F.+S.+Chiacchiaauthor=J.+Johanssonauthor=L.+Krimbouauthor=N.+C.+Wongauthor=J.+Genest&title=RVX-208%3A+a+small+molecule+that+increases+apolipoprotein+A-I+and+high-density+lipoprotein+cholesterol+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208. A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo</span></div><div class="casAuthors">Bailey, Dana; Jahagirdar, Ravi; Gordon, Allan; Hafiane, Anouar; Campbell, Steven; Chatur, Safia; Wagner, Gregory S.; Hansen, Henrik C.; Chiacchia, Fabrizio S.; Johansson, Jan; Krimbou, Larbi; Wong, Norman C. W.; Genest, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2580-2589</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to det. whether a novel small mol. RVX-208 affects apolipoprotein (apo)A-I and high-d. lipoprotein cholesterol (HDL-C) levels in vitro and in vivo.  Background: Increased apoA-I and HDL-C levels are potential therapeutic targets for reducing atherosclerotic disease.  Methods: HepG2 cells were treated with 0 to 60 μmol/l RVX-208 followed by assays for apoA-I and HDL-C prodn.  For in vivo studies, African green monkeys (AGMs) received 15 to 60 mg/kg/day RVX-208, and the serum was analyzed for lipoprotein levels, HDL-subparticle distribution, cholesterol efflux, and activity of lipid-modifying enzymes.  A phase I clin. trial was conducted in healthy volunteers (given 1 to 20 mg/kg/day of RVX-208) to assess safety, tolerability, and pharmacokinetics.  Results: The RVX-208 induced apoA-I mRNA and protein synthesis in HepG2 cells, leading to in- creased levels of pre-β-migrating and α-lipoprotein particles contg. apoA-I (LpA-I) in spent media.  Similarly, in AGMs, RVX-208 treatment for 63 days increased serum apoA-I and HDL-C levels (60% and 97%, resp.).  In addn., the levels of pre-β1-LpA-I and α1-LpA-I HDL-subparticles were increased as well as ATP binding cassette AI, ATP binding cassette G1, and scavenger receptor class B type I-dependent cholesterol efflux.  These changes were not mediated by cholesteryl-ester-transfer protein.  Treatment of humans for 1 wk with oral RVX-208 increased apoA-I, pre-β-HDL, and HDL functionality.  Conclusions: RVX-208 increases apoA-I and HDL-C in vitro and in vivo.  In AGMs, RVX-208 raises serum pre-β1-LpA-I and α-LpA-I levels and enhances cholesterol efflux.  Data in humans point to beneficial features of RVX-208 that might be useful for treating atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEGExcnx6drLVg90H21EOLACvtfcHk0lhub5nT6f43YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptV2msr0%253D&md5=aab9ac26e73704f1cd569e2ff47d0c51</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2010.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2010.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DD.%26aulast%3DJahagirdar%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DHafiane%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DChatur%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DChiacchia%26aufirst%3DF.%2BS.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DKrimbou%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DGenest%26aufirst%3DJ.%26atitle%3DRVX-208%253A%2520a%2520small%2520molecule%2520that%2520increases%2520apolipoprotein%2520A-I%2520and%2520high-density%2520lipoprotein%2520cholesterol%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2010%26volume%3D55%26spage%3D2580%26epage%3D2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujikawa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist</span> <span class="citation_source-journal">PLoS. One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83190&author=K.+G.+McLureauthor=E.+M.+Gesnerauthor=L.+Tsujikawaauthor=O.+A.+Kharenkoauthor=S.+Attwellauthor=E.+Campeauauthor=S.+Wasiakauthor=A.+Steinauthor=A.+Whiteauthor=E.+Fontanoauthor=R.+K.+Sutoauthor=N.+C.+Wongauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=P.+R.+Young&title=RVX-208%2C+an+inducer+of+ApoA-I+in+humans%2C+is+a+BET+bromodomain+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DTsujikawa%26aufirst%3DL.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DCampeau%26aufirst%3DE.%26aulast%3DWasiak%26aufirst%3DS.%26aulast%3DStein%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DFontano%26aufirst%3DE.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DWong%26aufirst%3DN.%2BC.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DRVX-208%252C%2520an%2520inducer%2520of%2520ApoA-I%2520in%2520humans%252C%2520is%2520a%2520BET%2520bromodomain%2520antagonist%26jtitle%3DPLoS.%2520One%26date%3D2013%26volume%3D8%26spage%3De83190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chung, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolven, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201320w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=576-586&author=C.+W.+Chungauthor=A.+W.+Deanauthor=J.+M.+Woolvenauthor=P.+Bamborough&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+1%3A+inhibitor+binding+modes+and+implications+for+lead+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery</span></div><div class="casAuthors">Chung, Chun-wa; Dean, Anthony W.; Woolven, James M.; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">576-586</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. proteins are key epigenetic regulators of gene transcription and readers of the histone code.  However, the therapeutic benefits of modulating this target class are largely unexplored due to the lack of suitable chem. probes.  This article describes the generation of lead mols. for the BET bromodomains through screening a fragment set chosen using structural insights and computational approaches.  Anal. of 40 BRD2/fragment x-ray complexes highlights both shared and disparate interaction features that may be exploited for affinity and selectivity.  Six representative crystal structures are then exemplified in detail.  Two of the fragments are completely new bromodomain chemotypes, and three have never before been crystd. in a bromodomain, so our results significantly extend the limited public knowledge-base of crystallog. small mol./bromodomain interactions.  Certain fragments (including paracetamol) bind in a consistent mode to different bromodomains such as CREBBP, suggesting their potential to act as generic bromodomain templates.  An important implication is that the bromodomains are not only a phylogenetic family but also a system in which chem. and structural knowledge of one bromodomain gives insights transferable to others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonNb7GnZnS_rVg90H21EOLACvtfcHk0ljRHOJgJBq6Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrnN&md5=5b7d7239d0de57266d94beef1ea080ae</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm201320w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201320w%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.%2BW.%26aulast%3DDean%26aufirst%3DA.%2BW.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25201%253A%2520inhibitor%2520binding%2520modes%2520and%2520implications%2520for%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D576%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primiano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciammetta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span> </span><span class="NLM_article-title">Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9831</span><span class="NLM_x">–</span> <span class="NLM_lpage">9837</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3010515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9831-9837&author=P.+V.+Fishauthor=P.+Filippakopoulosauthor=G.+Bishauthor=P.+E.+Brennanauthor=M.+E.+Bunnageauthor=A.+S.+Cookauthor=O.+Federovauthor=B.+S.+Gerstenbergerauthor=H.+Jonesauthor=S.+Knappauthor=B.+Marsdenauthor=K.+Nockaauthor=D.+R.+Owenauthor=M.+Philpottauthor=S.+Picaudauthor=M.+J.+Primianoauthor=M.+J.+Ralphauthor=N.+Sciammettaauthor=J.+D.+Trzupek&title=Identification+of+a+chemical+probe+for+bromo+and+extra+C-terminal+bromodomain+inhibition+through+optimization+of+a+fragment-derived+hit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit</span></div><div class="casAuthors">Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn; Brennan, Paul E.; Bunnage, Mark E.; Cook, Andrew S.; Federov, Oleg; Gerstenberger, Brian S.; Jones, Hannah; Knapp, Stefan; Marsden, Brian; Nocka, Karl; Owen, Dafydd R.; Philpott, Martin; Picaud, Sarah; Primiano, Michael J.; Ralph, Michael J.; Sciammetta, Nunzio; Trzupek, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9831-9837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs).  The significance of this subset of the epigenetic code is interrogated and interpreted by an acetyllysine-specific protein-protein interaction with bromodomain reader modules.  Selective inhibition of the bromo and extra C-terminal domain (BET) family of bromodomains with a small mol. is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti-inflammatory properties of such inhibitors.  Herein, we describe the discovery and structure-activity relationship (SAR) of a novel, small-mol. chem. probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques.  This has yielded a potent, selective compd. with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzpWnuXoLdrVg90H21EOLACvtfcHk0ljRHOJgJBq6Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE&md5=ba864f3916bea5f793dd0b26732784f0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm3010515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010515%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DFederov%26aufirst%3DO.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPrimiano%26aufirst%3DM.%2BJ.%26aulast%3DRalph%26aufirst%3DM.%2BJ.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520chemical%2520probe%2520for%2520bromo%2520and%2520extra%2520C-terminal%2520bromodomain%2520inhibition%2520through%2520optimization%2520of%2520a%2520fragment-derived%2520hit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9831%26epage%3D9837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodrow, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C. W.</span><span> </span><span class="NLM_article-title">Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201283q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=587-596&author=P.+Bamboroughauthor=H.+Dialloauthor=J.+D.+Goodacreauthor=L.+Gordonauthor=A.+Lewisauthor=J.+T.+Sealauthor=D.+M.+Wilsonauthor=M.+D.+Woodrowauthor=C.+W.+Chung&title=Fragment-based+discovery+of+bromodomain+inhibitors+part+2%3A+optimization+of+phenylisoxazole+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides</span></div><div class="casAuthors">Bamborough, Paul; Diallo, Hawa; Goodacre, Jonathan D.; Gordon, Laurie; Lewis, Antonia; Seal, Jonathan T.; Wilson, David M.; Woodrow, Michael D.; Chung, Chun-wa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">587-596</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are epigenetic reader modules that regulate gene transcription through their recognition of acetyl-lysine modified histone tails.  Inhibitors of this protein-protein interaction have the potential to modulate multiple diseases as demonstrated by the profound anti-inflammatory and antiproliferative effects of a recently disclosed class of BET compds.  While these compds. were discovered using phenotypic assays, here we present a highly efficient alternative approach to find new chem. templates, exploiting the abundant structural knowledge that exists for this target class.  A Ph di-Me isoxazole chemotype resulting from a focused fragment screen has been rapidly optimized through structure-based design, leading to a sulfonamide series showing anti-inflammatory activity in cellular assays.  This proof-of-principle expt. demonstrates the tractability of the BET family and bromodomain target class to fragment-based hit discovery and structure-based lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr6lsic9qjJrVg90H21EOLACvtfcHk0lgb4o-w7yEzIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFKktrfF&md5=e73b16b3fddf88b43b037264b000b276</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm201283q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201283q%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DGoodacre%26aufirst%3DJ.%2BD.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DSeal%26aufirst%3DJ.%2BT.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWoodrow%26aufirst%3DM.%2BD.%26aulast%3DChung%26aufirst%3DC.%2BW.%26atitle%3DFragment-based%2520discovery%2520of%2520bromodomain%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520phenylisoxazole%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D587%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppusetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">3,5-Dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6761</span><span class="NLM_x">–</span> <span class="NLM_lpage">6770</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200640v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6761-6770&author=D.+S.+Hewingsauthor=M.+Wangauthor=M.+Philpottauthor=O.+Fedorovauthor=S.+Uttarkarauthor=P.+Filippakopoulosauthor=S.+Picaudauthor=C.+Vuppusettyauthor=B.+Marsdenauthor=S.+Knappauthor=S.+J.+Conwayauthor=T.+D.+Heightman&title=3%2C5-Dimethylisoxazoles+act+as+acetyl-lysine-mimetic+bromodomain+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm200640v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200640v%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DUttarkar%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DVuppusetty%26aufirst%3DC.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3D3%252C5-Dimethylisoxazoles%2520act%2520as%2520acetyl-lysine-mimetic%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6761%26epage%3D6770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3217</span><span class="NLM_x">–</span> <span class="NLM_lpage">3227</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301588r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3217-3227&author=D.+S.+Hewingsauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=S.+Picaudauthor=A.+Tumberauthor=C.+Wellsauthor=M.+M.+Olcinaauthor=K.+Freemanauthor=A.+Gillauthor=A.+J.+Ritchieauthor=D.+W.+Sheppardauthor=A.+J.+Russellauthor=E.+M.+Hammondauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=Optimization+of+3%2C5-dimethylisoxazole+derivatives+as+potent+bromodomain+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm301588r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301588r%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DFreeman%26aufirst%3DK.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DA.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DOptimization%2520of%25203%252C5-dimethylisoxazole%2520derivatives%2520as%2520potent%2520bromodomain%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3217%26epage%3D3227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellapantula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasamurthy, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birudukota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, design and optimization of isoxazole azepine BET inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml4001485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=835-840&author=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=Y.+Leblancauthor=A.+C%C3%B4t%C3%A9author=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=R.+Sankaranarayananauthor=S.+Yellapantulaauthor=N.+B.+Srinivasamurthyauthor=S.+Birudukotaauthor=B.+K.+Albrecht&title=Discovery%2C+design+and+optimization+of+isoxazole+azepine+BET+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fml4001485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001485%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSankaranarayanan%26aufirst%3DR.%26aulast%3DYellapantula%26aufirst%3DS.%26aulast%3DSrinivasamurthy%26aufirst%3DN.%2BB.%26aulast%3DBirudukota%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%2520and%2520optimization%2520of%2520isoxazole%2520azepine%2520BET%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D835%26epage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3833</span><span class="NLM_x">–</span> <span class="NLM_lpage">3851</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301793a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3833-3851&author=L.+Zhaoauthor=D.+Caoauthor=T.+Chenauthor=Y.+Wangauthor=Z.+Miaoauthor=Y.+Xuauthor=W.+Chenauthor=X.+Wangauthor=Y.+Liauthor=Z.+Duauthor=B.+Xiongauthor=J.+Liauthor=C.+Xuauthor=N.+Zhangauthor=J.+Heauthor=J.+Shen&title=Fragment-based+drug+discovery+of+2-thiazolidinones+as+inhibitors+of+the+histone+reader+BRD4+bromodomain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain</span></div><div class="casAuthors">Zhao, Lele; Cao, Danyan; Chen, Tiantian; Wang, Yingqing; Miao, Zehong; Xu, Yechun; Chen, Wuyan; Wang, Xin; Li, Yanlian; Du, Zhiyan; Xiong, Bing; Li, Jian; Xu, Chunyan; Zhang, Naixia; He, Jianhua; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3833-3851</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recognizing acetyllysine of histone is a vital process of epigenetic regulation that is mediated by a protein module called bromodomain.  To contribute novel scaffolds for developing into bromodomain inhibitors, the authors utilize a fragment-based drug discovery approach.  By successively applying docking and x-ray crystallog., they were able to identify 9 fragment hits from diffracting more than 60 crystals.  In the present work, they described four of them and carried out the integrated lead optimization for fragment I, which bears a 2-thiazolidinone core.  After several rounds of structure guided modifications, they assessed the druggability of 2-thiazolidinone by modulating in vitro pharmacokinetic studies and cellular activity assay.  The results showed that two potent of 2-thiazolidinone compds. II and III have good metabolic stability.  Also, the cellular assay confirmed the activities of 2-thiazolidinones.  Together, they hope the identified 2-thiazolidinone chemotype and other fragment hits described herein can stimulate researchers to develop more diversified bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfi2pyYq6c4LVg90H21EOLACvtfcHk0lj2IoN-SKxyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksF2htL4%253D&md5=8308db5d83cb72b29f261cc134514ece</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301793a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301793a%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DFragment-based%2520drug%2520discovery%2520of%25202-thiazolidinones%2520as%2520inhibitors%2520of%2520the%2520histone%2520reader%2520BRD4%2520bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3833%26epage%3D3851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bellosta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsini, A.</span><span> </span><span class="NLM_article-title">Safety of statins: focus on clinical pharmacokinetics and drug interactions</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">III50</span><span class="NLM_x">–</span> <span class="NLM_lpage">III57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=III50-III57&author=S.+Bellostaauthor=R.+Paolettiauthor=A.+Corsini&title=Safety+of+statins%3A+focus+on+clinical+pharmacokinetics+and+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellosta%26aufirst%3DS.%26aulast%3DPaoletti%26aufirst%3DR.%26aulast%3DCorsini%26aufirst%3DA.%26atitle%3DSafety%2520of%2520statins%253A%2520focus%2520on%2520clinical%2520pharmacokinetics%2520and%2520drug%2520interactions%26jtitle%3DCirculation%26date%3D2004%26volume%3D109%26spage%3DIII50%26epage%3DIII57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wyce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smitheman, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbash, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy-Wilson, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span> </span><span class="NLM_article-title">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span> <span class="citation_source-journal">PLoS. One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e72967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1371%2Fjournal.pone.0072967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=24009722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72967&author=A.+Wyceauthor=G.+Ganjiauthor=K.+N.+Smithemanauthor=C.-W.+Chungauthor=S.+Korenchukauthor=Y.+Baiauthor=O.+Barbashauthor=B.+Leauthor=P.+Craggsauthor=M.+T.+McCabeauthor=K.+M.+Kennedy-Wilsonauthor=L.+V.+Sanchezauthor=R.+L.+Gosminiauthor=N.+Parrauthor=C.+F.+McHughauthor=D.+Dhanakauthor=R.+K.+Prinjhaauthor=K.+R.+Augerauthor=P.+J.+Tummino&title=BET+inhibition+silences+expression+of+MYCN+and+BCL2+and+induces+cytotoxicity+in+neuroblastoma+tumor+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models</span></div><div class="casAuthors">Wyce, Anastasia; Ganji, Gopinath; Smitheman, Kimberly N.; Chung, Chun-Wa; Korenchuk, Susan; Bai, Yuchen; Barbash, Olena; Le, Bao Chau; Craggs, Peter D.; McCabe, Michael T.; Kennedy-Wilson, Karen M.; Sanchez, Lydia V.; Gosmini, Romain L.; Parr, Nigel; McHugh, Charles F.; Dhanak, Dashyant; Prinjha, Rab K.; Auger, Kurt R.; Tummino, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e72967</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis.  Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a no. of hematol. cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways.  However, little is currently known about the activity of BET inhibitors in solid tumor models, and whether down-regulation of MYC family genes contributes to sensitivity.  Here we provide evidence for potent BET inhibitor activity in neuroblastoma, a pediatric solid tumor assocd. with a high frequency of MYCN amplifications.  We treated a panel of neuroblastoma cell lines with a novel small mol. inhibitor of BET proteins, GSK1324726A (I-BET726), and obsd. potent growth inhibition and cytotoxicity in most cell lines irresp. of MYCN copy no. or expression level.  Gene expression analyses in neuroblastoma cell lines suggest a role of BET inhibition in apoptosis, signaling, and N-Myc-driven pathways, including the direct suppression of BCL2 and MYCN.  Reversal of MYCN or BCL2 suppression reduces the potency of I-BET726-induced cytotoxicity in a cell line-specific manner; however, neither factor fully accounts for I-BET726 sensitivity.  Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth.  Taken together, our data highlight the potential of BET inhibitors as novel therapeutics for neuroblastoma, and suggest that sensitivity is driven by pleiotropic effects on cell growth and apoptotic pathways in a context-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecB0_0elFVbVg90H21EOLACvtfcHk0lj2IoN-SKxyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2iu7fI&md5=d39ce25a50de58f18a278a9f67935bbc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072967%26sid%3Dliteratum%253Aachs%26aulast%3DWyce%26aufirst%3DA.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DSmitheman%26aufirst%3DK.%2BN.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DBarbash%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DB.%26aulast%3DCraggs%26aufirst%3DP.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DKennedy-Wilson%26aufirst%3DK.%2BM.%26aulast%3DSanchez%26aufirst%3DL.%2BV.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26atitle%3DBET%2520inhibition%2520silences%2520expression%2520of%2520MYCN%2520and%2520BCL2%2520and%2520induces%2520cytotoxicity%2520in%2520neuroblastoma%2520tumor%2520models%26jtitle%3DPLoS.%2520One%26date%3D2013%26volume%3D8%26spage%3De72967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Marshall, J. C.</span><span> </span><span class="NLM_article-title">Why have clinical trials in sepsis failed?</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=195-203&author=J.+C.+Marshall&title=Why+have+clinical+trials+in+sepsis+failed%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DJ.%2BC.%26atitle%3DWhy%2520have%2520clinical%2520trials%2520in%2520sepsis%2520failed%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Histone recognition and large-scale structural analysis of the human bromodomain family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5010539&amp;key=10.1016%2Fj.cell.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5010539&amp;key=22464331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=214-231&author=P.+Filippakopoulosauthor=S.+Picaudauthor=M.+Mangosauthor=T.+Keatesauthor=J.+P.+Lambertauthor=D.+Barsyte-Lovejoyauthor=I.+Felletarauthor=R.+Volkmerauthor=S.+Mullerauthor=T.+Pawsonauthor=A.+C.+Gingrasauthor=C.+H.+Arrowsmithauthor=S.+Knapp&title=Histone+recognition+and+large-scale+structural+analysis+of+the+human+bromodomain+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Muller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-231</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks.  The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity.  Here, we present 29 high-resoln. crystal structures, covering all BRD families.  These proteins are: ASH1L, ATAD2, BAZ2B, BPTF, BRD1, BRD3(1), BRD3(2), BRD4(1), BRD4(2), BRD9, BRDT(1), CECR2, EP300, CREBBP, GCN5L2, KIAA1240, PB1(1), PB1(2), PB1(3), PB1(4), PB1(5), PB1(6), PCAF, PHIP(2), TAF1(2), WDR9(2), BRD4(1).  Comprehensive crossfamily structural anal. identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition.  Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences.  We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-contg. peptides by BRD4.  These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FSIcPoXZLVg90H21EOLACvtfcHk0lh80UWDe4SniA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D&md5=05583a01a1cd4c3b59fc59c00e4c4777</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMangos%26aufirst%3DM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DJ.%2BP.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DHistone%2520recognition%2520and%2520large-scale%2520structural%2520analysis%2520of%2520the%2520human%2520bromodomain%2520family%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D214%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Demont, E. H.; Gosmini, R.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline derivatives as bromodomain inhibitors and their preparation and use in the treatment of cancer, autoimmune and inflammatory diseases</span>. WO2010-EP66701,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+H.+Demont&author=R.+Gosmini&title=Tetrahydroquinoline+derivatives+as+bromodomain+inhibitors+and+their+preparation+and+use+in+the+treatment+of+cancer%2C+autoimmune+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26atitle%3DTetrahydroquinoline%2520derivatives%2520as%2520bromodomain%2520inhibitors%2520and%2520their%2520preparation%2520and%2520use%2520in%2520the%2520treatment%2520of%2520cancer%252C%2520autoimmune%2520and%2520inflammatory%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Damon, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugger, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of the cholesteryl ester transfer protein inhibitor torcetrapib</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/doi/10.1021/op060013i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5010539&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlOit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=472-480&author=D.+B.+Damonauthor=R.+W.+Duggerauthor=S.+E.+Hubbsauthor=J.+M.+Scottauthor=R.+W.+Scott&title=Asymmetric+synthesis+of+the+cholesteryl+ester+transfer+protein+inhibitor+torcetrapib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of the Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib</span></div><div class="casAuthors">Damon, David B.; Dugger, Robert W.; Hubbs, Stephen E.; Scott, Jill M.; Scott, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">472-480</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported their efforts used to synthesize kilogram quantities of cholesteryl ester transfer protein (CETP) inhibitor, torcetrapib (I), via a mid-stage resoln.  This account describes the research conducted to develop an asym. route to I.  The first asym. center is established via coupling of (R)-3-aminopentanenitrile to 1-chloro-4-trifluoromethylbenzene.  The resulting nitrile II is converted to amide III (R = H), which is reacted with ClCO2Me to afford ester III (R = CO2Me).  This ester undergoes diastereoselective cyclization to an immonium ion to provide tetrahydroquinoline core of I.  This approach permitted a streamlined synthesis of I.  Development of the process and synthetic rationale are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMdzJ1UrCm1LVg90H21EOLACvtfcHk0lh80UWDe4SniA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlOit78%253D&md5=be8a7c3c6343c9c5f03942ceed6204f9</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fop060013i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop060013i%26sid%3Dliteratum%253Aachs%26aulast%3DDamon%26aufirst%3DD.%2BB.%26aulast%3DDugger%26aufirst%3DR.%2BW.%26aulast%3DHubbs%26aufirst%3DS.%2BE.%26aulast%3DScott%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DR.%2BW.%26atitle%3DAsymmetric%2520synthesis%2520of%2520the%2520cholesteryl%2520ester%2520transfer%2520protein%2520inhibitor%2520torcetrapib%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26spage%3D472%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3uvw" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3uvw','PDB','3uvw'); return false;">PDB: 3uvw</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p5o" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3p5o','PDB','3p5o'); return false;">PDB: 3p5o</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zyu" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3zyu','PDB','3zyu'); return false;">PDB: 3zyu</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyf" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyf','PDB','4uyf'); return false;">PDB: 4uyf</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyg" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyg','PDB','4uyg'); return false;">PDB: 4uyg</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyh" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyh','PDB','4uyh'); return false;">PDB: 4uyh</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i107"><a href="/doi/suppl/10.1021/jm5010539">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20632"></div></div></div></div></div><hr /></hr><p class="last">Methods, bromodomain selectivity profile of <b>47</b>, BET binding curves of <b>47</b> by SPR, X-ray ligand density maps, NMR spectra, tables showing mean, standard deviation and number of test occasions, thermal melting results for <b>47</b>, receptor, transporter, and ion channel cross-screening of <b>47</b>, X-ray data collection and refinement statistics. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5010539/suppl_file/jm5010539_si_001.pdf">jm5010539_si_001.pdf (1.19 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The X-ray coordinates have been deposited with the Protein Data Bank. The codes are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyf">4uyf</a> (BRD2 N-terminal bromodomain with <b>47</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyg">4uyg</a> (BRD2 C-terminal bromodomain with <b>47</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4uyh">4uyh</a> (BRD2 N-terminal bromodomain with <b>28</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5010539&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm5010539%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5010539" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bc4648901995","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
